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Abstract
Abstract
A quarter of all fatalities in the world today is attributed to cancer-related illness. 
Despite a wide range of anti-cancer drugs being developed over the last sixty years or 
more, conventional chemotherapies still suffer from major drawbacks, including 
ineffectiveness and severe side effects, due to a lack of specificity. The emerging field 
of nanomedicine provides a whole range of materials and techniques for the 
development of customizable dmg delivery vehicles, which can assist the targeting of 
therapeutic agents to the desired location in the body and thus help to overcome some of 
the issues. Amongst these, carbon nanotubes (CNTs) have emerged as promising 
candidates, as they are capable of penetrating mammalian cell membranes and allow for 
the attachment of high loads of drugs and targeting agents.
This thesis investigates the potential of CNTs as a multimodal, targeted delivery system 
for the anti-cancer drugs doxorubicin and mitoxantrone. To introduce selectivity, a 
monoclonal antibody and folic acid were tested as active targeting agents. It was first 
shown that the drug delivery system is effectively taken up by cancer cells with 
subsequent intracellular release of the anti-cancer drug, which then translocates to the 
nucleus, while the nanotubes remain in the cytoplasm. Next, it was demonstrated that 
the efficacy of delivery is influenced by the dispersion stability of the functionalized, 
drug-loaded CNTs, which in turn is controlled by a large number of physical and 
biological parameters. To optimize the dispersion stability, different surface 
functionalization schemes were tested and it was found that covalent conjugation of 
amine-terminated PEG rendered stable CNT dispersions in various media and also 
reduced deleterious effects on cultured cells. Based on this knowledge, the initially 
developed drug delivery system was improved and it was shown in an in vitro cancer 
cell line model that the efficacy of the improved system exceeds that of the free drugs at 
low drug doses. The attachment of folic acid to the nanotubes, a widely-used active 
targeting approach, further enhanced the efficacy of the system.
Overall, this allows for the administration of lower drug doses and leads to improved 
safety due to reduced drug-related side effects.
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Chapter 1__________  Introduction
1 Introduction
The aim of this thesis was to develop a targeted delivery system for anti-cancer drugs 
using carbon nanotubes (CNTs) as delivery vectors. CNTs are one of the most striking 
discoveries in the quest for new materials in recent years, as they possess tremendous 
strength, an extreme aspect ratio, and excellent thermal and electrical conductivity 
among their properties. Apart from that, they have a huge potential for biomedical 
applications, as they can immobilize therapeutic molecules, such as proteins, antibodies, 
DNA, or drugs, and are capable of penetrating mammalian cell membranes, which 
makes them ideal candidates for dmg delivery systems.
Compared to other delivery vectors, CNTs offer several advantages, such as 
exceptionally high dmg loading due to their high surface area. Furthermore, payloads 
can not only be attached to the surface, but can also be incorporated into their inner 
cavity, which may provide a protective environment for dmgs of poor stability, thus 
affording diameter-dependent, controlled dmg release. Last but not least, recent studies 
have indicated the possibility for direct cytoplasmic delivery of dmgs mediated by 
CNTs due to their ability to pierce through cellular membranes, which could help 
avoiding the degradative lysosomal pathways that many other nanocarriers fail to 
circumvent.
However, despite the initial optimism regarding their use, CNTs show some inherent 
problems as dmg carriers. First and foremost, they are completely insoluble in water, 
which hinders their incorporation into physiological systems. Second, CNTs (in their 
entirity) are non-biodegradable, which means that they would persist in the body if 
failed to be eliminated or dissociated by the organism after administration. Third, 
although fully consisting of the non-hazardous element carbon, they may give rise to a 
toxicity risk due to their shape and high aspect ratio when found in large dimensions. 
Last but not least, most synthesis techniques produce fairly inhomogeneous bulk 
materials consisting of nanotubes of various different diameters, lengths, chiralities, and 
impurity contents, which complicates the understanding of their interaction with 
biological systems to a considerable extent.
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This thesis investigates the potential of CNTs as a multimodal, targeted delivery system 
for the anti-cancer drugs doxorubicin and mitoxantrone. Chapter 2 provides background 
information on CNTs as a material, including their synthesis, characterization, 
functionalization, interaction with mammalian cells, and toxicology. Subsequently, the 
literature on the application of nanotubes as a drug delivery system for the treatment of 
malignant diseases is reviewed. Chapter 3 then provides details of all materials and 
methods used in this thesis and discusses the background and value of certain 
techniques where necessary.
In Chapter 4, the first results chapter, a CNT-based, targeted dmg delivery system was 
developed by loading oxidised, single-walled carbon nanotubes (oxSWNTs) with the 
anticancer-dmg doxombicin. The system was then tagged with cancer-specific 
monoclonal antibodies to serve as targeting agents for a colon cancer cell line model. 
Furthermore, the system was labeled with a fluorescent dye to allow for the 
visualization of cellular uptake and its intracellular distribution via confocal 
fluorescence microscopy. The experiments showed that the dmg was delivered into 
mammalian cells by the developed CNT-based delivery system, where it detached from 
its carrier and translocated to the nucleus. However, the system exhibited poor 
therapeutic efficacy in cell viability assays, possibly due to its tendency to aggregate in 
biological environments. Thus, Chapter 5 was aimed at optimising the dispersability of 
functionalized CNTs in chemical and biological environments by investigating the 
stability of CNT dispersions. The dépendance of the nanotubes’ properties, such as 
length, diameter, and surface functionalization, will be discussed in the light of the 
dispersion efficacy in changing environments.
Based on the obtained results, an improved dmg delivery system was developed in 
Chapter 6 and its potency and efficacy tested in cell viability assays with a particular 
focus on increasing its selectivity by an appropriate targeting scheme. The data obtained 
shows routes by which to optimise the delivery of two anti-cancer dmgs, doxombicin 
and mitoxantrone, with enhanced therapeutic efficacy compared to the free dmgs after a 
72-hour incubation period with HeLa cervival carcinoma cells, and cancer-specificity 
owing to the incorporated targeting agent folic acid.
Finally, Chapter 7 concludes the thesis with a summary of the key achievements, a 
critical assessment of the suitability of CNTs for dmg delivery, and a look at possible 
future research strands.
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2 Literature review
The first part of this chapter introduces CNTs from a materials perspective, including 
their synthesis, characterization, purification, functionalization, and interaction with 
biological systems. The second part focuses on the disease “cancer” and highlights its 
characteristics, as well as the shortcomings of conventional cancer chemotherapies. The 
third and last part finally discusses the application of CNTs as a delivery platform for 
anti-cancer drugs and reviews the current state of research.
2.1 Carbon nanotubes -  A versatile material
CNTs, first described in 1952 by Radushkevich and Lukyanovich,^^^ are unique one­
dimensional nanostructures with fascinating chemical and physical properties, such as 
tremendous strength, high thermal conductivity and unique electronic properties. 
Indeed, they can be considered as prototypes for one-dimensional quantum w i r e s . I n  
the last ten years, CNTs have gained increasing interest in the biomedical field, not only 
as a platform for biosensors, but also as a new class of transport system, as they are 
capable of penetrating mammalian cell membranes and can immobilize biological or 
biomedical molecules on their surface or in their hollow cavities. However, biological 
applications of CNTs were limited for a long time due to the nanotubes’ chemical 
inertness and aqueous insolubility. In the last decades, these issues have been researched 
intensively and many functionalization methods have been developed to overcome these 
shortcomings.
The following subsection will focus on the synthesis, characterization, purification, and 
functionalization of CNTs, followed by a discussion on their interactions with 
biological systems and potential toxicity.
2.1.1 Definition & synthesis of carbon nanotubes
CNTs are an allotrope of carbon, like diamond, graphite, or fullerenes, whose unique 
one-dimensional nanostmcture confers interesting physical properties. Although
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Radushkevich and co-workers reported CNT-like structures as early as 1952,^ ’^^  ^ it was 
not until the observation of multi-walled carbon nanotubes (MWNTs) by lijima in 1991 
by means of high-resolution transmission electron microscopy ( HR- T EM) t ha t  the 
CNT field was seriously launched. Structurally, CNTs can be regarded as segments of 
graphene sheets, which have been rolled up to form seamless cylinders. Depending on 
the angle at which a sheet is rolled up (i.e. the nanotube’s chirality), the electrical and 
optical properties change drastically. Especially notable is the fact that CNTs can be 
metallic or semiconducting depending on their diameter and helicity.^^  ^ Eurthermore, 
CNTs can be made of more than one sheet of graphene (Figure 2-1). In contrast to 
single-walled carbon nanotubes (SWNTs), which are formed of a single sheet of 
graphene and were first described in the literature by lijima in 1993,^ ^^  MWNTs are 
assemblies of several, coaxially aligned concentric tubes.
Figure 2-1 Transmission electron m icroscopy (TEM) im ages and schem atic drawings o f  single-, double-, 
and MWNTs. The nanotube coordinates were created  with the “Nanotube coordinate genera tor” by Dr.
Shigeo Maruyama, University o f  Tokyo.
In the last fifteen years, CNT research has expanded very rapidly. In the beginning, their 
extraordinary mechanical and electrical properties attracted the most a t t e n t i o n : t h e  
stiffness of CNTs measured in terms of its Young’s modulus (ratio of stress over strain)
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can be as high as 1 TPa, which makes them 5 times stiffer than steel, and their tensile 
strength or breaking strain can reach values of 63 GPa, which is around 50 times higher 
than steel/^^^ However, since this early stage, the range of possible applications has 
greatly expanded and CNTs can be regarded as one of the most versatile materials 
existing at present. CNTs are currently being studied for various applications, including 
field emission,^^^’^ ^^  molecular electronics,^^^’^ "^  ^ solar cells and energy storage,^^^’^ ^^ 
scanning probe microscopy,^^^’^ ^^  and s e n s i n g ^ t o  name only a few. Closer to the 
focus of this thesis, CNTs are also a subject of huge interest in the biomedical field.
24]
CNTs have originally been obtained in the soot of an arc discharge reactor. Since 
then, much research has been carried out on their synthesis and various techniques have 
emerged that are able to produce different types of nanotubes, depending on the desired 
a pp l i ca t i on . In  most cases, a catalyst is required to induce or modify growth, often 
composed of transition metals, such as iron, cobalt, or nickel, which has a strong 
influence on the toxicological profile of the obtained nanotube material. The following 
paragraph will briefly elaborate on the two main types of CNT synthesis techniques, 
which are based on physical vapour deposition (PVD) or chemical vapour deposition 
(CVD).'^ ’'
PVD techniques rely on the condensation of carbon evaporated at high temperatures 
(typically 3000 - 4000 °C) from a solid carbon source using arc discharge or laser 
ablation. The obtained nanotubes are in the form of a powder and exhibit a broad length 
and diameter distribution, depending on the experimental conditions and the catalyst 
used. Common impurities obtained alongside CNTs are carbonaceous, including 
fullerenes, amorphous carbon, and graphite sheets/onions. It is noteworthy that the 
synthesis of MWNTs by the arc discharge technique does not require a catalyst.
CYD techniques are based on the decomposition of a carbon source - either over a 
heated substrate, on which the catalyst can be deposited or even patterned, or in a 
thermal reactor, in which unsupported catalyst particles are created in situ. The process 
can be purely thermal or plasma-assisted and the applied temperatures are much lower 
compared to arc discharge or laser ablation; e. g. typically lower than 1200 °C. The 
diameter and length of the tubes can be controlled by tuning the composition and size of 
the catalyst particles and the synthesis time. This method is especially useful to obtain 
arrays of vertically-aligned nanotubes for applications in electronics or sensing. The
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main impurities in CVD-derived CNTs are metallic catalyst nanoparticles attached to 
the tube, which it has grown from, next to graphitic nanostructures and amorphous 
carbon. A major disadvantage of this method is that the obtained nanotubes can be 
highly defective.
2.1.2 Characterization of carbon nanotubes
Although the general structure of CNTs is relatively simple, the material itself can vary 
tremendously, depending on the synthesis technique. Furthermore, different types of 
purification treatments may alter the composition of the initial material. Thus, when 
working with CNTs, it is crucial to analyze their characteristics, such as diameter and 
length distribution, dispersion state, defect density, and impurities.
The main characterization techniques of interest can be divided into microscopic 
techniques, spectroscopic techniques, and thermogravimetric techniques. Microscopic 
techniques are the only tools that allow for the direct observation of the morphology and 
dimensions of CNTs in a bulk sample. Scanning electron microscopy (SEM) has 
traditionally been one of the most popular tools for the characterization of CNTs, as it 
provides a general idea of the morphology and purity of a CNT sample in connection 
with simple and straightforward sample preparation. TEM, on the other hand, requires 
the laborious preparation of thin, solid specimen (< 200 nm), but affords very detailed 
information about a CNT sample, such as the number of walls, length, diameter, filling 
state, and even c h i r a l i t y . A  major drawback of both techniques is the fact that the 
image frame visualizes less than 1 picogram of material, which makes it impossible to 
achieve a quantitative and statistically significant assessment of the quality of CNT 
material in a reasonable amount of time.^ ^^  ^ The third listed microscopic technique is 
atomic force microscopy. In fact, the term “microscopy” is not quite correct for this 
technique, as atomic force microscopes do not use light, as in conventional 
microscopes, but scan a sharp probe over a surface and thus create three-dimensional 
surface profiles rather than two-dimensional projections. Moreover, most AFM modes 
can work in ambient air or even liquid environments, which allows for the imaging of 
biological macromolecules and living organisms. With respect to the characterization of 
CNTs, AFM is mainly used to obtain information about height and length distributions, 
as well as surface coatings.
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Moving on to the spectroscopic methods, the major techniques for characterizing CNTs 
are UV/vis/NIR absorption spectroscopy and Raman spectroscopy. In UV/vis/NIR 
absorption spectroscopy, the intensity of a beam of light is compared before and after 
interaction with a sample. This provides information about the concentration of a 
sample solution, since according to Beer Lambert’s Law, absorbance and concentration 
are directly proportional. Furthermore, the vis/NIR part of a CNT spectrum (600 to 
2500 nm) exhibits characteristic absorption features due to the so-called “van-Hove 
singularities”, which originate from the one-dimensional nature of the nanotubes, 
inducing quantization of the density of s t a t e s . A c c o r d i n g  to Itkis et al., the intensity 
of these characteristic features compared to the featureless baseline provides a measure 
of the purity of the CNT material. However, these discrete absorption bands can only 
be observed for good dispersions and non-oxidized CNTs, since strong acid treatment 
impairs their electronic p r o p e r t i e s . R a m a n  spectroscopy is another extremely 
powerful tool for the characterization of SWNTs, providing detailed information on the 
diameter distribution, electronic structure, chirality, and purity of a CNT s a m p l e . I t  is 
usually referred to as ‘resonant Raman spectroscopy’, since the strength of the obtained 
signal is greatly enhanced when the excitation wavelength of the laser is in resonance 
with the energy differences between the van-Hove singularities. The major 
characteristic bands found in a Raman spectrum of SWNTs are the “radial breathing 
mode” (RBM), the D-band and the G-band. The RBM results from low-energy radial 
vibrations of carbon atoms in the nanotube backbone and its frequency is inversely 
proportional to the tube d i a m e t e r . T h e  disorder-induced D-band is indicative of 
broken symmetry in the sp^-hybridized rings and the G-band is a tangential vibrational 
mode characteristic for all graphitic materials. The intensity ratio of D-band to G-band 
is often used to estimate the defect density of CNTs.^^^  ^The drawback of this resonance- 
based method is that a wide range of excitation wavelengths is required in order to 
obtain a full picture of a nanotube sample, which usually consists of a variety of tubes 
with different diameters and chiralities.
The last one of the characterization techniques presented in the framework of this 
chapter is thermo gravimetric analysis (TGA). TGA determines changes in the weight of 
a sample when heated under a controlled atmosphere and records them as a weight-loss 
curve. The weight change that occurs when a CNT sample is burned under an oxidative 
atmosphere is a superposition of the weight loss due to oxidation of carbon into gaseous 
carbon dioxide and the weight gain due to oxidation of the residual metal catalyst. The
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relative amount of the different fractions of carbonaceous impurities in as-prepared 
CNTs can be identified if their combustion temperatures are well separated. Amorphous 
carbon, for example, bums in air at a lower temperature than graphitic c a r b o n . A  
sample containing a high quantity of carbonaceous impurities would thus cause a 
noticeable weight loss below 400 °C, followed by a second weight loss at higher 
tem peratures.N evertheless, TGA is still primarily used for the determination of the 
amount of residual metal catalyst in CNT samples.
In summary, it is important to underline that even though each of the discussed 
characterization techniques is very useful for determining certain characteristics of CNT 
bulk samples, they all have limitations in the data produced and the conclusions that can 
be drawn. Hence, no single technique can give a complete description of a CNT sample 
-  on the contrary, due to the complexity of CNT samples the whole range of techniques 
is usually needed in order to get a satisfactory idea of the investigated material.
2.1.3 Purification of carbon nanotubes
As-prepared CNTs usually contain a range of impurities originating from the synthesis 
process, which can be divided into carbonaceous impurities and metallic impurities. 
These impurities can interfere with the desired properties of the nanotubes, whether for 
fundamental science or industrial use. Thus, many purification techniques have been 
developed in order to improve the quality of the raw CNT m a t e r i a l . M o s t  are based 
on oxidative processes and can be carried out in liquid phase (acid oxidation) or gas 
phase.
Acid oxidation describes the treatment of CNTs with strong acids or acid mixtures, 
which gasify amorphous carbon and oxidize metallic catalyst particles, as long as these 
are not encapsulated by carbon shells. This process is known to reduce the length of the 
nanotubes and to introduce carboxylic groups; primarily to the tips and defective sites 
along the sidewalls, as these spots feature increased chemical r e a c t i v i t y . T h e  
introduction of carboxylic groups by acid oxidation not only opens up the whole field of 
functionalizing CNTs by means of organic chemistry, but also renders the nanotubes 
soluble in water and other hydrophilic solvents. However, the generation of new defects 
impairs the electronic properties of the nanotubes. Furthermore, acid oxidation 
generates so-called “oxidation debris” by breaking up CNTs during oxidation^ "^ ^  ^ or 
oxidising carbonaceous, non-tubular stmctures present in pristine CNT s a m p l e s . T h i s
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debris has been shown to consist of partially oxidized polyaromatic f r a g m e n t s w h i c h  
tend to attach to the CNT surface by 7 t-stacking and thereby increase the stability of 
CNT dispersions by acting as a sur factant .Though mostly advantageous, this can be 
a pitfall for effective covalent functionalization of CNTs, if the latter occurs at the level 
of the debris and not the actual CNT surface. Washing with 0.01 M NaOH upon acid 
oxidation has been reported to remove oxidation debris by converting the acidic groups 
of the debris into their conjugate salts, which ultimately leads to the dissolution of 
debris due to enhanced aqueous solubility. In summary, acid oxidation is 
considered to be a very effective, but harsh purification method for CNTs, which can 
sometimes result in the loss of 90% of the initial material.
10 nm
Figure 2-2 M etallic catalyst particles encapsulated in graphite onions (own image)
Gas oxidation makes use of the fact that CNTs are less sensitive to oxidation than other 
carbon species produced in the synthesis process, which can thus be removed in 
preference to nanotubes. This method is primarily applied to remove carbonaceous 
impurities and to expose metallic catalyst particles encapsulated in graphite onions 
(Figure 2-2). However, gas oxidation does not remove metallic impurities. This can 
cause problems, because metal particles could catalyze oxidation of the nanotubes at
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low temperatures in the presence of oxidizing g a s e s , w h i c h  eventually leads to their 
destruction. It has been proven beneficial to apply a combination of acid oxidation and 
heat treatments, which can effectively remove both impurity species. Unwanted 
functionalities and defects on the nanotubes generated during the purification process 
can subsequently be removed by vacuum annealing, which restores the graphitic 
structure of the nanotubes.
Besides these commonly used purification methods, an entirely different technique has 
been developed in our group by Jeynes et al..^ ^^  ^ Therein, CNTs are solubilized by 
wrapping with RNA, an interaction based on Tt-stacking. Centrifugation then allows for 
separation of the RNA-wrapped CNTs from the impurities and in the final step, the 
RNA-wrapping is removed by the enzyme RNAse to yield unmodified, highly pure 
SWNTs.
2.1.4 Functionalization of carbon nano tubes for biomedical
applications
In order to apply CNTs for biomedical purposes, two major technical barriers have to be 
overcome: their insolubility in water and their chemical inertness. In this context, many 
functionalization schemes have been developed to facilitate their integration into 
biological and physiological environments and the attachment of payloads. Beyond that 
it has been reported that functionalization also improves the biocompatibility of CNTs 
in vitro and in vivoP^^ This indicates that the applied functionalization chemistry has a 
strong influence on the fate of the nanocarrier and its payload upon administration to 
biological systems, which will be discussed in the following subsections.
Rendering carbon nanotubes soluble in water and physiological environments
Functionalization techniques developed to render CNTs water-soluble can be divided 
into non-covalent and covalent approaches. In non-covalent functionalization 
techniques, CNTs are usually wrapped or covered with molecules acting as surfactants. 
A plethora of molecules have been investigated for this purpose, including 
conventional, low molecular weight-surfactants,^^^’^ '^  ^ (poly-) peptides,^^^  ^ proteins, 
nucleic acids,^ ^^  ^ bile salts,^ ^^  ^ polymers,PEG-composites,^^^^ and many more. The 
lipophilic parts of these molecules attach to the sidewalls of nanotubes via hydrophobic
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interactions or 7C-stacking, whereas the hydrophilic parts stick out into the solution and 
provide aqueous solubility. An interesting approach is the wrapping of CNTs with 
single-stranded DNA or RNA, as this also increases the biocompatibility of the 
nanotubes and enables them to interact with living tissue.^^^’^ ’^^ ^^  The advantage of non- 
co valent functionalization schemes lies in the preservation of the nanotubes’ intrinsic 
sp  ^ structure, which determines their electronic characteristics. However, non-covalent 
binding is susceptible to environmental factors, such as pH and salt concentration, and 
is mostly less stable than covalent binding.
Covalent functionalization chemistry, on the other hand, provides stronger bonds by 
introducing chemically reactive groups to the relatively inert sp  ^ structure of the 
n a n o t u b e s . T h i s  methodology requires rather harsh treatments, such as oxidation 
with concentrated inorganic acids,^ "^*^  fluorination by elemental fluorine^^^  ^ or a 1,3 
dipolar cycloaddition reaction^^^  ^ and inevitably introduces defects to the nanotube 
structure. The main technique used in this thesis is acid oxidation, which introduces 
carboxylie and other oxygen-containing groups to the CNT surface, thus enabling 
covalent attachment of functional molecules, while at the same time rendering the 
nanotubes soluble in water. The acid oxidation protocol has to be adjusted for every 
nanotube sample of a different origin with respect to acid concentration, time and 
temperature, as those samples with a high initial rate of defects and those containing 
tubes with small diameters are more sensitive to oxidation and thus are destroyed more 
e a s i l y . L i  et al. have compared different acid oxidation methods for SWNTs with 
respect to purity and found that pre-sonication in diluted nitric acid, followed by 
refluxing in a 3:1 mixture of concentrated sulphuric and nitric acid yielded the best 
results.
Attaching payloads
Anti-cancer drugs, targeting agents and imaging agents are the main payloads of interest 
for drug delivery applications. The applied chemistry for their attachment to CNTs 
plays a crucial role for the therapeutic success of the drug delivery system and the fate 
of the different components upon administration. Regarding targeting and imaging 
agents, it is desirable to link them to their carrier in a stable manner, which is usually 
accomplished via covalent bonds and allows them to remain connected with their carrier 
from administration to elimination. A widely used approach, also frequently employed
11
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in this thesis, includes the reaction of the introduced carboxylie groups on the CNT 
surface with amino groups of biomolecules, facilitated by EDC/NHS chemistry. 
Because the carboxylie groups of oxidized nanotubes are not reactive enough to 
undergo spontaneous reactions with amino groups, they are first converted into amine- 
reactive esters using N-hydroxysulfosuccinimide (sulfo-NHS) and 1-Ethyl-3-[3- 
dimethylaminopropyl] carbodiimide hydrochloride (EDC).^^^’^®^ Both sulfo-NHS and 
EDC are soluble in water and thus allow for performing coupling reactions in 
physiological environments. Another slightly more time-consuming method involves 
the transformation of the carboxylie acid moieties into the respective acyl chlorides by 
means of thionyl chloride, which, same as NHS-esters, are significantly more reactive 
towards a m i n e s . A p a r t  from covalent functionalization approaches based on 
oxidation of CNTs, other options exist, which often employ organic reactions or radical 
r eac t i ons . Wi t h i n  the different types of organic reactions, Georgakilas et al. have 
developed the 1,3-dipolar cycloaddition reaction of azomethine ylides, which creates 
pyrrolidine rings distributed along the nanotubes’ sidewalls and tips.^ "^^  ^This method has 
been successfully applied for the attachment of peptides, fluorescent markers and 
different types of drugs to CNTs^ ^^  ^ and even permits the design of double 
functionalized CNTs.^^ ^^
The core part of the system -  for example, an anti-caneer drug -  however, needs to be 
transported safely to the target site by the nanocarrier, but then released in order to exert 
its cytotoxic action. This can for example be achieved by attaching the drug to its carrier 
via a covalent bond cleavable at intracellular conditions. Prominent examples are 
disulfide bonds, which break up in the reductive environment of the c y t o p l a s m , o r  
hydrazone bonds, which are susceptible to a drop in pH, as encountered in the acidic 
microenvironment of tumors and subcellular compartments, such as lysosomes. Another 
option are bonds, which can be cleaved by physiological enzymes, such as carbamate or 
ester b o n d s . A  different strategy is to attach the drug to its carrier in a non-covalent 
manner. This can be achieved by electrostatic interactions, hydrophilic interactions, 
hydrogen bonding, or Ti-staeking. The latter is a widely-used mechanism in association 
with CNTs, as it relies on aromatic structures with ji-conjugated systems molecules, 
which interact by intermolecular overlapping of p-orbitals. The stacking forces become 
stronger, as the number of ji-electrons increases. Generally, 7C-7i-interactions are 
prominent if they involve molecules that are uncharged and flat, as is the case for 
pristine CNTs of larger d i a m e t e r s . I n  the case of drug molecules as potential
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candidates for 7t-stacking, however, the aromatic rings of their respective Ji-conjugated 
systems are often substituted with functional groups comprising heteroatoms, such as 
oxygen or nitrogen. This makes the situation slightly more complicated: substitution 
with “electron-poor” functional groups, such as carboxyl and quinone, makes the 
molecule an electron acceptor, whereas substituation with “electron-rich” groups, such 
as hydroxyl or amine, makes it an electron donor. On the one hand, this weakens Tt-TC- 
interactions,^^^  ^ on the other it gives rise to so-called “ti-tt electron donor-acceptor 
interactions” (EDA). Regarding carbon nanotubes, the introduction of carboxylie groups 
would render them electron acceptors -  just like the drug molecules used in this thesis, 
whose quinone groups renders them electron acceptors. This is unfavourable for both n- 
% interactions and EDA. However, it also has to be taken into account that carboxylie 
groups become negatively charged with increasing pH, thus giving rise to electrostatic 
interactions with positively charged functional groups, such as the primary amine group 
of doxorubicin and the two secondary amine groups of mitoxantrone. Moreover, 
hydrogen bonds are likely to form, for example links between the hydroxyl groups of 
doxorubicin or mitoxantrone and the carboxylie groups of oxidized CNTs, similar as 
has been reported for the loading of doxorubicin onto graphene oxide.
Overall, this discussion demonstrates that whilst the sorption of molecules onto pristine 
CNTs may be rather simple, sorption onto oxidized CNTs may involve various 
mechanisms, which are influenced by the local environment, such as pH and salt 
concentration. In some cases, pH-changes can even be employed for targeted drug 
release. A typical example is the non-covalent binding of the anti-cancer drug 
doxorubicin to CNTs via n-% interactions, which was adopted in Chapter 4 and 6 in this 
thesis: At a high pH, the molecule is uncharged, which promotes strong hydrophobic 
interactions with the nanotubes’ sidewalls and causes poor solubility in water. At a low 
pH, however, the molecule becomes charged due to protonation of the amino group in 
its sugar moiety, which increases its hydrophilicity and solubility in water. This 
property can be used in relation to cellular uptake pathways based on endocytosis, as 
first demonstrated by Liu and co-workers, who showed that the slightly acidic 
environment inside endosomes triggered the release of doxorubicin from SWNTs due to 
increased hydrophilicity.
An entirely different approach to functionalization of CNTs with drugs is the filling of 
their inner cavity. This approach allows for the protection of unstable drugs and
13
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controlled drug release at the desired site of action depending on the tube diameter. 
However, although in the recent past CNTs have been filled successfully with a variety 
of molecules, including fullerenes, metals, DNA/RNA and polymeric nanoparticles, 
their filling with therapeutic agents is an approach still in its infancy. Hilder and co­
workers have carried out a great deal of theoretical work on the filling of CNTs with 
drugs. In their first article on this subject, they looked at the suction behaviour of 
cisplatin, a widely-used, platinum-based anti-cancer drug, and concluded that a CNT 
should have a diameter of about 1 nm to entrap cisplatin and take advantage of the 
maximum suction e n e r g y . I n  another publication, they investigated the encapsulation 
of paclitaxel and doxorubicin, two anti-cancer drugs with more complicated molecular 
s t r uc t ur es . I n  these cases, the highest probability of achieving both encapsulation and 
maximum uptake (or suction energy) occurs in the diameter range of about 1.83 -  2.54 
nm for paclitaxel and 1.77 -  2.10 nm for doxorubicin. The filling of carbon nanotubes 
with platinum anti-cancer drugs has thus far been achieved by two groups, both part of 
the Marie Curie research training network CARBIO, which has been the funding source 
for this PhD, and will be discussed later
2.1.5 Interaction of carbon nano tubes with cells: uptake mechanism 
and intracellular distribution
As soon as it became apparent that CNTs were able to transverse cellular membranes, a 
new area for their application was launched: the use of CNTs as intracellular 
transporters. CNTs can immobilize biological or biomedical molecules on their surface 
or in their internal hollow cavity and have therefore been applied in numerous studies to 
transport a broad speetrum of molecules into mammalian cells, including peptides, 
proteins, DNA, immunogenic molecules, and d r u g s . E a r l y  studies have loaded 
CNTs with peptides and proteins as model cargos, whereas more recent work shows a 
trend towards the use of CNTs for targeted gene and drug delivery.
The applieation of CNTs as intracellular transporters requires a good understanding of 
their interaetion with mammalian cells, especially with regard to uptake mechanism, 
intracellular distribution, elimination from cells and possible adverse effects. The first 
study undertaken in this direction, which was also the first to demonstrate the 
translocation of CNTs across cellular membranes, was carried out in 2004 by Pantarotto 
and CO-w o r k e r s . T h e r e i n ,  water-soluble, amino-functionalized SWNTs were
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conjugated to a fluorescent dye via a short organic linker or a peptide. Both conjugates 
were internalized by two different cell lines -  however, the peptide- SWNTs were found 
to accumulate in the nuclei of the cells, whereas the directly-labeled SWNTs distributed 
in the cytoplasm. Since internalization was not affected by temperature or the presence 
of endocytosis inhibitors, the authors claimed the uptake mechanism to be endocytosis- 
independent and hypothesized that the cylindrical shape and high aspect ratio of 
functionalized CNTs promotes their mechanical penetration through the plasma 
membrane. A study carried out shortly afterwards by Kam et al. also demonstrated 
cellular uptake of SWNTs, this time functionalized with a fluorescent dye or a 
fluorescently-labeled p r o t e i n . I n  contrast to the previous study, their results suggested 
an endoeytie uptake mechanism, since no uptake was observed at low temperatures 
inhibiting endocytosis and nanotubes were found to co-loealize with endosomes. 
Furthermore, both types of nanotubes were only observed in the cytoplasm, but not in 
the nucleus.
These two studies started the controversy regarding the internalization mechanism of 
CNTs and their fate inside cells, which has still not been fully resolved. Figure 2-3 
summarizes the results of various uptake studies with regard to the type of 
functionalization used, demonstrating that uptake meehanism and intracellular 
distribution of the applied CNT formulations differ widely from one study to the next. 
This indieates that the interaction of CNTs with mammalian cells very likely depends 
on the physical and chemical properties of the nanotubes, as well as on the cellular 
system being used. Particularly, in the case of non-covalent funetionalization methods, 
possible interaetions of the attached surfactants or biomolecules with plasma proteins in 
cellular growth media might alter the interaction with cells significantly.
Because the uptake mechanism determines the fate of drug or gene-loaded CNT 
conjugates inside cells, it is of utmost importance for delivery applications. In the case 
of an endoeytie uptake pathway, CNT conjugates are initially enclosed inside 
intracellular vesicles, so-called endosomes, which are located in the periphery of the 
cells and have a mildly acidic pH. In the next step of this pathway, fusion with 
lysosomes causes a drop in pH to approximately 5.5 and incorporation of hydrolytic 
enzymes into the vesicles. These conditions can cause degradation of drugs and nucleic 
acids and therefore, the CNT conjugates need to escape the lysosomes in order to 
maintain the efficacy of the therapeutic entity. This is often achieved by pH-dependent 
binding of the cargo to CNTs and will be explained in more detail later.
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Covalent
functionalization
Non-covalent
functionalization
intrinsic
fluorescence
Figure 2-3 Internalization o f  functionalized CNTs into mammalian cells: a) amino- SWNTs covalently 
functionalized with a FITC-labeled peptide in 3T3 human fibroblasts^^^^ b) oxSWNTs covalently  
functionalized with fluorescein in HL 60 leukemia cellJ^^^ c) amino-SWNTs covalently functionalized  
with FITC in HeLa cervical cancer cells^^^  ^d) oxSWNTs non-covalently functionalized with Alexa Fluor- 
labeled streptavidin in the presence o fF M  4-64, a red membrane and endocytotic vesicle marker, in 
HeLa cells^^^  ^e) as-grown SWNTs non-covalently labeled  with fluorescein-PEG  in BT474 breast cancer 
ceiy^^^ f )  as-grown SWNTs non-covalently functionalized with Cy3-DNA in HeLa cells^^^  ^g) intrinsic 
visible fluorescence o f  amino-SWNTs in A549 lung carcinoma cells (cellular membranes stained in red  
with WGA-TRITC and nuclei counterstained in blue with ToPro3^^^^  ^h) intrinsic NIR fluorescence o f  
Rituxan-SWNT conjugates in Raji B-cell lymhoma cellJ'^^^ i) area map o f  the Raman RBM signal o f  
HiPco SWNTs in 3T3 human fibroblasts
The non-endocytotic, needle-like uptake pathway, however, transports the cargo directly 
into the cytoplasm and hence avoids lysosomal degradation. This is a clear advantage 
for delivery applications -  however, the nanotubes might be able to pierce other
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intracellular membranes in a similar way and hence, their fate after delivery of the cargo 
needs to be well understood.
In summary, more work is needed to understand the interaction of CNTs with 
mammalian cells, particularly taking into account the different shapes, surface 
properties, and functionalization schemes of the applied CNTs, and the effect of the 
type of cells used. A recent study by Mu et al. clarified some of these i s s u e s . T h e  
researchers investigated the cellular uptake and fate of MWNTs by TEM and developed 
a model, in which the nanotubes are divided into two classes, clusters and single tubes. 
According to their findings, clusters were taken up by cells through energy-dependent 
endocytotic processes, whereas single nanotubes were found to enter cells though direct 
membrane permeation. A particular interesting finding of this study is that nanotube 
bundles trapped in endosomes released single nanotubes, which thereupon escaped the 
endosomes by penetrating the endosomal membranee and entered the cytoplasm. Most 
nanotubes were shown to eventually end up in lysosomes for excretion. The same study 
furthermore evaluated the effect of surface charge on cell uptake by comparing 
carboxylated (-) with amine-terminated (+) nanotubes. Interestingly, no difference in 
cellular interactions was observed due to heavy protein coating on both types of tubes, 
which led to compensation of the surface charges.
The study indicates that it is indeed possible to control the interactions of nanotubes 
with cells by choosing an appropriate functionalization scheme and ensuring a good 
dispersion stability. These two aspects will also be discussed in the framework of the 
next subsection, which focuses on CNT toxicology and biodistribution, and will in fact 
continue to play an important role throughout the whole thesis.
2.1.6 Toxicology
With CNTs gradually playing a bigger role for bioapplications, it has become apparent 
that these nanostructures may have adverse health effects owing to their small size and 
extreme aspect ratio. Due to the growing public and commercial concern about the 
safety of nanomaterials, the field of nanotoxicology has been developing swiftly in the 
last years. With respect to CNTs, most of the studies undertaken can be divided into 
three areas: their impact on workers involved in their manufacturing and handling, the 
potential harmful effects of therapeutically applied CNTs on the patient, and the toxicity 
issues that arise through the ineorporation of CNTs in commercially available products,
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leading to the aspect of ecotoxicity. This section will attempt to give an overview of the 
recent situation in each of the mentioned areas.
The first area of CNT toxicology involves their impact on workers involved in their 
manufacturing and handling. A superficial resemblance of CNTs and asbestos fibres has 
led to intense investigation of their pulmonary toxicity, since inhalation of asbestos 
fibres is known to induce a chronic inflammatory medical condition of the lungs named 
“asbestosis”, which eventually leads to the formation of malignant mesothelioma. A 
study by Poland and co-workers comparing CNTs with asbestos has gained wide 
attention in the media in the beginning of 2008. Their report described exposure of the 
mésothélial lining of the body cavity of mice (as a surrogate for the mésothélial lining 
of the chest cavity) to long, rigid MWNTs and demonstrated their asbestos-like, length- 
dependent, pathogenic behaviour, which was characterized by inflammation and the 
formation of lesions known as g r anul omas . However ,  from a critical point of view 
one could argue that this study did not follow the natural route of exposure, inhalation, 
but introduced the nanomaterial directly into the body by intraperitoneal injection.
Short or 
tangled 
carbon 
nanotubes
Effective phagocytosis
Clearance
through
lymphatic
system
Long and 
rigid carbon 
nanotubes Tissue damage, 
mutagenesis, 
carcinogenesis
Incomplete phagocytosis
Figure 2-4 Effect o f  CNT structure on phagocytosis: short and entangled nanotuhes are easily engulfed  
by m acrophages fo llow ed  by lymphatic drainage, whereas long end rigid nanotubes cannot be 
phagocytosed and hence accumulate in the tissue, where they prom ote carcinogenesis (adapted from
Nevertheless, the toxicologic paradigm made by the same group, in which a fibre 
thinner than 3 pm, longer than 20 pm and biopersistent in the lungs can be hazardous.
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should be taken seriouslyJ^®^  ^This paradigm is based on the circumstance that long and 
rigid nanofibres cannot be engulfed by macrophages in contrast to short or entangled 
fibres (see Figure 2-4), which leads to their accumulation in the tissue and promotes 
inflammatory, mutagenic and eventually carcinogenic e f f e c t s A  more natural and 
likely route of exposure has been followed in a study by Shvedova and co-workers, 
who prepared stable and uniform CNT dispersions by a newly developed aerosolization 
technique. C57BL/6 mice were exposed to aerosolized CNTs in a whole body inhalation 
chamber for 5 h per day on 4 consecutive days and were found to develop inflammatory 
responses, oxidative stress, collagen deposition, fibrosis, and mutations of the K-ras 
gene in their lungs. In another study, Mutlu et al. have addressed the question, whether 
pulmonary toxicity is due to the high aspect ratio of CNTs or rather their tendency to 
form toxic a g g r e g a t e s . T h e y  found that nanoseale dispersed were taken up by 
macrophages after intratracheal administration to mice and gradually cleared from the 
body over time, whereas aggregated SWNTs induced granuloma-like structures and 
mild fibrosis in the large airways. Overall, the findings of these studies indicate that 
CNTs can pose an occupational hazard and hence, strict safety precautions should be 
taken by workers to avoid inhalation.
The second area of CNT toxicology, namely potential adverse effects on patients 
subjected to them as part of a therapeutic formulation, arises from the unique chemical 
and physical properties they possess in comparison with other pharmaceutical agents 
and e xc i p i en t s . Whi l e  short-term effects like cytotoxicity are already widely studied, 
data regarding long-term effects, such as mutagenicity and carcinogenicity, are searse, 
since CNTs have only been actively investigated for therapeutic purposes for about a 
decade. According to various studies, the toxicity of CNTs in the human body seems to 
depend on a large number of parameters, such as their structure, length, aspect ratio, 
degree of aggregation, extent of oxidation, surface topology, bound functional groups, 
and speetrum of present impurities, as well as the concentration and dose cells or 
organisms are exposed to.^ ^^ ^^  Furthermore, the route of exposure plays a major role, as 
it determines the types of tissues that first come into contact with the nanotubes. 
Therapeutic CNTs are mostly introduced into the body via local or systemic injection. 
In the first case, the nanotubes get directly into contact with the target tissue and are 
taken up by cells before entering the bloodstream. To examine this scenario, several in 
vitro studies have been carried out in order to investigate the effect of CNT exposure on 
mammalian cells. In many cases (though not all), CNTs and aggregates did not show
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any immediate cytotoxicity/^ ^ b u t  were sometimes found to cause accelerated 
oxidative stress, affect cell proliferation, provoke inflammatory reactions, induce 
morphological alterations to the cellular structure, and damage mitochondria/^
These effects must not be underestimated, as they might result in more severe long-term 
toxic effects. On the other hand they strongly depend on the dimension of the nanotubes 
(aspect ratio/surface area), their agglomeration state and behaviour and the type of 
funct ional i zat i on.^^Recent  studies even indicate that oxCNTs can be degraded by 
certain cells of the immune system, e.g. neutrophils and maerophages,^^^^’^ ^^  ^ although 
CNTs are generally considered as a non-biodegradable material. In summary, most of 
the experimental results lack comparability and the findings of many are even 
contradictory, since different types of nanotubes with different amounts and kinds of 
impurities, different cell lines, different preparation procedures and different detection 
methods were used.
The ease of systemic injection of CNTs for therapeutic purposes is an entirely different 
scenario. Here, the first aspect to consider is the interaction of CNTs with blood 
components (plasma proteins, blood cells, and platelets) and their recognition by the 
immune system. A study by Meng et al. in 2005 has investigated the effect of SWNTs 
on plasma proteins and found that fibrinogen readily adsorbed to the nanotube surface, 
whereas albumin and platelets did not adhere.^^^^  ^ These results were confirmed by 
Salvador-Morales and eo-workers (2006), who explored protein adsorption and 
complement activation by purified, non-functionalized CNTs.^ ^^ '^  ^ The binding of 
proteins to CNTs was shown to be highly selective, since out of many plasma proteins 
only few adsorbed to the nanotubes in a large quantity, including fibrinogen and 
apolipoproteins. The study further revealed that double-walled CNTs (DWNTs) activate 
the human complement system via both the classical and the alternative pathway, 
whereas SWNTs only activated the classical pathway. The activation of the complement 
system via the classical pathway usually leads to the generation of inflammatory 
peptides and might further induce the coating of the nanotubes by opsonins, the 
accumulation of neutrophils, and the adherence of phagocytic cells. If the nanotubes are 
too large to be phagocytosed (see Figure 2-4), this might cause tissue damage and 
granuloma formation. However, the researchers hypothesize that the activation of the 
human complement system by CNTs might be diminished or eliminated by alteration of 
the surface chemistry by funetionalization.
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One of the first systematic in vivo toxicity evaluation of functionalized SWNTs 
following intravenous injection has been carried out by Schipper et al/^ ^^  ^ They 
examined the aeute and chronie toxicity of functionalized SWNTs when injected into 
the bloodstream of mice and found that single administrations of high doses did not lead 
to aeute or chronic toxicity, although the PEG-fiinetionalized SWNTs persisted in liver 
and spleen macrophages for 4 months. However, the reseaehers acknowledge that due to 
the small number of animals the study must be considered as a pilot study, since small 
differences between the treatment groups could not be detected with this experimental 
design. A similar study carried out by Wang and co-workers tried to provide a general 
toxicologieal profile by focusing on the toxicity of SWNTs to main o r g a n s . T h e  
nanotubes remained in mice for 3 months after intravenous exposure and although 
serum and pulmonary inflammation were observed, no obvious cell apoptosis 
(programmed cell death) or changes in immunological indicators occurred. The authors 
propose the main toxicologieal mechanism to be oxidative stress in liver and lungs. A 
differently-designed in vivo study investigating the impact of CNTs on living organisms 
has been carried out by Leeuw and eo-worker s . There i n,  drosophila (fruit fly) larvae 
were raised on food containing 10 ppm of disaggregated SWNTs. Nanotubes were 
imaged in intact living larvae and dissected tissue specimen by NIR fluorescence 
spectroscopy. The study showed no short-term toxicity, impaired growth, or impaired 
fertility in mature individuals that have been fed dispersed CNTs.
Long-term toxicity aspects, such as mutagenicity and carcinogenicity of systemically 
introduced CNTs, have so far only been investigated in very preliminary studies, but 
will have to be assessed very carefully before taking CNT-based therapeutic systems to 
the stage of clinical trials.
The third category of CNT toxicology deals with environmental aspects and is so far the 
least investigated one. Considering that disposed CNT waste might lead to their ultimate 
release in the ground water, some studies have explored their impact on the aquatic 
environment. For example, Mouehet and colleagues examined the eeotoxieological 
potential of CNTs in amphibian larvae at a wide range of concentrations in water by 
analyzing the toxicity and genotoxicity of DWNTs in Xenopus laevis larvae after 12 
days of static exposure under laboratory c o n d i t i o n s . T h e  results showed no 
genotoxicity in erythrocytes of the larvae exposed to DWNTs in water, but an acute 
toxicity at very high nanotube concentrations related to physical blockage of the gills 
and/or the digestive tract. In a similar study carried out by Smith and co-workers,
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rainbow trouts were exposed to SWNTs dispersed in water with the help of a surfactant 
for 10 days/^^^  ^ Nanotube exposure was shown to cause a dose-dependent rise in 
ventilation rate, gill pathology, and mucus secretion, with CNT precipitates on the gill 
mucus. No major haematological disturbances were observed; however, subtle cellular 
pathologies raised concern about cell cycle defects, neurotoxicity, and other yet 
unidentified factors that may mediate systemic pathologies. The last study to be 
mentioned in the scope of ecotoxicity exposed zebrafish embryos to dispersed SWNTs 
and DWNTs, which resulted in a hatching delay at higher nanotube concentrations.
The researchers assume that this effect was most likely induced by the cobalt and nickel 
catalyst impurities rather than the nanotubes. However, this nevertheless shows that 
raw, unpurified CNTs have the potential to affect aquatic life when released into the 
environment.
The experimental evidence to date makes it difficult to draw a final conclusion about the 
safety of CNTs, especially about their use as therapeutic agents. Despite the amount of 
work already completed, many more studies are needed in order to obtain a clear 
understanding about the toxicity of CNTs. In particular, a standard material and 
standard methods for the characterization and functionalization of CNTs and for toxicity 
studies are needed in order to make valid comparisons -  especially taking into 
consideration that some types of cytotoxicity assays may lead to false positive results 
due to adsorption of their colorimetric reaction product to CNTs.^ ^^ ^  ^ In summary, it 
appears sensible that toxicologieal and pharmacological studies are always run 
alongside in order to obtain a clear picture of both the beneficial and the potential 
adverse health effects of CNT-based therapeutics.
2.2 Cancer -  Pathophysiology and therapy
Cancer is among the top three killers in modern society, next to heart diseases and 
cerebrovascular diseases. In 2009, approximately eight million people died from cancer 
worldwide according to the WHO. Although much progress has been made in reducing 
mortality rates, stabilizing incidence rates, and improving survival, cancer still accounts 
for more deaths than heart disease in people under 85 years.
This subsection will give an overview of cancer and review present-day cancer 
treatments and associated problems. The main types of anti-cancer drugs will be 
discussed, as well as the concept of drug targeting.
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2.2.1 Pathophysiology of cancer
Caneer is the result of a process caused by multiple factors, which begins when one cell 
of an organ or tissue gets damaged or altered in a way that causes it to break free from 
its regulatory controls, resulting in uncontrolled growth, invasion of the surrounding 
tissue and metastasis (Figure 2-5).
# # Primary Cancer
Local invasion
Angiogenesis
Lymph vessel 
Tissue boundary
Metastasis: 
Invasion of other 
parts of the body 
via blood and 
lymph vessels
Blood vessel
Figure 2-5 D evelopm ent and spread o f  cancer (adapted from
This abnormal behaviour is the result of a series of mutations in key regulatory genes. 
The cells become progressively more abnormal, as more genes become mutated or 
modified. Genetic abnormalities found in cancer typically affect two classes of genes: 
cancer promoting “oncogenes” and “tumor suppressor genes”. The activation of 
oncogenes and/or the loss of tumor suppressor activity introduces malignant properties 
to healthy cells, e.g. limitless replicative potential, invasive growth and metastasis, 
insensitivity to anti-growth signals, self-suffiency in growth signals, and inhibited 
apoptosis. In the case of solid tumors, the supply with oxygen and nutrients must be 
ensured. In order to expand, tumors encourage blood vessel growth, a process termed 
“angiogenesis”, which allows the tumor to grow beyond the limitations of passive 
nutrient diffusion and to become connected to the bloodstream. Angiogenesis is induced
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by specific signals sent out by tumors, which cause nearby blood vessels to form new 
extensions to the tumor (budding), delivering nutrients and oxygen. Importantly, the 
blood vessels also serve as a passageway for the movement of tumor cells to other parts 
of the body and play a major contributory role in the process of metastasis.
The exact causes of such mutations are still the subject of intense investigation. Several 
substances have been identified as “mutagens” (substances that cause DNA mutations) 
and “carcinogens” (mutagens that cause cancer) over the last three hundred years. 
Prominent examples are tobacco smoke, which contains over 50 known careinogens,^^ "^^  ^
or asbestos, a naturally occurring fibrous silicate mineral that has been widely used in a 
variety of building and household products, until it was found to cause an almost 100% 
lethal type of c a n c e r . A p a r t  from chemical carcinogens, a variety of other causes can 
be responsible for the induction of DNA damage, for example prolonged exposure to 
UV radiation from the sun or artificial s o u r c e s , o r  viral and bacterial infections.^^^^  ^
Furthermore, gene mutations may be passed down from a parent to a child and result in 
an increased cancer risk, which is known as “hereditary caneer syndrome”; however, 
these are relatively rare.^ ^^ ^^  DNA damage and mutations may also occur without any 
known external cause and give rise to spontaenous (non-somatic) mutations, which are 
currently thougth to contribute to the greater proportion of all human cancers.
2.2.2 Problems associated with conventional cancer chemotherapies
The major therapeutic approaches for the treatment of cancer are surgery, 
chemotherapy (including hormonal treatment), and radiation therapy. This rather wide 
range of treatment modalities already indicates that cancer is not a “simple” disease, but 
rather a group of diseases. In fact, caneer can be regarded as a multitude of independent 
disorders resulting in malignant cell growth. Even though all cancers have to overcome 
the same spectrum of regulatory controls in order to develop, the involved cell types and 
affected genes often differ, which results in a vast heterogeneity of more than a hundred 
different types of cancers. In the light of this overwhelming complexity, it becomes 
apparent why the development of a single cure or a so-called “magic bullet” has so far 
proved elusive.
In many cases, chemotherapeutic drugs exert their destructive effect on cells by 
damaging DNA, impairing mitosis, or inhibiting some aspect of DNA synthesis. 
Although many available anti-caneer drugs have distinct mechanisms of actions, they
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lack specificity for cancerous cells. In fact, most of them simply “target” rapidly 
dividing cells, for caneer cells have largely been associated with unrestrained growth. 
However, fast-dividing cells can also be found in hair follicles, the bone marrow, the 
stomach, or the lining of the gastrointestinal tract, which explains some of the most 
common side effects of chemotherapies. Furthermore, this therapeutic approach is only 
effective for tumors with reasonably high growth fractions, such as some types of 
leukemia and aggressive lymphomas. Another problem associated with standard cancer 
chemotherapies is the induction of drug resistance over time. For this reason, caneer 
chemotherapy may often comprise the use of drug combinations to increase efficacy, for 
example of drugs targeting DNA in combination with drugs targeting microtubules.
2.2.3 An brief overview of “classic” anti-cancer drugs
Anti-caneer drugs can be categorized according to their meehanism of action. Most of 
them affect cell division or DNA synthesis and function in some way, for example by 
damaging the DNA of the affected cancer cells (genotoxic drugs), by inhibiting the 
synthesis of new DNA strands to stop the cell from replicating (antimetabolites), or by 
inhibiting mitosis (spindle inhibitors). The first drug ever used for chemotherapy was 
originally developed for an entirely different purpose, namely as a chemical warfare 
agent during World War I. Since people exposed to mustard gas were found to have 
very low white blood cell counts, it was reasoned that a similar effect might be 
achievable for cancerous cells, particularly those of the lymphocyte population, such as 
the high levels seen in lymphoma patients. Follow-up medical studies after the second 
World War rapidly confirmed this assumption and soon the nitrogen mustards became 
the prototype for a whole class of chemotherapeutic drugs: the alkylating agents.
Alkylating agents belong to the class of genotoxic drugs, which stop tumor growth by 
cross-linking guanine bases of DNA strands, thus preventing the strands to uncoil and 
separate in the process of cell division. Commonly used alkylating agents are nitrogen 
mustard derivatives (cyclophosphamide, chlorambucil). Other classes of genotoxic 
drugs comprise the platinum-based drugs (cisplatin, carboplatin, and oxaliplatin), which 
damage DNA by producing interstrand crosslinks, as well the topoisomerase-inhibitors 
(e.g. irinotecan or etoposide), which disrupt DNA replication by preventing the key 
enzymes topoisomerase I and II from cutting and reconnecting DNA strands.
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Antimetabolites, another class of chemotherapeutic agents, also interfere with DNA 
synthesis, but in a different way. Molecules belonging to this group possess similar 
structures to the building blocks of DNA -  adenine, guanine, thymine, and cytosine -  
but are yet different enough to prevent their ineorporation into DNA strands. As a 
result, the treated cells are unable to synthesize new DNA strands and are hence unable 
to divide and grow. Examples of antimetabolite chemotherapeutic drugs are 6- 
mercaptopurine, 5-fluorouracil, and gemeitabin.
An entirely different mechanism of action to prevent cells from dividing is observed for 
the so-called spindle poisons. Mitotic spindles are part of the cytoskeleton in eukaryotic 
cells and help to separate the chromosomes into the daughter cells during cell division. 
Spindle poisons, such as the vinca alkaloids (vincristine, vinblastine) and the taxanes 
(paclitaxel, docetaxel) disrupt the formation of these spindles by interacting with their 
subunits -  the microtubules -  and therefore interrupt cell division.
Apart from these three main groups, many other chemotherapeutic agents exist, whose 
mechanisms of action do not neatly fit into one of these categories. The 
“anthraeyelines”, which are amongst the most important antitumor drugs available, are 
one such example. Their exact mechanism of action is complex: they are known to 
interact with DNA by intercalation and inhibition of topoisomerase 11 and further cause 
free-radical generation, chromosome damage, mitochondrial effects and membrane 
effeets.^^^^  ^A prominent representative of this category is doxorubicin, which is widely 
used for the treatment of several solid tumors, and daunorubicin and idarubicin, which 
are used exclusively for the treatment of leukemia.
A characteristic attribute of all mentioned chemotherapeutic drugs mentioned is their 
inherent toxicity, leading to common side effects, such as nausea, bone marrow toxicity, 
hair loss, loss of appetite, and fatigue. However, some drugs are associated with serious, 
life-threatening side effects in some individuals, such as cardiotoxicity (doxorubicin), 
nephrotoxicity (platinum-based drugs), encephalopathy (cyclophosphamide) or 
hepatotoxieity (cyclophosphamide, methotrexate, 6-mercaptopurine). Thus, the 
challenge for oncology in the 21st century is to design targeted therapies, which deliver 
the drugs directly to the target location and thus not only allow for the application of 
smaller drug doses due to increased therapeutic efficacy, but also minimize the damage 
to non-caneerous cells and associated side effects. Targeted cancer therapies not only
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include molecular-targeted drugs, but also combinations of drugs and targeting agents, 
and will be discussed in the next section.
2.2.4 Drug targeting: as crucial as the drug itself
As discussed in the previous sections, most cancer treatments suffer from a lack of 
efficacy due to insufficient selectivity for their target. In this context, different types of 
targeting strategies are currently under investigation. Principally, oncological targeting 
strategies can be divided into three categories (Figure 2-6): molecular targeting, active 
targeting, and passive targeting.
Figure 2-6 Schematic ovennew o f  cancer targeting strategies
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The following subsections will discuss these three categories with a particular focus on 
drug delivery systems. This will set the stage for the final subsection, which will review 
the literature on CNTs as a platform for targeted drug delivery.
Molecular targeting strategies
Molecular targeting strategies comprise drugs and other therapeutic agents, which block 
the growth and spread of cancer by interfering with specific molecules or proximal 
events in signaling transduction cascades involved in tumor growth and progression.^ "^^^  ^
This includes drugs interfering with cell growth signaling (signal transduction 
inhibitors), tumor blood vessel development (angiogenesis inhibitors), promoting the 
specific death of caneer cells (apoptosis inducers), or stimulating the immune system to 
destroy cancer cells (immune system modulators). Examples for FDA approved 
molecular targeted drugs are the so-called “tyrosine kinase inhibitors”, which interfere 
with tyrosine kinase-dependent cellular signaling pathways involved in tumor 
development and progression, such as imatinib (Gleevec®) or dasatinib (Sprycel®) for 
the treatment of chronie myeloid leukaemia. The first therapeutic monoclonal antibody 
that gained FDA approval for human use was trastuzumab (Herceptin®). It binds to the 
human epidermal growth factor receptor 2 (HER-2), which is expressed at high levels in 
some breast cancers, and possibly prevents it from sending growth-promoting signals.
Although molecular targeting may be effective in individual patients (namely those who 
possess the target for the drug in question) and furthermore elicit relatively low toxicity, 
response rates in the general patient population for a particular cancer are often as low 
as 10-20% due to the high complexity of the disease and genetic variations. In 
comparison, conventional, “old-style” anti-caneer drugs, which often target the 
downstream consequences of activated signaling pathways, exhibit a rather broad 
efficacy, but are highly toxic due to their lack of speeifieity.^ "^^ ^^
Active targeting strategies
Active targeting strategies usually involve the conjugation of a therapeutic agent to a 
recognition moiety. This may increase the effective drug concentration at the target 
site,^ "^^ ^^  which allows lowering the dose of the drug and hence may prevent associated 
toxicities, especially in chronic treatments. Targeting agents can either be conjugated
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directly to anti-cancer drugs, rendering the so-called “immunoconjugates”, or both the 
targeting agent and the drug can be attached to a nano-carrier.
Types o f targeting agents
The characteristics of the targeting moiety are very important for circulation time, cell 
uptake, and elimination. The most intensively studied targeting agents, at least from a 
historical perspective, are monoclonal antibodies and Fab fragments (protein structures 
containing only the variable region of an antibody). Both recognize specific surface 
structures, so called “antigens”, which are overexpressed on tumors or cancerous cells. 
Ideally, antigenic targets for monoclonal antibodies should be expressed on malignant 
cells only, be present in abundance on the cell surface, and should not be shed into the 
blood circulation or the surrounding tissue. Examples for tissue-specific cell surface 
markers are the proteins CD20, CD33, CD52 and other representatives of this class, 
which are found on B cells, leukemic blast cells, and T- and B- lymphocytes and are 
already used in FDA-approved drug- and radioimmunoconjugates. Furthermore, growth 
factor receptors, such as HER2/neu and the epidermal growth factor receptor (EGFR) 
have emerged as good targets for antibody-targeted therapies. Another example for an 
antigen of clinical importance is careinoembryonic antigen (CEA), a peripheral 
membrane protein overexpressed by colorectal carcinomas and also a number of lung, 
breast, ovary, and pancreas c a r c i n o m a s . A s  it is often released - or shed - into the 
circulation by these tumours, giving rise to measurable blood levels, it has established 
great importance as a routine diagnostic tumor marker.
Overall, monoclonal antibodies are effective targeting agents; however, they are 
associated with several innate problems, such as insufficient tumor penetration, 
circulating free antigen, binding to non-specific Fc receptors, changes in the antigen 
over time, and interaetion with the immune system.^ '^^ ’^^ '^ ^^ Besides, the conjugation 
method has a great influence on antibody affinity: when carried out in a random way, 
for example by creating amide bonds between carboxylie acid groups of the nanoearrier 
or drug and primary amine groups of the antibody or Fab fragment, the binding sites of 
the antibody can be bloeked.^ "^^ ^^  It is thus advantegous to employ a conjugation method, 
which allows for attaching the antibody in a correctly oriented manner - for example by 
the use of Protein A, which binds to the Fc fragment of antibodies.
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To overcome the problems of antibody-targeting, many researchers started to 
investigate other active targeting options. A rather novel approach is the use of 
aptamers, which are synthetic, single-stranded nucleic acid molecules able to fold up 
into unique 3D structures, which gives them molecular recognition properties similar to 
antibodies. Aptamers offer the advantage to be readily produced by chemical methods 
and elicit little or no immunogenieity in therapeutic applications. Furthermore, they can 
be produced for a variety of targets, ranging from small molecules over amino acids and 
peptides to proteins, and usually retain their binding properties even after 
immobilization on a carrier material.^ "^^ ^^  However, RNA-based aptamers are 
particularly prone to hydrolytic breakdown by cytoplasmic nucleases and are generally 
rapidly eliminated from the human body by renal clearanee.^ '^^^  ^These problems may be 
overcome by modifications of the molecules, such as méthylation of the bases, end cap 
modifications, or conjugation of PEG or cholesterol as anchor groups. 
Nevertheless, the use of aptamers as targeting agents is still at an early stage and their 
future role in drug delivery applications remains to be seen.
Another type of active targeting is based on ligand-reeeptor interaetions. An example 
from the anti-angiogenetic area is the targeting of integrins oCvPs, which are endothelial 
cell receptors for extracellular matrix proteins possessing the RGD sequence (arginine- 
glyeine-aspartic acid) and are highly expressed on neovascular endothelial cells.^^^ ’^^ '^ ^^ 
Conjugation of RGD peptides to nanovectors can lead to higher levels of cellular 
internalization and furthermore affect vascular endothelial growth factor receptor-2 
(VEGFR-2) signaling due to an intrinsic association with this signaling pathway,^^^^  ^
leading to downregulation of the receptor and finally to reduced angiogenesis. Another 
example for active targeting based on ligand-reeeptor interaetions relevant to the area of 
cancer therapeutics is the interaction of folate with its r e c e p t o r . F o l i c  acid is a 
vitamin and necessary for the synthesis of nucleotides, the DNA building blocks. Its 
counterpart, the folate receptor, is significantly upregulated by a broad speetrum of 
human cancers, in some cases by two orders of magnitude, facilitating cellular 
internalization of folate-conjugated nanovectors by receptor-mediated 
e n d o c y t o s i s . N o r m a l  cells, however, will only transport folate via this receptor, 
but not folate conjugates of any type,^ "^^ ^^  which adds an extra level of specificity. The 
folate targeting approach has been widely employed in the last decade using various 
types of vectors, and remains very promising for future applications. Particularly for 
chemotherapy, folate-conjugated nanovectors loaded with anti-cancer drugs have shown
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huge potential in overcoming the problem of multi-drug resistance by evading P- 
glycoprotein-mediated efflux, which is considered to be a common problem in caneer 
drug adminsitration/^^^'^^^^ Folate targeting is employed in Chapter 6 of this thesis to 
enhance the selectivity of the CNT-based drug delivery system.
Immunoconjugates
Imunoconjugates are antibodies conjugated to a second molecule, which can be a toxin, 
a radioisotope or a label. In 2000, the first antibody-drug immunoeonjugate 
(Mylotarg®) was approved by the FDA for the treatment of some patients with acute 
myeloic leukemia. It consists of the monoclonal antibody gemtuzumab, which is 
targeted at the cell surface protein CD33 present on the surface of leukemic blast cells, 
and the drug ozogamicin, which prevents DNA synthesis. Once the complex binds to 
CD33, the receptor-antibody conjugate is internalized and the drug released by 
hydrolysis. So far, Mylotarg® remains the only FDA approved antibody-drug 
immunoeonjugate -  however, two radiolabeled antibodies targeting the CD20 cell 
surface protein overexpressed by certain types of B-cell non-Hodgkin lymphoma, 
Bexxar® and Zevalin®, have also made their way into the market.
Besides conventional immunoconjugates, so-called “pretargeting strategies” are 
currently the focus of intense investigation. In this approach, antibody-based targeting 
and delivery/generation of the toxic agent is separated into two s t e p s . T h e  most 
prominent example is ADEPT, or “antibody-directed enzyme prodrug therapy”, in 
which target selectivity is achieved by an antibody in an antibody-enzyme conjugate, 
binding to antigens preferentially expressed on the surface of tumor cells or the tumor 
interstitium. In the first step, this complex is administered and accumulates at the target 
site. In the second step, a non-toxie prodrug is injected, which is converted into a 
cytotoxic drug in situ by the enzyme in the conjugate at the t u m o r . A  major 
advantage of ADEPT is the amplification effect, as one molecule of enzyme catalyzes 
the conversion of many prodrugs into their cytotoxic form. This leads to higher drug 
concentrations at the tumor site compared to intravenous administration of the drug 
alone. Furthermore, a broad array of prodrugs can be used for site-specific activation, 
especially those with high toxicity.
Overall, therapies employing immunoconjugates have evolved a great deal over the past 
few years. Although several challenges still lie ahead, advances in protein engineering
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are likely to permit a greater control of antibody-based targeting, clearance and 
pharmakokinetics for the next generation of immunoconjugates, which will result in 
significantly improved delivery to tumorsJ^^^^
Drug delivery systems featuring active targeting agents
Another option for improving the clinical efficacy of active targeted drugs lies in the use 
of a drug delivery system. Many nano-sized carriers have been developed for this 
purpose in the last decades, as their small size enables their passage through narrow 
capillaries and endothelial spaces. Furthermore, they possess high adaptability, allowing 
for the loading of various types of therapeutic agents and targeting moieties. Typically, 
a nanocarrier designed for targeted drug delivery consists of a core constituent material, 
a therapeutic payload, and a targeting agent.^ ^^ ^^  This multifunctional concept allows for 
the delivery of large amounts of therapeutic agents per targeted site of action, which is a 
major clinical improvement over simple immuno-targeted drugs. In this thesis, CNTs 
are used as a “core material” and a monoclonal antibody, as well as folic acid, as active 
targeting agents.
Passive targeting strategies
Besides active targeting, drug delivery systems also allow for passive targeting, which 
often relies on mechanisms based on the size and physical properties of the nanocarrier 
or involves cleavable bonds. Most-widely known in this context is the so-called 
“enhanced permeation and retention (EPR) effect”, which originates from the leaky 
vasculature of tumor-associated, newly created blood vessels, and the lack of effective 
lymphatic drainage in tumor tissues.^^^^  ^ Both effects contribute to tumor interstitial 
drug accumulation, and are widely exploited by vector-based drug delivery systems. 
The earliest one was approved by the FDA over 10 years ago for the treatment of 
Kaposi’s sarcoma and comprises a liposome-encapsulated, PEGylated formulation of 
the anthraeycline anti-cancer drug doxorubicin (Doxil®/Caelyx®).^^^^^ Since then, three 
further products have reached the market: a PEGylated, liposomal formulation of 
daunorubicin (DaunoXome®), a non-PEGylated, liposomal preparation of doxorubicin 
(Myocet®) and a product featuring the anti-cancer drug paclitaxel bound to albumin 
nanoparticles (Abraxane®). The latter is a major improvement compared to traditional 
paclitaxel formulations in terms of toxicity: since paclitaxel is very hydrophobic and
32
Chapter 2___________________________________________________Literature Review
hence poorly bioavailable, it has usually been formulated with the pharmaceutic 
excipient Cremophor-EL, which is known to cause severe hypersensitivity reactions and 
toxic tissue side effects. Albumin, however, is the major protein in human blood and 
much more biocompatible than Cremophor-EL, therefore allowing for the delivery of 
higher drug doses at lower toxicity levels.
Another passive targeting approach applied by vector-based drug delivery systems 
exploits distinctive features of the tumor microenvironment to achieve drug 
accumulation at the target site. For example, solid tumors often exhibit a lower 
extracellular pH than the surrounding tissues due to lactic acid produced by hypoxic 
cells,^^^  ^ whereas the intracellular pH is essentially identical or slightly more basic in 
tumors than in normal tissue. As a consequence, the cellular pH gradient is substantially 
reduced or reversed in these tissues; a fact that has been exploited by various studies for 
drug delivery applications. One such example is the work of Ko et al., who developed 
pH-responsive and biodegradable polymeric micelles loaded with doxorubicin as a 
tumor-targeted drug delivery system, showing noticeable pH-dependent micellization- 
demicellization behaviour with rapid release of the drug doxorubicin from the micelles 
in weakly acidic environments, but very slow release under physiological 
conditions.
In summary, the greatest gain in therapeutic selectivity is likely to be achieved by 
synergistic combinations of active and passive targeting strategies. In this respect, 
vector-based targeting strategies offer a great advantage, being capable of combining 
the EPR effect as a passive targeting strategy with active targeting by means of 
conjugated agents. The next section will discuss drug delivery systems employing 
CNTs as delivery vectors with a particular focus on the targeting methods, and give an 
overview of the literature to date.
2.3 Carbon nanotubes as a multimodal drug delivery 
system for cancer therapy
In the last five years, CNTs have emerged as a new type of targeted drug delivery 
system, especially in the field of oncology. Both their surface and their inner cavity 
allow for loading with drugs and other therapeutic and diagnostic entities, such as 
targeting or imaging agents. Furthermore, CNTs are capable of penetrating mammalian
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cell membranes and have been demonstrated to shuttle a broad spectrum of molecules 
into mammalian cells. The first studies undertaken in this area have mainly focused on 
functionalization issues, whereas subsequent in vitro studies have tried to optimize 
CNT-based drug delivery systems with respect to therapeutic efficacy and targeting 
capability. Current studies are attempting to tackle the challenge of in vivo settings in 
order to move a step further towards the clinic and to investigate the fate of the 
nanotubes in living systems after fulfilling their therapeutic task.
2.3.1 In vitro studies
Table 2-1 summarizes all relevant in vitro drug delivery studies based on CNTs to date 
in chronological order to give an overview of the literature.
Table 2-1 In vitro drug delivery studies employing CNTs as a nanovector
Wu et 2005 MWNTs CVD amphotericin B none
Pastorin et 2006 MWNTs not specified methotrexate none
Ali-Boucetta et 2008 MWNTs CVD doxorubicin none
Feazell et 2007 SWNTs HiPco cisplatin prodrug
Liu et 2007 SWNTs HiPco doxorubicin RGD peptide
Chen et 2008 SWNTs HiPco second-generation 
taxoid (SB-T-1214)
prodrug -t- biotin
Dhar et 2008 SWNTs HiPco cisplatin prodrug 4- folic acid
Hampel et 2008 MWNTs CVD carboplatin none
Heister et 2009 SWNTs CVD doxorubicin monoclonal antibody 
(anti-CEA)
Ou et al.’’’ " 2009 SWNTs not specified none monoclonal antibody 
(anti-integrin
Zhang et al.’” ” 2009 SWNTs not specified doxorubicin folic acid
Lay et al.’” ” 2010 SWNTs,
MWNTs
not specified paclitaxel none
Li et al.’” ” 2010 SWNTs not specified doxorubicin monoclonal antibody 
(anti-P-gp)
Samori et al.’”’’ 2010 MWNTs CVD methotrexate none
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The first study on in vitro drug delivery with CNTs has been carried out by Wu et al. in 
2005. They conjugated the antibiotic drug amphotericin B to MWNTs; a drug 
considered problematic due to its poor aqueous solubility and narrow therapeutic index. 
Both issues could be resolved by conjugating amphotericin B to MWNTs, which 
reduced the toxicity of the drug towards mammalian cells whilst preserving its 
antifungal a c t i v i t y . O n e  year later, the same group reported the delivery of the first 
anti-cancer drug to human T lymphocytes. The investigated drug, methotrexate, is 
widely used in chemotherapies, but suffers from poor cellular uptake and induction of 
drug resistance in cancer cells. Its internalization could be facilitated through 
conjugation to MWNTs, although its antitumor activity was not evaluated. In both 
studies, the drugs have been attached to the nanotubes in a covalent fashion. One of the 
first studies employing a non-covalent functionalization technique has been carried out 
by Ali-Boucetta and co-workers, who attached the anti-cancer drug doxorubicin to 
MWNTs via Tt-TC-interactions, as described in the last subsection. A simplified MTT 
viability assay with human breast cancer cells demonstrated that doxorubicin-nanotube 
conjugates exhibited significantly enhanced cytotoxicity compared to the drug alone, 
indicating that nanotubes are a feasible option for mediating the delivery of drugs into 
cells and enhancing their therapeutic efficacy.
These studies have provided a solid foundation for future drug delivery studies - 
however, the aspect of targeting had not been considered, yet. The first step in this 
direction was undertaken by Feazell and co-workers, who conjugated a platinum(IV) 
prodrug to SWNTs via a cleavable disulfide bond.^ ^^ ^^  The use of a prodrug permits to 
circumvent many pathways in the body that are known to deactivate platinum(II)-based 
anti-cancer drugs. In a cytotoxicity test, a testicular carcinoma cell line was treated with 
the free platinum(IV) prodrug and the nanotube-conjugate to compare therapeutic 
efficacy. Whilst the platinum(IV) prodrug did not have a significant effect on cell 
viability, the prodrug-nanotube conjugate showed a substantial increase in cytotoxicity 
and surpassed that of cisplatin alone when compared on a per platinum basis.
Compared to the passive and simple targeting approach in that study, a subsequent 
study by Liu et al. applied a more advanced targeting approach.^^^  ^ Pristine SWNTs 
were solubilized via an amine-terminated, phospholipid-PEG-based surfactant and 
loaded with doxorubicin in the same way as described in the study by Ali-Boucetta et 
al [166] a cyclic RGD peptide was attached to the amine groups of the surfactant as
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a ligand to integrin ttvPs receptors, which are up-regulated in a wide range of solid 
tumors.
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Figure 2 -7  Targeted drug delivery o f  doxorubicin by functionalized SWNTs as developed by Liu et al.:^ ^^  ^
a) Concentration-dependent survival curves o fU 87M G  integrin cCyps-positive cells and b) M CF-7  
integrin cc^.fis-negative cells, treated with the various sam ples as indicated. The viable cell percentage  
was m easured by the MTS assay. The drug-nanotube conjugates had a low er cytotoxic effect than the free  
drug on both types o f  cells, while the targeted nanotube-drug conjugates exhibited increased toxicity to 
U87MG cell,s but not to M CF-7 cells; showing that RGD peptides selectively enhanced doxorubicin  
delivery by SWNTs and toxicity to integrin a^.^j-positive cells.
Cell viability assays using integrin ttvps-positive U87MG human glioblastoma cancer 
cells revealed that free doxorubicin exerted the highest cytotoxicity with an IC50 of 
about 2  pM, followed by the targeted nanotube-drug conjugates with an IC50 of about 3 
pM and finally the untargeted nanotube-drug conjugates with an IC50 of about 8 pM 
(Figure 2-7). This demonstrated that targeting of integrin receptors via an RGD peptide 
is a valid and promising method in an in vitro setting. Although the free drug was more 
effective than the conjugates, this is a result to be expected in in vitro assays, as there 
are no real barriers for membrane-permeable drugs. In an in vivo setup, however, drugs 
are subjected to many different environments and influences before reaching their 
target, and in this scenario, their attachment and delivery by a vector might be of 
significant advantage.
Another active targeting approach has been pursued by Chen and co-workers, who 
conjugated a taxane prodrug to SWNTs via a cleavable disulfide linker, which released 
the drug upon internalization, converting it into its active form. Additionally, the 
vitamin biotin was attached to serve as a targeting agent. This idea is based on a study
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of Russell-Jones et who reported that biotin receptors are overexpressed on a
wide range of tumor types and thus may serve as a new tumor-specific target in a 
similar manner to the widely recognized folate receptors. An MTT cytotoxicity assay 
revealed that the targeted nanotube-drug conjugates featured superior cytotoxicity in 
L I210 leukemia cells than the drug alone.
A study by Dhar et al. followed up the work of Feazell et al./^^^  ^which was published a 
year earlier and described the delivery of a platinum(IV) prodrug by CNTs, albeit 
without a targeting strategy. Their subsequent study, however, includes the conjugation 
of folic acid to the nanotube-drug complexes as a targeting ligand for folate 
receptors.^^^^  ^ As described earlier in this chapter, this targeting strategy is based on the 
fact that folate receptors are significantly upregulated by a number of human cancers, 
thus facilitating cellular internalization of folate-conjugated nanovectors by receptor- 
mediated endocytosis. Indeed, the cytotoxicity of the targeted nanotube-drug conjugates 
was enhanced by a factor of 6.8 relative to complexes comprising the drug and the 
targeting agent only. This once more emphasizes the key role of the drug delivery 
vector.
The next study to be discussed was carried out by Hampel et al. in 2008 and has 
embarked on a very different strategy in terms of drug loading. Instead of attaching the 
drug to the outer walls, the anti-cancer drug carboplatin was filled into MWNTs by a 
wet chemical approach (Figure 2-8).^ ^^ ^
5mn
Figure 2-8 MWNT filled  with carboplatin clusters (courtesy o f  IFW Dresden).
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In vitro studies revealed that the carboplatin-filled nanotubes exerted a concentration- 
dependent cytotoxic effect on human bladder cancer cells, whereas unfilled nanotubes 
did not affect cell viability in a significant manner.
A study published by Ou et al. in the same year focused solely on the targeting 
a s p e c t . T h e  applied targeting approach was again based on integrin oCyps receptors -  
however, the researchers argue that RGD peptides, although commonly used as 
targeting ligands for integrin receptors, have a relatively low specificity due to their 
universal targeting ability to other integrins. Furthermore, they state that some RGD 
peptides are prone to degrade rapidly in vivo and have therefore decided to use a 
monoclonal antibody to integrin cCyps receptors instead. The antibody was attached to 
CNTs via protein A, which ensures site-specific binding of the antibody in contrast to 
random conjugation via EDC/NHS chemistry. Protein A is a protein found in the cell 
wall of bacteria, which binds to the Fc region of immunoglobulins. Using it as a linker 
between the nanotubes and the antibody ensures that the antibody is attached in the right 
orientation without blocking its binding site.
Zhang et al. conducted the first study attempting controlled drug r e l e a s e . T h e r e i n ,  
two polysaccharides were selected to wrap the surface of oxSWNTs: the cationic 
chitosan and the anionic alginate. Using them either on their own or in combination for 
CNT functionalization allowed for manipulating the surface potential of the modified 
nanotubes. This not only enabled the researchers to control the amount of drug loading 
when using charged drug molecules, but also to control the release rate of the associated 
drug inside cells. The drug delivery system displayed excellent stability under 
physiological conditions, whilst releasing the drug at reduced pH typical of the tumor 
environment and intracellular lysosomes, resulting in cell death.
Three further in vitro studies shall be discussed in this subsection, all published very 
recently at the time of writing this thesis. The first one by Lay et al.^ ^^ ^^  presents a very 
straightforward approach of drug loading. SWNTs and MWNTs are first PEGylated in a 
covalent manner for better aqueous solubility and improved biocompatibility. Next, the 
anti-cancer drug paclitaxel is adsorbed onto the side walls of CNTs by simple mixing 
and ultrasonication in methanol. Paclitaxel exhibits a low aqueous solubility and does 
not possess an extended aromatic structure, which would allow attachment to CNTs via 
n-n interactions. Thus, the coupling reaction is performed in methanol, in which both 
the nanotubes and paclitaxel are soluble, and the researchers assume that drug loading is
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promoted by hydrophobic interactions with the CNT surface and possibly also by 
integration into the nanotubes’ interior. A drug release study showed a sustained release 
profile with around 40% of the drug being released from both types of nanotubes at pH 
7 within 33 days. In cell viability assays with HeLa and MCF7 cancer cells, paclitaxel- 
loaded nanotubes showed increased cytotoxicity compared to paclitaxel alone, likely by 
solving the problem of the drug’s poor aqueous solubility and allowing for sustained 
release.
The next study by Li et al. not only developed a CNT-based drug delivery system, but 
also addressed the problem of multi-drug resistance (MDR) in cancer cells, using either 
multi-drug resistant or non-resistant K562 human leukemia cells as a test system. A 
major cause for MDR is the upregulation of P-glycoprotein (P-gp), a trans-membrane, 
energy-dependent efflux pump capable to transport a broad variety of substrates out of 
cells. SWNTs were conjugated to a P-gp antibody and loaded with the anti-cancer drug 
doxorubicin. Drug release after cell uptake was triggered by near-infrared irradiation. 
The drug binding capacity was much lower than in other publications using a similar 
system with a maximum CNT/drug weight ratio of 0.04:1, whereas Liu et al. achieved a 
ratio of 4:1.^ ^^  ^ Regarding in vitro drug release, about 20% doxorubicin were released 
within 24 h, but up to 60% with the aid of NIR irradiation. The uptake pathway was 
found to be endocytosis-based and confocal microscopy studies were carried out in 
order to visualize the intracellular distribution of the CNT-drug-complexes. 
Unfortunately, the confocal images are of rather poor quality: while it can be clearly 
seen that the nanotube complexes are localized on the cell membrane in the case of the 
non-resistant cells, supposed localization of the complexes in the cytoplasm of the drug- 
resistant cells is barely visible. However, in vitro cell viability studies were performed 
using P-gp antibody-tagged SWNTs as a delivery system and a 2.4-fold higher 
cytotoxicity compared to the free drug could be achieved for the multi-drug resistant 
cells.
The last study to be discussed in this subsection is a follow-up study of that published 
by Pastorin et al. in 2006,^ ^^  ^ which has been discussed earlier. Herein, the cytotoxicity 
of MWNT-methotrexate complexes is investigated in relation to the type of linker used. 
Two cleavable linkers were investigated: the tetrapeptide Cly-Leu-Phe-Cly and 6- 
hydroxyhexadecanoic acid. Cellular uptake of the complexes by MCF7 breast cancer 
cells was confirmed by confocal microscopy and cell viability assays showed a similar 
cytotoxicity profile to methotrexate when 6-hydroxyhexadecanoic acid was used as a
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linker (forming an ester bond), while using the tetrapeptide as a linker resulted in a 
significant enhancement of cytotoxicity. This is likely due to enzymatic hydrolysis of 
the drug tethered by the cleavable peptide inside the cells, in comparison to the more 
stable ester bond.
2.3.2 In vivo studies
Following up the promising achievements of the in vitro studies discussed in the last 
subsection, researchers are now more and more working in in vivo settings. So far, five 
noteable in vivo studies have been carried out using CNTs as a delivery vector for 
therapeutic agents, which are summarized in Table 2-2.
Table 2-2 In vivo drug delivery studies employing CNTs as nanovectors
M cD evitt et 2007 SW NTs C V D therapeutic radio­
isotopes (“ hn , ®°Y)
m onoclonal antibodies 
(rituximab, lintuzumab)
Liu et 2008 SW NTs H iPco paclitaxel none
(possibly EPR effect)
Bhirde et 2009 SW NTs H iPco cisplatin epidermic growth factor 
(EOF)
W u et 2009 M W NTs not specified 10-hydroxy-
camptothecin
none
(possibly EPR effect)
Liu et 2009 SW NTs H iPco doxorubicin none
(possibly EPR effect)
Chaudhuri et 2010 SW NTs not specified doxorubicin none
(possibly EPR effect)
Chaudhuri et 2010 SW N Ts & 
fullerenols
not specified doxorubicin none
(possibly EPR effect)
In the first study by McDevitt et al. in 2007, constructs of SWNTs and monoclonal 
antibodies against the CD20 and CD33 cell surface proteins (rituxumab and lintuzumab) 
were used to deliver a radionuclide to mice bearing lymphoma x e n o g r a f t s . A p a r t  
from the targeting aspect and quantification of tumor uptake, this study was one of the 
first to yield results about blood clearance and distribution of the nanotube complexes to 
key organs. The study showed that covalent attachment of antibodies to the nanotube-
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radionuclide conjugates dramatically altered biodistribution and pharmacokinetics when 
comparing tumor-bearing and non-tumor-bearing mice, indicating that the targeting 
effect was antibody-mediated and not a result of the CNT portion of the construct.
In 2008, Liu and co-workers conducted the first successful study which demonstrated 
efficacious in vivo tumor treatment in mice using CNTs as drug delivery v e c t o r s . T h e  
microtubule binding anti-cancer drug paclitaxel was conjugated to branched 
polyethylene glycol chains on SWNTs via a cleavable ester bond. These conjugates 
afforded much longer blood circulation times than paclitaxel alone or PEGylated 
paclitaxel and led to a 10-fold higher tumor uptake, most likely mediated through the 
EPR effect. Additionally, they showed similar efficacy to paclitaxel alone in in vitro 
experiments and a higher efficacy in suppressing tumor growth in the murine 4T1 breast 
cancer model. Future work is planned to enhance treatment efficacy by conjugating 
targeting ligands to their complexes, which would combine a passive and an active 
targeting strategy in a synergistic approach.
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Figure 2-9 Targeted drug delivery system fo r  the anti-cancer agent cisplatin using CNTs as delivery  
vectors as developed by Bhirde et alJ'^^  ^(a) Illustration o f  chemical reactions used to attach EGF, 
cisplatin, and quantum dots to carboxylated SWNTs (red) using ED C  as the coupling agent, (b) 
Schematic showing SWNT bundles bioconjugated with EGF and cisplatin targeting the cell surface 
receptor EGFR on a single head and neck squamous carcinoma cell.
Shortly afterwards, Bhirde and colleagues published the first study, which demonstrated 
in vivo drug delivery by an active targeting approach (Figure 2-9).^ *^ ^^  They 
functionalized SWNTs with the first-line anti-cancer drug cisplatin, epidermal growth 
factor (EGF) as a targeting agent, and quantum dots for imaging purposes, by covalent
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coupling chemistry (Figure 2-9). The approach is based on the fact that many squamous 
carcinoma cells overexpress EGFR (epidermal growth factor receptor). Preliminary in 
vitro studies showed that SWNT-cisplatin-EGF dispersions with 1.3 pM cisplatin were 
more cytotoxic than 10 pM free cisplatin. In the follow-up in vivo study, nude bearing 
tumor xenografts were injected with the nanotube-bioconjugates and tumor growth was 
monitored for two weeks. Mice treated with a non-targeted nanotube-cisplatin conjugate 
did not show tumor regression, whereas mice treated with the targeted conjugates 
showed a rapid decrease in tumor size.
WWNTs 3 5 fligfkg eq 
MWNTs 3 2.5 mgAg eg. 
HCPT injectioi 5 mgfkg m 
HCPT injecticn 2.5 eq. 
MW^NTs 2 
-O ' Ssiirt©
0 2 A 6  8 10 12 14 16
Days
MWNTs 3
(5 mg&g
HCPT injection
(5 pq.J
Saline
Figure 2-10 CNT-mediated delivery o f  the anti-cancer agent H CPT as developed by Wu et a lJ ’^^  ^(a) In 
vivo anti-tumor effect o f  the anti-cancer drug H CPT and HCTP-CNT conjugates, expressed as the 
average values o f  the relative tumor volume. *P < 0.05 (versus H CPT injection group at the equivalent 
dose from  the 5th day), (b) Typical photographs o f  excised sarcom as from  mice on the 16th day after  
treatments with MWNTs 3 (5 mg/kg equiv), H CPT injection (5 mg/kg equiv), and saline.
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The next study to be presented was performed by Wu et and features a drug-
deliver system, in which the anti-cancer agent 10-hydroxyeamptothecin (HCPT) was 
attaehed to MWNTs via diaminotriethylene glycol (Figure 2-10). The latter is a 
bifunctional PEG molecule with a chain length of 3, which supposedly avoids the 
shortcomings of longer PEG chains, such as activation of the complement system in a 
time- and concentration-dependent manner and blocking the interactions between 
nanotubes and cells. The treatment of mice bearing hepatic H22 tumors revealed that the 
nanotube-drug complexes inhibited tumor growth mueh more effectively than HCPT 
alone (Figure 2-10), presumably due to enhancement of the drug’s bioavailability, 
prolonged blood circulation owing to the use of CNT vectors, enhanced cellular uptake, 
and concentrated drug action through multivalent presentation of the drug molecules on 
a single nanotube.
In the same year, Liu et al. published a study, which took their in vitro efforts (discussed 
in the last subsection) a step further to an in vivo setup.^ ^^ ^^  The drug delivery system 
developed in their in vitro study consisted of SWNTs loaded with the anti-cancer drug 
doxorubicin, which was non-covalently functionalized with a linear phospholipid-PEG, 
conjugated to an RGD peptide as a targeting a g e n t . T h e i r  subsequent in vivo study 
employed branched PEG molecules to afford longer blood circulation times and 
dispensed with the targeting agent. Experiments on mice bearing lymphoma xenografts 
showed that the CNT-based drug delivery system exhibited a marked reduction in 
toxicity compared with free doxorubicin or the commercially available liposomal 
formulation Doxil®, while exhibiting comparable therapeutic efficacy. When the 
overall effieaey was tested by a model defined by morbidity-free survival, CNTs loaded 
with doxorubicin were found to be superior to doxorubicin alone or to Doxil®.
Two further studies, both published in 2010, have successfully employed CNTs as a 
drug delivery system in an in vivo setting. Both studies have been conducted by 
Chaudhuri and co-workers at Harvard Medical School. In the first study, doxorubicin 
was conjugated to oxidized CNTs via an enzymatically cleavable carbamate bond using 
pyrenebutanol as a linker. This functionalization scheme resulted in a drug-CNT 
weight ratio of 0.28:1. Furthermore, PEG chains were conjugated to the carboxylic 
moieties of the nanotubes. The system allowed for sustained release of the active drug 
in cell lysate with a steady increase for up to about 50 h. The same behaviour was found 
in in vitro studies, where the cytotoxicity of the nanotube-doxorubicin conjugates was 
lower than that of the free drug after 24 h and 48 h, but almost as high as that of the free
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drug after 72 h. In vivo studies in a mouse B16-F10 melanoma model showed effective 
reduction of tumor growth without the systemic toxicity of free doxorubicin, even 
without employing an active targeting scheme.
Their next study looked at CNT drug delivery from a very different a n g l e . T h e y  
studied the effect of two of their developed drug delivery system (the one just 
discussed^^^  ^ and another one featuring fullerenols as nanovectors '^^®^) on angiogenesis 
using a zebrafish embryo model. Due to the transparency of zebrafish embryos, 
angiogenesis from the subintestinal vessel ean be easily visualized. Interestingly, the 
treatment of embryos with CNT-doxorubicin complexes induced angiogenesis (Figure 
2-11), whereas fullerenol-doxorubicin conjugates resulted in a dose-dependent 
inhibition of angiogenesis.
Matrigel control CNT-Dox Fulierenol-Dox
CNT Fuiierenoi
Figure 2-11 Effect o f  nanoparticle- and nanotube-doxorubicin conjugates on angiogenesis in em bryonic 
zebrafish. The sam ples were injected in the yolk sac near the subintestinal vessels o f  48  h pf em bryos and  
incubated fo r  further 48  h. Images were taken after alkaline phosphatase staining in order to visualize the 
b lood vessels. Arrows indicate the sprouting o f  neovascidature. Graphs show the m orphom etric 
quantification o f  the effects on the number o f  nodes. A dapted from  Chaudhuri et al.^’^^^
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As a next step, the effect of the two complexes were studied in an in vivo syngeneic 
B16/F10 melanoma model. In this model, doxorubicin alone had no effect on 
angiogenesis. Fuiierenoi alone and fullerenol-doxorubicin complexes, however, induced 
a significant inhibition of angiogenesis, whereas CNTs alone and CNT-doxorubicin 
conjugates increased angiogenesis, similar to the results in the zebrafish model. 
Interestingly, CNT-doxorubicin complexes exerted a similar tumor inhibition to 
fullerenol-doxorubicin complexes, despite the contrary effects on angiogenesis. This 
suggests that the tumor-diminishing chemotherapeutic effect can overcome the tumor 
growth-promoting angiogenic effect. As a possible mechanism for the latter, the 
researchers propose the clustering of Ovps integrins, resulting in the activation of focal 
adhesion kinase (FAK) and downstream PI3-Akt signaling pathways implicated in cell- 
survival and angiogenesis.
The promising results of the presented in vivo studies represent a milestone in the 
development of CNTs as clinically successful therapeutic agents, although a consensus 
on the best material or functionalization method has yet to be reached. Moreover, more 
work needs to be conducted to understand and improve the pharmacological properties 
of CNT-drug formulations and their side effects. For example, short and well- 
functionalized CNTs seem to be eliminated via the kidneys, but feature a very short 
blood cireulation time (~ 30 min),^ ^^ ^^  which is unfavourable for most treatment options. 
On the contrary, PEGylation of CNTs increases their blood half life and decreases RES 
uptake, but causes the nanotubes to persist in the body for mo n t h s , a l t h o u g h  an 
encouraging study by Ruggiero et al. reveiled that kidneys seem to be able to eliminate 
nanotubes with a molecular weight of up to 500 kDa by glomerular filtration,^^^^  ^
despite the fact that the molecular weight cut off is generally thought to be 30-50 kDa.
Recapitulating, the possibilities of designer drug delivery systems based on CNTs 
appear to be immense and the coming years will reveal the true value of this material in 
comparison to more established drug delivery systems.
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3 Experimental Techniques
This chapters contains the entire methodology of this thesis, including the preparation of 
water-soluble CNTs by acid oxidation, various characterization methods, major 
functionalization schemes, drug binding and stability studies, as well as general tissue 
culture techniques and in vitro cell viability assays.
3.1 Material
All carbon nanotubes used in this thesis are summarized in Table 3-1; plus information 
on the respective synthesis method, supplier, and sample characteristics.
Table 3-1 Sample information fo r  all carbon nanotubes applied  in this thesis
SWeNT® SG 65 
“CoMoCAT SWNTs”
CoMoCAT® Southwest 
NanoTechnologies 
(Norman, OK, U.S.A.)
Supplied by Sigma- 
Aldrich (Poole, UK)
Order No. 70414 
Lot No. MKBB63098
0 :  0.8 ±0.1 nm
Carbon content: > 90%
Chirality: > 50% =(6,5)
>90% o f tubes are 
semiconducting
Nanolab SWNTs CVD NanoLab, Inc. Order No. D1.5L1-5-S 
Lot No. 90907
Purity: >95%  
0 :  -  1.5 nm 
Length: 1-5 pm
DWNTs CVD Synthesized at 
CmiMAT-LCMIE, 
Université Paul 
Sabatier in Toulouse, 
France
Lot No. PL93(CTA27) Outer 0 :  2.05 nm 
Inner 0 :  1.35 nm 
DWNT content: 77%
MWNTs long & thin CVD Sigma-Aldrich Order No. 636525 
Lot. No. 03826TB
Outer 0 :  10-20 nm 
Inner 0 :  5-10 nm 
Length: 0.5-200 pm 
Carbon content: > 95%
MWNTs short & thick CVD Sigma-Aldrich Order No. 659258 
Lot. No. 04121HD
Outer 0 :  110-170 nm 
Length: 5-9 pm 
Carbon content: > 90%
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Antibodies: The monoclonal CEA antibody with specificity for CD66e (MCA1744F) 
was purchased from AbD Serotec (Kidlington, UK).
Cell lines & culture media: WiDr cells (CCL-218™) and MCF7 cells (H T B -2 2 ™ ) 
were both purchased from ATCC (supplied by LGC Promochem, Teddington, UK) and 
cultured as described in subsection 3.7. MEM (31095-029) and Opti-MEM medium 
(31985-047) were obtained from Invitrogen (Paisley, UK).
Polyethyleneglycol (PEG)-derivatives:
Polyoxyethylene bis(amine) Mw2000 (PEG 2000-NHi), 0-(2-Aminoethyl)-0'-(2- 
carboxyethyl)polyethylene glycol 3,000 hydrochloride (PEG 3000-COOH), and 
poly(ethylene oxide), 4-arm, amine terminated (branched PEG 2 5 OO-NH2) were 
purchased from Sigma-Aldrich (Poole, UK). Carboxy-PEGg-amine (PEG 440-COOH) 
was obtained from Thermo Fisher Scientific (Cramlington, UK) and l,2-distearoyl-5«- 
glycero-3 -phosphoethanolamine-N- [amino(polyethylene glycol)-2000] (ammonium 
salt) (PL-PEG 2 OOO-NH2) from Avanti Polar Lipids Inc. (Alabaster, US).
Other chemicals: Doxorubicin hydrochloride (44583), mitoxantrone dihydrochloride 
(M6545), 5(6)-carboxyfluorescein N-hydroxysuccinimide ester (NHS-fluorescein, 
21878), bovine serum albumin (BSA, A3294), 1-ethyl-3-[3-dimethyl-aminopropyl] 
carbodiimide hydrochloride (EDC, E1769), N-hydroxysulfo-succinimide (sulfo-NHS, 
56485), 2-mercaptoethanol (63700), and ethanolamine hydrochloride (E6133) were all 
purchased from Sigma-Aldrich (Poole, UK).
Other chemicals and reagents were purchased from Sigma-Aldrich or Invitrogen and 
used without further treatment.
3.2 Oxidation of carbon nanotubes
As-prepared SWNTs are usually contaminated with metal catalyst particles, amorphous 
carbon and graphitic nanoparticles. However, the application of CNTs for biomedical 
purposes has created a demand for high purity material, especially if the sidewalls of 
CNTs are to serve as platforms for the non-covalent attachment of biomolecules. For
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the work presented here, acid oxidation was chosen as a method for purification and 
functionalization, as it effectively removes metallic catalyst particles and reduces the 
amount of amorphous carbonFur thermore ,  oxidising acids open the ends of CNTs 
and introduce carboxylic acid groups at the open ends and at defect sites. Depending on 
their strength and oxidising power, they may also create new defect sites along the side 
w a l l s . T h i s  is particularly useful when the nanotubes are to be further functionalized, 
as it affords a higher density of functionalities. As mentioned earlier, Li et al. have 
compared different oxidation methods for CVD-synthesized SWNTs and found that 
nitric acid pre-sonication, followed by refluxing in a mixture of concentrated acids yield 
the best results with respect to p u r i t y . T h i s  two-step process was slightly adapted for 
the work presented in this thesis.
Experimental:
Acid oxidation of CNTs was carried out as follows: 100 mg CNTs were dispersed in 20 
mL concentrated nitric acid, sonicated with a tip sonicator (MSE Soniprep 150, 
amplitude 8 pm) for 6x 10s, and incubated in a water bath at 95 °C for 2h. After 
oxidation, the acid was diluted with water and the mixture centrifuged for 10 min at 
50,000g, followed by extensive washing with deionized water. These pre-treated CNTs 
were then redispersed in a 3:1 mixture of concentrated nitric and sulfuric acid and the 
above described process repeated. Afterwards, the oxidized CNTs were vacuum filtered 
using a 0.2 pm polycarbonate filter (Whatman Ltd.) until the eluate was clear and of 
neutral pH (unwashed sample).
After this procedure, the nanotubes are still covered with so-called oxidation debris. 
This debris can be removed by an additional washing step with a 10 mM sodium 
hydroxide solution. Therefore, the resulting CNT dispersion of the first washing step 
was split into two parts; one was washed with 0.01 M sodium hydroxide to remove 
oxidation debris, followed by washing with water until the eluate was clear and of 
neutral pH (NaOH-washed sample). Both parts were then sonicated with a tip sonicator 
for 6x 10s and centrifuged three times at 75,000g to remove big agglomerates and CNT 
bundles. The concentration of these dispersions was determined gravimetrically.
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3.3 Characterization of pristine and oxidized carbon 
nanotubes
As discussed before, the term “carbon nanotube” does not describe a simple, chemical 
structure, but a whole class of materials, which vary in their numbers of walls, diameter 
distribution, length distribution, chirality, purity, catalyst material, impurity species and 
defects. Thus, characterizing the applied material is crucial in order to ensure quality 
and reproducibility. The nanotubes in this work were characterized by scanning electron 
microscopy (SEM), high resolution transmission electron microscopy (HR-TEM), 
atomic force microscopy (AFM), Raman spectroscopy, UV/vis/NIR spectroscopy, 
thermogravimetric analyis (TGA), and Zeta potential measurements of CNT 
dispersions.
3.3.1 Scanning electron microscopy
Scanning electron microscopy (SEM) is a microscopic technique which creates high- 
resolution, quasi three-dimensional images by focusing a high-energy beam of electrons 
onto the surface of a sample and detecting signals from the interaction of the incident 
electrons with the sample's surface. The type of signals gathered in a SEM varies and 
can include secondary electrons, characteristic X-rays, and backscattered electrons. Its 
primary use mode is secondary electron imaging; however, detecting back-scattered 
electrons emitted from a sample can provide information about the elemental 
composition of the sample, e.g. metal fillings in CNTs. In this work, SEM was applied 
to obtain information on the size (i.e. its projection), shape and structure of CNT 
samples.
Experimental:
Powder samples were prepared by placing a small amount of SWNT powder onto a 
piece of double-sided adhesive tape stuck to a metal stub. Liquid samples were prepared 
by placing a 2 pL drop of a 10 pg/mL SWNT suspension onto a small piece of silicon 
stuck to a metal stub and evaporating residual water using a hot plate. The metal stubs 
holding the samples were then placed into the vacuum chamber of an FEI 200 Nova 
NanoSEM and images acquired using a voltage of 10 kV and a spot size of 3.0 to 5.0.
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3.3.2 High resolution transmission electron microscopy
Transmission electron microscopy (TEM) is a microscopic technique, in which an 
electron beam is transmitted through an ultra thin specimen. An image is formed from 
the interaction of the electrons transmitted through the specimen as the beam passes 
through. In comparison to light microscopy, TEM can image at significantly higher 
resolutions, owing to the small de Broglie wavelength of electrons. In the case of CNTs, 
HR-TEM enables cross sectional imaging and thus delivers information about the 
number of walls, length and diameter, filling state, and chirality.
Experimental:
For sample preparation, oxCNTs were diluted with ethanol and briefly sonicated in a 
water bath for dispersion. 3-5 drops of this suspension were then placed onto a 300 
mesh copper TEM grid and excess liquid was removed with help of a filter paper. 
Finally, images were taken by Mr. Lucien Datas at the University of Toulouse (France) 
using a JEOL-JEM 2100 high résolution-transmission electron microscope.
3.3.3 Atomic force microscopy
Atomic force microscopy (AFM) is a type of scanning probe microscopy (SPM), which 
provides three-dimensional surface profiles of materials by scanning a sharp probe over 
the specimen. Due to the very short working distance between the tip and the sample 
surface, the effects of repulsive/attractive atomic forces can be detected. For most 
measurements in this thesis, AFM was carried out in “tapping mode”. In this mode of 
operation, the cantilever is driven to oscillate up and down at near its resonance 
frequency by a small piezoelectric element mounted on the AFM tip holder. Due to the 
interaction of forces acting on the cantilever when the tip comes close to the surface 
(van-der-Waals forces, dipole-dipole interactions, electrostatic forces, etc.) the 
amplitude of this oscillation decreases as the tip approaehes the sample. An electronic 
servo uses a piezoelectric actuator to control the height of the cantilever above the 
sample. The servo adjusts the height to maintain a set cantilever oscillation amplitude as 
the cantilever is seanned over the sample. A tapping mode-AFM image is therefore 
produced by imaging the force of the oscillating contacts of the tip with the sample 
surface. In contrast mode, on the other hand, the cantilever drags across the surface at
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constant force and the deflection of the cantilever is measured by focusing a laser beam 
onto the back of the cantilever and detecting the position of the refleeted beam with a 
photodiode.
Compared to other microscopic techniques, AFM can produce a true, three-dimensional 
surface profile of a sample, rather than a two-dimensional projection. Moreover, most 
AFM modes can work in ambient air or even liquid environments, which allows for 
imaging of biological macromolecules and living organisms. The resolution of AFM 
images is higher than that of most other teehniques; however, the maximum scanning 
area is much smaller and the scanning speed lower. In the case of CNTs, AFM can 
provide information about the length and diameter distribution.
Experimental:
For AFM sample preparation, oxCNTs were diluted with water to obtain a 
concentration of 10 pg/mL. A droplet of 2 pL was plaeed onto a freshly cleaved mica 
substrate (1 cm^) and dried in air. AFM measurements were performed using a Veeco 
Dimension 3100 Atomic Force Microscope in tapping mode or a PicoPlus instrument 
(Agilent Technologies, Chandler, AZ) operated in contact mode. Both modes were 
carried out at room temperature with a lateral scan rate of 1 - 1.5 Hz at 512 lines. Data 
analysis was carried out using “Gwyddion 2.9”, a free SPM data visualization and 
imaging tool released under the GNU General Public License. The AFM images in 
Chapter 5 and 6 have been obtained by Constanze Lamprecht at the University of Linz 
(Austria) in the framework of collaborative publications.
3.3.4 Raman spectroscopy
Raman spectroscopy probes the lattice vibrations or "phonons" in a material through 
inelastic scattering of light. The frequency of light scattered from a moleeule may be 
changed based on the structural characteristics of the molecular bonds. A 
monochromatic light source (laser) is required for illumination, and a spectrogram of 
the scattered light then shows the deviations caused by state changes in the molecule. 
More precisely, the laser interaets with quantized types of vibrations oecurring in a rigid 
crystal lattice, the phonons, resulting in a shift of the energy of the laser photons. In a 
typieal scattering event, an electron is excited from the valence energy band to the
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conducting energy band by absorbing a photon. The excited photon is scattered by 
emitting or absorbing phonons and relaxes to the valence band by emitting a photon. By 
measuring the intensity of the scattered light as a function of frequency downshift of the 
scattered light, which is what is plotted in Raman spectra, an accurate measure of the 
phonon frequencies of a material can be obtained.^^^^  ^ In contrast to fluorescence 
spectroscopy, the Raman effect can take place for any frequency of incident light.
Raman spectroscopy of SWNTs differs from Raman spectroscopy of crystal lattices in 
various ways due to the unique structure of carbon nanotubes. An SWNT can be 
imagined as a graphene sheet rolled up to a seamless cylinder. Because of the periodic 
boundary conditions in the radial direction, the reciprocal wave vector is quantized, 
leading to a confinement of electrons in this direction. This phenomenon gives rise to 
spikes in the DOS, the “van Hove singularities”. When the energy of the incident light 
matches the energy difference between spikes, Raman scattering becomes a resonant 
process. Calculations have shown that the electronie transitions between the van Hove 
singularities depend on both the diameter and the electronic character of SWNTs. 
Therefore, changing the energy of the incoming photon allows for probing selectively 
whether the nanotubes are semi-conducting or metallic.
A typical Raman spectrum of SWNTs exhibits three characteristic bands. The first band 
corresponds to the "Radial Breathing Modes" (RBM), whose frequencies are inversely 
proportional to the tube diameters. The second band (G-band) is composed of several 
tangential modes due to stretching vibrations of the SWNT sidewall carbon-carbon 
bonds and gives insight on the electronic properties of SWNTs. The third Raman peak, 
the D-band, is indicative of defects in the graphitic structure. The intensity ratio of the 
D- and G-band provides valuable information about the quality of bulk samples: the 
higher the ratio, the higher the quantity of structural defects.^ ^^ "^ ’^ ^^  ^However, in the case 
of short nanotubes (about 100 nm or less) it also increases with decreasing tube length, 
obeying a dependence of Ir/Ic ~ l/lengthcm^^^^
Experimental:
Samples for Raman spectroscopy were prepared by placing a small quantity of CNT 
powder or a droplet of an oxCNT suspension onto a glass slide or cover slip. 
Measurements were performed using a NT-MDT NTEGRA Spectra Probe
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NanoLaboratory with excitation at 633 nm or a Renishaw microRaman instrument at an 
excitation wavelength of 785 nm.
3.3.5 UV/visible absorption spectroscopy
In absorption spectroscopy, the intensity of a beam of light measured before and after 
interaction with a sample is compared. This provides information about concentration, 
as according to Beer Lambert’s Law { A -  e-c- l ) ,  the absorbance A is proportional to 
the sample concentration c. The extinction coefficient e  is an intrinsie material property 
and can be obtained by generating a calibration curve with known concentrations at a 
fixed pH. In addition, SWNT samples display characteristic absorption features in the 
vis/NIR part of the spectrum (600 to 2500 nm), originating from the interband 
transitions in semiconducting and metallic SWNTs. The M u transition for metallic 
nanotubes occurs from -400 to 650 nm, whereas the Sn and S22 transitions for 
semiconducting nanotubes are found between 900 to 1600 nm, and 550 to 900 nm, 
respeetively. The width and fine structure of these bands originate from the distribution 
of SWNT diameters and chiralities.
Experimental:
Molecular absorption spectra were recorded with a Helios alpha UV/visible 
spectrophotometer from Thermo Scientific, using a 1 cm optical pathway quartz 
cuvette. As-prepared CNT samples in powder form were rendered soluble in water by 
wrapping with RNA as described elsewhere.^^^  ^ Oxidized CNT samples were diluted to 
a concentration that gave absorbance values in the linear range.
3.3.6 Thermogravimetric analysis
Thermogravimetric analysis (TGA) determines changes in weight in relation to changes 
in temperature, resulting in a weight-loss curve. In the case of CNT samples, TGA is 
mostly carried out in air and the samples are heated up to 1000 °C. This procedure 
removes the entire carbonaceous material and thus allows for the determination of the 
amount of metal catalyst in CNT samples. The weight change is typically a
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superposition of the weight loss due to oxidation of carbon into gaseous carbon dioxide, 
and the weight gain due to oxidation of residual metal catalyst into solid oxides.
Experimental:
For a typieal TGA experiment, -1 mg of nanotube material was placed in the sample 
holder of a Rheometric Seientific TG 760 series instrument and the material heated up 
at a rate of 10 °C/min, while the weight was measured and recorded continuously.
3.3.7 Zeta potential measurements of CNT dispersions by PALS
The DLVO theory developed by Derjaguin, Landau, Verwey and Overbeek describes 
the stability of colloidal dispersions as a function of attractive forces, such as van-der 
Waals and tc-tc interactions, and repulsive forces caused by the electrostatic double layer 
surrounding each particle.^^^^’^ ^^  ^Both the Zeta potential and width of the electric double 
layer contribute to the total repulsive force. The Zeta potential is defined by the 
potential difference between the stationary layer of fluid attached to the dispersed 
particles and the dispersion medium. It cannot be measured directly, but has to be 
calculated from the experimentally-determined electrophoretic mobility of dispersed 
particles using theoretical models. In principle, dispersions with high Zeta potentials 
(negative or positive) are electrically stabilized, whereas colloids with low Zeta 
potentials tend to coagulate.
Experimental:
The particle size distributions of oxCNT dispersions were measured for 20 pg/mL 
oxCNT dispersions in water using a Brookhaven ZetaPALS (Holsville, New York) by 
means of phase analysis light scattering (PALS) and the results were subjected to a 
mathematical transformation in order to account for the anisotropy of a tubular sample, 
as described by Cherkasova et al.^ ^^ ^^  In particular, this method is based on the 
assumption that the ZetaPALS instrument calculates the diameter d for spheres 
hydrodynamically equivalent to non-spherical particles dispersed in fluids, entailing that 
the translational diffusion coeffieients of both particles are equal. This leads to the 
equation below, which relates the diameter d calculated by the ZetaPALS instrument to 
the length I of anisotropic structures, depending on the aspect ratio a:
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• hi(ci + ^ l — 1)
l = \ d  - -
As the aspect ratio is the quotient of length / and tube diameter dcm  (determinable by 
AFM height analysis), it can be replaced in the equation by a = lld ( .^ , leaving only / 
as unknown.
The Zeta potential Ç, was measured using the same instrument and 5 mM citrate or 
phosphate buffers from pH 2 to 12 (ionic strength = 30 mM), and the results were 
plotted as a funetion of pH. Each data point is the mean value of 10 runs, each 
comprising 20 measurement cycles. The  ^ values are calculated from the particle 
mobilities by means of the Helmholtz-Smoluchowski equation.
3.4 Functionalization schemes
For most biomedical applications, pristine CNTs have to be functionalized for better 
solubility in water, improved biocompatibility and conjugation of further molecules. 
The latter can be conjugated covalently to acid-functionalized CNTs or attached to the 
nanotube surface in a non-covalent manner. The following section provides background 
information and experimental details on all functionalization strategies employed in this 
thesis.
3.4.1 Non-covalent strategies
The two non-covalent functionalization approaches used in this thesis comprise the 
wrapping of CNTs with RNA for better dispersion stability and their loading with the 
anti-cancer drugs doxorubicin and mitoxantrone.
Experimental 1: RNA-wrapping of pristine and oxidized carbon nanotubes
Pristine and oxidized CNTs can be wrapped with RNA in order to debundle tubes and 
render them soluble in water. Particularly Chapter 5 makes use of this technique and 
compares it with other functionalization schemes with regard to dispersion quality and 
stability.
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In order to prepare pristine, RNA-wrapped CNTs, 20 mg RNA was dissolved in 10 mL 
water and mixed with 20 mg pristine CNTs. The mixture was tip sonicated for 6x 10s 
and in a water bath for 90 min. Next, the dispersion was centrifuged at 75,000g for 15 
min to remove insufficiently functionalized CNTs. The supernatant was collected and 
filtered through a 0.2 pm polycarbonate filter to remove excess RNA. Finally, the 
concentration was determined gravimetrically and adjusted to 50 pg/mL or 200 pg/mL.
In order to wrap oxidized CNTs with RNA, 1 mg RNA was dissolved in 1 mL water 
and added to 20 mL of a 50 pg/mL oxCNT dispersion. The mixture was tip sonicated 
for 6x 10s and repeatedly filtered through a polycarbonate filter (0.2 pm pore size) to 
remove excess RNA. Finally, the RNA-wrapped oxCNTs were resuspended in water.
Experimental 2: Attachment o f doxorubicin and mitoxantrone to oxCNTs
In order to attach the anti-cancer drugs doxorubicin or mitoxantrone to oxCNTs, the 
compounds were dispersed in sodium phosphate buffer pH 8 (doxorubicin) or 9 
(mitoxantrone) and incubated overnight while stirring. The following day, unbound 
drug was removed by filtering and washing using Amicon Ultra® 30 kDa centrifugal 
filter devices (Millipore) and the drug-loaded SWNTs resuspended in water at a SWNT 
concentration of 50 pg/mL. In order to determine how much drug has bound to the 
nanotubes, the eluate of the centrifugation steps were collected and analyzed by UV/vis 
absorption spectroscopy at 479 nm (doxorubicin) or 608 nm (mitoxantrone).
3.4.2 Covalent strategies
All covalent functionalization schemes presented in this thesis are based on oxidized 
CNTs as a starting material, whose carboxylic groups can be conjugated to amine 
groups of biomolecules by EDC/NHS coupling chemistry. EDC/NHS coupling 
chemistry was used in this thesis for the following conjugations:
-  Labeling of BSA with NHS-fluorescein (Chapter 4)
-  Conjugation of BSA to oxidized CNTs (Chapter 4)
-  Conjugation of antibodies to BSA-CNT conjugates (Chapter 4)
-  PEGylation of oxidized CNTs (Chapter 5 & 6)
-  Conjugation of folic acid to PEGylated CNTs (Chapter 6)
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The reaction conditions are very similar for each of the listed conjugation reactions, 
based on a protocol developed by Grabarek et al.J^ ^®^  For the sake of simplicity, 
experimental details are given below for two of the listed examples.
Experimental 1: PEGylation o f oxidized CNTs
100 pg oxSWNTs were mixed with sodium phosphate buffer pH 7.6 (final 
concentration 5 mM) and EDC/sulfo-NHS at final concentrations of 20 mM/50 mM and 
incubated for 15 min at room temperature while stirring. In order to quench an excess of 
EDC (only necessary if the second molecule also features carboxylic groups), 2- 
mercaptoethanol was added to a final concentration of 20 mM and the mixture 
incubated for a further 10 minutes. Next, the respective PEG molecule is added, usually 
at a final concentration of 1 mM, and the samples incubated for 2 h at room temperature 
while stirring. Finally, unbound PEG was removed by filtration through 0.2 pm 
polycarbonate filters and the PEGylated nanotubes redispersed in water at a 
concentration of 50 pg/mL.
Experimental 2: Labeling of BSA with NHS-fluorescein
In this labeling procedure, the fluorescent dye NHS-fiuoreseein (10 mg/mL in DMSO) 
was mixed with BSA in sodium phosphate buffer 20 mM pH 8.5 at varying ratios and 
the mixture incubated for 2 h in darkness at room temperature while stirring. This 
reaction is once more based on EDC/NHS chemistry, with the only difference that the 
dye fluorescein was already purchased as an NHS-ester, thus eliminating the need for an 
activation step. To remove excess fluoreseein, the mixture was filtered and washed 
repeatedly using Amicon Ultra® 30 kDa centrifugal filtration devices (Millipore) until 
the eluate was clear. The fluorescein-BSA conjugates were resuspended in sodium 
phosphate buffer 20 mM pH 7.4 at a BSA concentration of 5 mg/mL.
The degree of labeling (fluorescein/BSA molar ratio) was determined by separately 
calculating the protein and fluorophore molar coneentrations of the conjugate by UV/vis 
absorption spectroscopy and expressing these concentrations as a ratio as described in 
Thermo Seientific’s Tech Tip #31 (“Calculate dyeiprotein molar ratios”).
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3.5 Stability studies of carbon nanotubes in chemical and 
biological enviroments
The experiments described in this section were carried out in the framework of Chapter 
5, which was aimed at improving the dispersion stability of oxidised CNTs in chemical 
and biological environments.
3.5.1 Stability studies of oxCNT dispersions in buffers of varying 
pH and concentrations
100 mM buffer solutions of pH 2 to 12 were produced using mixtures of 100 mM citric 
acid/trisodium citrate solutions for pH 2-6 and 100 mM monobasic/tribasic sodium 
phosphate solutions for pH 7-12. As citrate and phosphate have the same valency, this 
guarantees the same ionic strength for all buffer solutions. Furthermore, the distribution 
of the pKa values guarantees good buffering properties over the whole pH range with an 
exception of pH 9 and 10 (located within the steep part of the titration curve). For these 
cases, it was separately confirmed that the buffering capaeity is sufficient to maintain a 
stable pH after addition of oxidized CNTs. In the next step, 20 pg/mL oxCNT solutions 
were mixed with the buffers at various concentrations to achieve a final oxCNT 
concentration of 10 pg/mL and final buffer concentrations of 10, 20, 30, 40, or 50 mM, 
and incubated at room temperature for 4 days.
3.5.2 Stability study of oxSWNTs in cellular growth media of 
varying serum concentrations
Fetal calf serum (FCS) was added to MEM-based, phenol red-free cellular growth 
medium (GIBCO®, Invitrogen, Paisley, UK) supplemented with GlutaMAX® and 
antibiotics in order to create FCS concentrations of 0%, 2.5%, 5%, 7.5% and 10%. 
Next, five different Nanolab SWNT samples were mixed with the different media 
formulations at final CNT concentrations of 10 pg/mL. After one day of incubation, all 
samples were centrifuged at 14,500 g for 10 min and the supernatants analyzed by 
UV/vis spectroscopy at a wavelength of 730 nm, which is outside the absorption 
window of FCS.
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3.6 Drug binding and release studies
The experiments described in this section are associated with Chapter 6, which focuses 
on the optimization of the developed drug delivery system with regard to drug loading, 
dispersion stability, and therapeutic efficacy.
3.6.1 Degradation of doxorubicin and mitoxantrone as a function of 
pH, light, and temperature
100 pL of a 1 mM doxorubicin or mitoxantrone solution was mixed with 50 pL water 
and 50 pL sodium phosphate buffer 100 mM pH 5-9, respectively. The preparations 
were then kept in the fridge or at room temperature for 3 days. Afterwards, HeLa cells 
were incubated with the various drug solutions at concentrations ranging from 0.05 pM 
up to 10 pM for 72 h (doxorubicin samples) or 96 h (mitoxantrone samples). Finally, 
the cytotoxicity of the drug solutions were tested in MTT cell viability assays (see 
below for further details) and IC50 values were obtained by fitting with the four- 
parameter model using OriginPro 7.5.
3.6.2 Effect of pH on drug loading
100 pL oxSWNTs (50 pg/mL) were mixed with 50 pL of a 1 mM doxorubicin or 
mitoxantrone solution, 25 pL sodium phosphate buffer 100 mM at pH 5, 6, 7, 8, or 9, 
and 425 pL water. Next, the samples were incubated for 24 h at 4 °C and subsequently 
filtered using 300 kDa Nanosep® centrifugal devices with Omega™ membranes (Pall 
Corporation, Porthsmouth, UK). The filtrate and the flow-through of the first wash were 
collected for UV/vis analyis (at 479 nm for doxorubicin or at 550 nm for mitoxantrone) 
in order to determine the amount of unbound drug. The wavelength of 550 nm was 
chosen because the absorbance values at the maxima were outside the linear range.
3.6.3 Effect of the PEG type on drug loading and dispersion 
stability
CoMoCAT® oxSWNTs were conjugated to various types of PEG according to the 
procedure described in section 3.4.2, including PEG 2 OOO-NH2, PEG 440-COOH, PEG
59
Chapter 3____________________________________________ Experimental Techniques
3000-COOH, and branched PEG 2500-NH2. Additionally, a fifth sample was prepared 
by non-covalently functionalizing CoMoCAT® oxSWNTs with PL-PEG 2 OOO-NH2.
Next, 10 pg of each oxS W N T peg sample were mixed with 100 pM doxorubicin or 
mitoxantrone and sodium phosphate buffer pH 8 (doxorubicin samples) or pH 9 
(mitoxantrone samples) at a final buffer concentration of 5 mM. After an incubation 
period of 24 h at 4 °C, all samples were split in half. The first halves were used to 
determine the amount of unbound drug by filtration through 300 kDa Pall Nanosep® 
centrifugal devices with Omega™ membranes. Both the filtrates and the flow-throughs 
of the first wash were collected for UV/vis analyis (at 479 nm for doxorubicin or at 550 
nm for mitoxantrone). A sample of the same composition but without oxS W N T speg 
served as the 100% value. The second halves were used to determine the dispersion 
stability (weight percentage of dispersed tubes). Therefore, the samples were 
centrifuged at 12,000 g for 5 min and the supernatants analyzed by UV/vis spectroscopy 
at 730 nm (doxorubicin samples) or at 850 nm (mitoxantrone samples). Note that both 
wavelengths are outside the absorbance range of either drug to ensure measuring solely 
the absorbance signal of the oxS W N T speg-
3.6.4 Effect of the PEG density on drug loading and dispersion 
stability
CoMoCAT® oxSWNTs conjugated to branched PEG 2 5 OO-NH2 were prepared as 
described in section 3.4.2. The applied PEG concentrations ranged from from 5 mM to 
0.1 mM to obtain different PEG densities. The evaluation of drug binding and 
dispersion stability was carried out in the same way as described in the previous section.
3.6.5 Drug release over time at different conditions
Doxorubicin and mitoxantrone were loaded onto oxSWNTs functionalized with 
branched PEG 2 5 OO-NH2 at a drug/CNT ratio of 1:2, which guarantees 100% drug 
binding. After incubation overnight at 4 °C, the samples were mixed with 100 mM 
sodium phosphate buffer pH 5.5, pH 7.4, or cellular growth medium (MEM, phenol red- 
free) and incubated at 37 °C for 24 h, 48 h, or 72 h. After each time point, 500 pL of 
each sample were filtered using 300 kDa Pall Nanosep® centrifugal devices and the
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amount of drug in the eluates analyzed by UV/vis absorption spectroscopy (at 479 nm 
for doxorubicin or at 608 nm for mitoxantrone).
3.7 In vitro studies
The next sections will introduce and describe typical procedures of in vitro studies, 
including the maintenance of cultured cells, the preparation of treated cells for confocal 
microscopy, and cell viability assays.
3.7.1 Cell lines
The two cell lines used in this thesis were WiDr human colon cancer cells, which 
express CE A as a target structure, and HeLa cervical carcinoma cells.
The WiDr human colon cancer cell line was derived from a 78-year old female 
Caucasian and expresses carcinoembryonic antigen (CEA) at a rate of 118 ng/10^ 
cells/10 days (LGC Promochem Product Information Sheet). Growth medium was 
Eagle’s Minimal Essential Medium (MEM) supplemented with 2 mM L-glutamine, 
10% fetal bovine serum, 1 mM sodium pyruvate, 0.1 mM non-essential amino acids, 
and penicillin/streptomycin (100 units/mL penicillin and 100 pg/mL streptomycin) for 
use in a 5% CO2 in air atmosphere.
HeLa cervical carcinoma cells were originally derived from a 31-year old female black 
patient named Henrietta Lacks and have been widely used in research labs for 
approximately 60 years. The cells were cultured in Eagle’s Minimal Essential Medium 
(MEM) supplemented with 2 mM L-glutamine, 10% fetal bovine serum, 0.1 mM non- 
essential amino acids, and penicillin/streptomycin (100 units/mL penicillin and 100 
pg/mL streptomycin) for use in a 5% CO2 in air atmosphere.
3.7.2 Tissue culture
Tissue culture refers to the growth of tissues or cells separate from the organism. It is a 
valuable tool for pharmaceutical or toxicological in vitro studies, as it provides a highly 
selective environment, which can be easily controlled and manipulated. In this thesis, 
WiDr colon cancer cells and HeLa cervical carcinoma cells were used for in vitro
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experiments. Both cell lines are “adherent” and consequently grow on tissue culture 
treated plastic surfaces. For growth and maintenance, the cells are covered with tissue 
culture medium and kept at an appropriate temperature and gas mixture in a cell 
incubator, typically 37 °C and 5% CO2 in air. As long as free surface is available in the 
tissue culture flask, the cells grow in a monolayer with typical doubling times of about 
25 -  30 h. Once the cells are confluent, i.e. completely cover the bottom of the flask, 
they have to be “passaged”. In this procedure, the cells are detached by the help of the 
enzyme trypsin and a small number of cells is transferred into a new vessel. Cells are 
typically grown for about 20 passages.
Experimental:
In a typical passaging procedure, the old/spent medium in the tissue culture flask was 
discarded once the cells were 80-90% confluent. Next, the cells were washed with 
prewarmed PBS to remove any residual medium and incubated with pre-warmed trypsin 
at 37 °C for several minutes. As soon as the cells detached from the bottom of the flask, 
fresh tissue culture medium was added to stop the reaction and the mixture was spun 
down at 600 g for 2 minutes. The supernatant was discarded and the cells resuspended 
in fresh medium. Approximately 20% of this cell suspension was then transferred into a 
new tissue culture flask containing fresh growth medium.
3.7.3 Confocal microscopy for qualitative uptake studies
Confocal laser scanning microscopy can be used to image the interactions of 
fluorescently-labeled molecules or materials with cells. The specimen is illuminated 
with light of a specific wavelength, which is absorbed by the fluorophore and causes it 
to emit light of longer wavelengths that can be detected by the microscope. The key 
feature of confocal microscopy is its ability to produce in-focus images of thick 
specimens. In contrast to a conventional (wide-field) fluorescence microscope, where 
the entire specimen is illuminated, a confocal microscope uses point illumination and a 
pinhole in front of the detector to eliminate out-of-focus information. Only the light 
within the focal plane can be detected, so the image quality is much better than that of 
wide-field images. In this thesis, confocal microscopy was used to image the uptake and 
intracellular distribution of fluorescent anti-cancer drugs, i.e. doxorubicin and 
mitoxantrone, as well as fluorescently labeled CNTs and antibodies.
62
Chapter 3____________________________________________ Experimental Techniques
Experimental:
In a typical experiment, cells were seeded into a 24-well plate containing cover slips at a 
density between STO"^  cells and 10  ^ cells per well and grown overnight to allow 
attachment to the cover slips. The next day, the respective samples were added directly 
into the medium of the respective well (mostly at final SWNT concentrations of 10-25 
pg/mL), followed by an incubation period of several hours. In the experiments in 
Chapter 4, samples with poor dispersion stabilities were tip sonicated for 2x 10 s and 
centrifuged for 60 s at 12,000 g prior their addition to the wells. After the incubation 
period, the medium was discarded and the cells washed repeatedly with pre-warmed 
PBS to remove residual medium. A formaldehyde solution (4% in PBS) was then added 
to the wells for about 10 to 15 minutes to fix the cells. After removing the fixation 
solution and washing three times with PBS, the cells were incubated with a 1:10,000 
solution of ToPro3 nuclear stain for 10 min. After another three washing steps with 
water, the cover slips were taken out of the wells, mounted onto glass sides using 
VECTASHIELD® fluorescent mounting medium and sealed with nail polish.
Confocal microscopy was carried out using a Zeiss LSM 510 confocal microscope 
equipped with an Argon/2 laser in multi-channel mode. Fluorescein-labeled structures 
were excited at 488 nm and emission detected at 500-550 nm, doxorubicin excited at 
488 nm and detected at 650-710 nm and T0PR03 excited at 633 nm and detected at 
650-710 nm. Pictures were taken at 63x magnification by means of a C-Apochromat 
63x/1.4 Oil objective.
3.7.4 Cell viability assays for quantitative uptake studies
Confocal microscopy provides valuable information about the qualitative interaction of 
molecules and materials with living cells. In order to obtain quantitative information on 
cell proliferation, viability, and other live-cell functions, especially during treatment 
with drugs, a number of other methods have been developed. In many cases, this is 
accomplished by dye exclusion or uptake stains, such as trypan blue, which are 
excluded by cells with an intact cell membrane and taken up by cells with disruptured 
cell membranes - or vice versa. Other types of assays measure the activity of enzymes, 
which convert the assay reagent into a coloured product, allowing for colorimetric 
detection. One such example is the MTT assay, which measures the activity of 
mitochondrial enzymes reducing MTT to yield a purple formazan product. Only viable
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cells are able to metabolize tétrazolium salts, such as MTT. Another widely-used assay 
is the LDH assay, which is based on the fact that dying cells release the cytosolic 
enzyme lactate dehehydrogenase. The choice of the assay has to be made carefully 
when working with nanotubes, as some dyes, particularly the more lipophilic ones, have 
been shown to attach to CNTs in the course of the assay and cause false positive 
results.^^^^  ^ This problem can be circumvented by replacing the medium containing the 
nanotubes with fresh medium after the incubation period, before addition of the assay 
reagent.
Experimental:
In order to perform a standard MTT assay as developed by Mosmann et al.,^ ^^ ^^  cultured 
cells in single cell suspension were seeded into a 96-well plate at a density of 10"^  
cells/well. The plate was incubated overnight at 37 °C until the cells were about 50% 
confluent. On the following day, a dilution series of the respective samples in cellular 
growth media was prepared and 50 pL of each sample added to the appropriate well(s) 
containing 200 pL cellular growth medium (resulting in a 1:5 dilution). For all 
experiments in this thesis, logarithmic concentration range of 8 sample dilutions was 
used, each added in quadruplicate. The plates were left to incubate for 72 or 96 h. After 
this incubation period, the medium containing the samples was replaced by fresh 
medium and 25 pL of MTT dye (thiazolyl blue tétrazolium bromide) was added to each 
well. The plates were incubated for another 4 h, after which the medium was aspirated 
off and the formazan crystals, which have been formed at the bottom of the wells, were 
dissolved in 200 pL DMSO. Finally, the plates were transferred into a plate-reading 
spectrophotometer (Labsystems Multiskan RC) and the absorbance of each well was 
read at 540 nm.
Dose-response curves were generated by plotting cell viability against drug 
concentration. In order to obtain IC50 values, curves were fitted using the four-parameter 
model, a widely-used model for fitting sigmoidal dose-response curves based on the 
equation below, with AiowMgh being the minimal/maximal cell viability and p  being the 
“hill slope”.
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4 Triple functionalization of carbon 
nanotubes for targeted cancer therapy
In this chapter, a new method is developed for functionalizing SWNTs with three 
different agents for multimodal drug delivery. This includes the anti-cancer drug 
doxorubicin, a monoclonal antibody for targeting purposes, and the fluorescent marker 
fluorescein, all of which are attached to oxidized SWNTs at non-competing binding 
sites. The proposed methodology allows for the targeted delivery of the anti-cancer drug 
to cancer cells and the visualization of the cellular uptake of SWNTs by confocal 
microscopy. Doxorubicin is chosen as a therapeutie agent, as it is widely used for the 
treatment of many cancers and furthermore possesses a fluorescent hydroxy-substituted 
anthraquinone chromophore with an emission spectrum ranging from 500 to 750 nm, 
enabling intracellular tracking of the drug by confocal microscopy. Fluorescein is used 
to label SWNTs in order to co-localize them inside cells by confocal microscopy next to 
doxorubicin. The monoclonal antibody is able to recognize carcinoembryonic antigen 
(CEA), which is expressed by a number of colorectal carcinomas, such as the WiDr 
colon cancer cell line used in this thesis, and a few other carcinomas, often as an 
indicator of metastatic disease. Most CEA-expressing cell lines rapidly internalize CEA 
antibodies (in less than 30 min),^ ^^ ^^  which is a prerequisite for their use as targeting 
agents. Although antibodies might have drawbacks in in vivo settings, we considered 
this approach a suitable model system for the in vitro studies presented in this thesis.
The overall design of the nanotube-drug complexes is based on the hypothesis that 
functionalized SWNTs are taken up by CEA-expressing WiDr colon cancer cells via 
endocytosis. Following uptake, the lower pH inside endosomes is expected to trigger 
the release of doxorubicin from the nanotube due to increased hydrophilicity of the 
drug, which can then translocate to the nucleus and exert its cytotoxic action.
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4.1 Oxidation of CNTs and sample characterization
Pristine and oxidized Nanolab SWNTs were characterized by SEM, HR-TEM, AFM, 
Raman spectroscopy, and TGA in order to evaluate their purity and their physical and 
chemical properties.
The SEM image of oxSWNTs (Figure 4-1) demonstrates that acid oxidation entangles 
clumps of nanotubes that are present in the bulk sample. The oxSWNTs seem to form 
small bundles, which are covered with a thin layer of a material that has been shown to 
consist of decomposed products of carbonaceous impurities,^ "^ ^  ^ such as partially 
oxidized graphitic fragments, and amorphous carbon. Thermal oxidation can be applied 
to remove these remaining impurities; however, they improve the solubilization 
properties of CNTs by acting as a surfactant.
HV I mag WD ; pressure | det : spot!  ____ 500 n m ------ - -----
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Figure 4-1 Characterization o f  oxidized SWNTs by SEM (magnification = 120K).
The TEM picture in Figure 4-2 reveals more detailed information about the bundling 
state of the nanotubes. Apart from single nanotubes, bundles of up to -15 nanotubes can 
be observed, which are again covered with oxidation debris.
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Figure 4-2 HR-TEM image o f  oxidized SWNTs a t two magnifications.
AFM analysis was applied to extract a height profile and to generate a length 
distribution of the oxSWNTs (Figure 4-3). The height profile features seven SWNT 
bundles with diameters in the range of about 2 to 4 nm. Given that the average diameter 
of a single SWNT is about 1 nm, this corresponds to bundles consisting of 3 to 10 
nanotubes. The length distribution was used to quantify the extent of shortening by the 
oxidation process. The maximum of the size distribution after oxidation lies at 450 ± 50 
nm and 83% of the tubes were found to be between 200 nm and 1000 nm long. 
Considering that the lengths of SWNTs in the pristine sample ranged from 1 to 5 pm, 
this corresponds to a shortening of 80%.
The Raman spectrum (Figure 4-4) shows all features that are characteristic for SWNTs: 
the radial breathing mode (RBM), the D-band and the G-band.^^^^’*^^^  The RBM results 
from low-energy radial vibrations of carbon atoms in the nanotube backbone and hence 
its frequency is inversely proportional to the tube diameter according to 
CÜ = 223.51 d +12.5, where d is the tube diameter in nm and co the Raman shift in wave 
n u m b e r s . T h e  RBM in the Raman spectrum in Figure 4-4 ranges from 170 cm"^  to 
410 cm ^ corresponding to a diameter distribution between about 0.6 and 1.4 nm with 
an average diameter of approximately 1 nm.
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Figure 4-3 a) AFM  image o f  oxidized SWNTs (frame size 5 /urn ), b) height profile extracted from  a) and  
c) length distribution obtained by measuring 500 nanotubes using Gwyddion.
Maximum intensities are observed at 228 cm"\ 284 cm '\ and 403 cm'^; relating to 
accumulated diameters around 1.06, 0.82, and 0.57 ± 0.01 nm. The disorder-induced D- 
band at 1380 cm‘  ^ indicates the presence of defects, whereas the G-band at 1640 cm'^ is 
a tangential vibrational mode characteristic to all graphitic materials.
The D/G intensity ratio is a good indicator for the quality of bulk samples: the higher 
the ratio, the higher the quantity of structural defects.^^^^  ^For the oxSWNTs analysed by 
Raman spectroscopy in Figure 4-4 the Id/Ig ratio was found to be 7.2% ±0.1%, which 
suggests a low amount of defects. In comparison, Worsely et al. obtained an Id/Ig ratio 
of 14% for their sample of nitric acid-treated SWNTs (Carbon Solutions, Inc., produced 
by arc discharge) in a study from 2009^ ' '^^^ , although the acid treatment used was 
somewhat weaker due to their use of nitric acid only (and not a mixture of nitric and 
sulfuric acid). The lower Id/Tg ratio of the oxidised nanotubes used in this chapter is 
likely due to a better quality of the starting material.
Lastly, oxSWNTs were analyzed by TGA to determine the amount of metal catalyst in 
the bulk sample. The metal residue was found to be 11 ± 1% for both pristine SWNTs
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and oxSWNTs (Figure 4-5). This indicates that the present metallic catalyst particles are 
encapsulated in carbon shells (so-called nano-onions)/^^^^ which protect them from acid 
oxidation, but also prevent them from being released in biological environments and 
causing toxic effects.
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Figure 4-4 Raman spectrum o f  oxidized SWNTs (excitation 633 nm).
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Figure 4-5 TGA weight loss cur\>e o f  pristine SWNTs (black) and oxidized SWNTs (red).
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4.2 Functionalization with doxorubicin, BSA-fluorescein, 
and CEA antibodies
oxSWNTs were functionalized with three different agents at non-competing binding 
sites in order to build a multimodal drug delivery system. This includes a monoclonal 
antibody for targeting purposes, an anti-cancer drug, and a fluorescent dye to enable 
visualization of cellular uptake. Figure 4-6 shows a schematic illustration of the 
structure, which is proposed for the nanotube-drug-BSA conjugates. The distribution of 
functional groups after acid oxidation of CNTs has already been investigated in 
previous studies, which showed that functional groups are found at the ends of the tubes 
and along the sidewalls.
antibody
SWNT
doxorubicin
fluorescein
i, BSA
Figure 4-6  Schematic illustration o f  the doxorubicin-fluorescein-BSA-antibody-SW NT com plexes 
(red=doxorubicin, green=fluorescein, light blue=BSA, dark b lue-an tibodies).
AFM analysis of a sample of doxorubicin-fluoreseein-BSA-SWNTs (Figure 4-7) 
reveals globular structures of several nanometers in height distributed along two CNTs. 
Considering that the hydrodynamic diameter of BSA is 4 x 14 nm (-^ ellipsoidal 
s h a p e ) a n d  the diameter of dried BSA somewhat smaller, this suggests that BSA 
molecules have been attached to the CNT sidewalls.
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2.50 nm
0.00 nm
Figure 4 -7  AFM  image o f  doxorubicin-fluorescein-BSA-SWNT complexes (without antibodies).
Regarding the applied functionalization techniques, a non-covalent method was chosen 
for attachment of doxorubicin to allow for its release after cellular uptake, whereas 
covalent methods were employed to attach fluorescein and CEA antibodies to oxidized 
SWNTs, The latter was achieved by using the hydrophilic protein bovine serum 
albumin (BSA) as a multifunctional linker. In total, BSA possesses 60 amino groups in 
lysine chains and 99 carboxylic groups as part of glutamic and aspartic acid residues. 
Those residues located on the protein surface are available for conjugation reactions and 
thus provide two different types of binding sites for the covalent attachment of 
molecules. In the approach presented in this chapter, BSA is conjugated to carboxylic 
groups of oxSWNTs by one of its amine groups, to NHS-fluorescein via the remaining 
amine groups, and to monoclonal CEA antibodies via its carboxylic groups. Since 
multiple copies of fluorescein and antibodies can be attached to one BSA molecule, the 
degree of eoupling is inereased manyfold. The functionalization procedure is a critical 
process comprising four steps, whieh can easily result in many kinds of unwanted 
crosslinking reactions. Hence, the reaction parameters have to be selected and adjusted 
carefully, as will be described in the following.
4.2.1 Labeling of bovine serum albumin (BSA) with fluorescein
In the first synthesis step, the protein BSA is labeled with the amine-reaetive dye NHS- 
fluorescein. Here, it is crucial to find the optimal NHS-fluoreseein concentration in 
order to leave enough free amino groups on the BSA for the later attachment of CNTs.
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However, leaving too many free binding sites would lead to crosslinking of nanotubes 
via BSA and consequently preeipitation. Thus, optimization of the fluorescein/BSA 
ratio was performed by testing three different weight ratios (1:20, 1:50, and 1:100) in 
their binding properties to SWNTs. Furthermore, the degree of fluorescein labeling was 
determined by UV/vis absorption spectroscopy.
4.2.2 Non-covalent attachment of doxorubicin to oxidized SWNTs
In the seeond synthesis step, the anti-cancer drug doxorubicin is non-covalently 
attached to the sidewalls of oxSWNTs via %-stacking and hydrophilic interactions with 
carboxylic groups. The strength of this non-covalent binding is pH dependent: At a low 
pH, the amino group in the sugar moiety of doxorubicin is protonated, which increases 
the molecule’s hydrophilicity and thus its solubility in water. However, at a higher pH, 
the amino group beeomes deprotonated, resulting in stronger hydrophobic interactions 
with the nanotubes’ side walls and lower solubility in water. Liu et al. have attached 
doxorubicin non-covalently to the side walls of SWNTs by overnight incubation at pH 
However, Janssen et al. reported that doxorubiein hydrochloride has its maximum 
stability at pH 4 ,™  indicating that processing the drug at pH 9 may cause its 
degradation and consequently its loss of cytotoxicity. Thus, to ensure a high drug 
loading whilst maintaining doxorubicin’s therapeutic properties, the reaction was 
carried out at a slightly lower pH of 8.5. According to Beijnen et al., who generated a 
pH-dependent decomposition profile for doxorubicin at 50 °C corrected for buffer and 
ionic strength influences, the deeomposition rate of doxorubicin at pH 8.5 is 
approximately 35% lower than at pH 9.0.
The amount of doxorubicin bound to the nanotubes was calculated by determining the 
quantity of unbound doxorubicin in the eluate of the filtration step by UV/vis absorption 
spectroscopy. It was found that 87.5% of doxombicin had attached to the nanotubes, 
whereas 12.5% had been washed off. In terms of weight, the ratio of doxorubicin to 
oxidized SWNTs is 20:1, which demonstrates the enormous binding capacity of the 
nanotubes. Liu et al. have determined a weight ratio of 4:1 in a similar experiment^^^^ -  
however, the surfaee of their (non-oxidized) SWNTs was already covered with 
phospholipid-PEG-molecules to a certain extent, which were previously applied to 
solubilize the nanotubes.
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4.2.3 Connection of fluorescein-labeled BSA and doxorubicin- 
loaded SWNTs
In the third synthesis step, the fluorescein-labeled BSA was conjugated to the 
doxorubicin-loaded oxSWNTs. In order to avoid non-specific binding of BSA to the 
nanotubes’ sidewalls, it was crucial to load them with doxorubicin before conjugation 
with fluorescein-BSA. In order to find out the optimal fluorescein/BSA ratio, three 
fluorescein/BSA complexes at different weight ratios (1:20, 1:50, and 1:100) were 
prepared and their binding to SWNTs evaluated in a qualitative and quantitative 
manner. In theory, a BSA molecule possesses 60 amino groups, which are the binding 
sites for both fluorescein and the drug-loaded nanotubes. Thereof, an estimated 5-10% 
are located on the protein surface and ready to engage in coupling reactions, i.e. 3-6 
amino groups per protein molecule. Ideally, after fluorescent labelling all binding sites 
but one should be occupied, which can then be used for coupling to a nanotube. If all 
binding sites were occupied with dye molecules, no nanotube binding could occur, 
whereas if a protein molecule possessed several free binding sites after labelling with 
the dye, there would be a risk of crosslinking nanotubes, resulting in agglomeration and 
a lower percentage of binding. Experimentally, it was found that an initial 1:20 weight 
ratio of fluorescein/BSA yielded a molar ratio (moles dye per mole protein) of 3.9 ± 0.2 
after the coupling reaction and subsequent washing, whereas an 1:50 weight ratio 
resulted in a molar ratio of 2.3 ±0.1 and a 1:100 weight ratio in a molar ratio of 1.3 ± 
0.1 and agglomeration of the sample (Table 4-1). Based on these results it was decided 
to use an initial weight ratio of 1:50 ratio in all following experiments.
Table 4-1 Influence o f  the fluorescein/BSA ratio on the binding o f  the respective conjugates to SWNTs
Degree of labeling 3.9 ± 0.2 2.3 ±0.1 1.3 ±0.1
Agglomeration + + +++
4.2.4 Attachment of monoclonal CEA antibodies to doxorubicin- 
fluorescein-BSA-SWNT conjugates
In the last synthesis step, monoclonal antibodies were attaehed to the still unoccupied 
carboxylic groups of the BSA (now part of the doxorubicin-fluorescein-BSA-SWNT
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complexes). Here, it has to be considered that whenever two protein ligands undergo a 
eoupling reaction catalyzed by EDC and sulfo-NHS, excessive EDC has to be quenched 
by 2-mereaptoethanol, as otherwise carboxylic groups of both eoupling partners (BSA 
and CEA antibodies) would be activated and cause extensive erosslinking. Additionally, 
it needs to be considered that this method connects the antibody to the nanotube-earrier 
in a random way, whieh might in some eases block its binding site.
4.3 Delivery of the drug-SWNT conjugates to WiDr colon 
cancer cells
To study the uptake of doxorubicin-fluorescein-B SA-SWNTs complexes by WiDr 
colon cancer cells and investigate the suitability of functionalized SWNTs as a drug 
delivery system, WiDr cells were incubated with the nanotube-drug complexes for 4 h. 
Afterwards, laser scanning confocal microscopy was applied to track the location of 
doxorubicin and the fluorescein-labeled SWNTs inside cells.
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Figure 4-8 Absorption and emission spectra o f  fluorescein and doxorubicin.
Confocal microscopy is a special type of fluorescence microscopy, whieh only detects 
light within the focal plane by eliminating out-of-focus information via point 
illumination and a pinhole in front of the detector. In order to find the right parameters
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for excitation wavelengths and emission filters, the excitation and emission spectra of 
fluorescein and doxorubicin were compared (Figure 4-8). To avoid crosstalk between 
the channels, the excitation wavelength was set to 488 nm for both fluorescein and 
doxorubiein and emission of fluorescein detected between 500 and 530 nm, whereas 
emission of doxorubiein was detected between 650 to 710 nm.
—:-----V—...ygr-vTK-----
micleut 
cytoplasm
'4-9 Confocal image o f  WiDr cells incubated with doxoriibicin-fluorescein-BSA-SW NT complexes 
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As stated earlier, the whole drug delivery experiment is based on the hypothesis that 
functionalized SWNTs are taken up by WiDr cells by endocytosis. The lower pH inside 
endosomes is expected to trigger the release of doxorubiein from the nanotubes due to 
inereased hydrophilicity. Indeed, Figure 4-9 clearly demonstrates, that doxorubiein (red) 
does not eo-localize any longer with the fluorescein-labeled SWNTs (green) after 
internalization by WiDr cells, but is found to accumulate in the nuclei of cells (seen as 
round structures positioned in the centre of the cell). The fluorescently-labeled 
nanotubes, however, are mainly observed outside the nuclei within the cytoplasm. Areas 
in the cell where doxorubiein and fluoreseein-labeled nanotubes eo-loealize can be 
observed along the border between the cytoplasm and the nucleus, the so-called 
“nuclear envelope”, and on the cell membrane. The delivery efficacy in this experiment 
was 100%, meaning that all cells have taken up the SWNT complexes.
nucleus cytoplasm
a =
nucleus
V
b =
c =
Figure 4 -JO Confocal images o f  controls: a) fluorescein-BSA; b) cloxorubicin-SWNTs; c) doxorubicin 10 
jiM. Panel a) shows that BSA-fluorescein on its own (without being connected to nanotubes) is only taken 
up by cells to a sm all extent, whereas doxorubicin on its own (panel c) is able to pass the celhdar
membrane due to passive diffusion.
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Several controls were performed to corroborate these findings, including fluorescein- 
BSA conjugates, doxorubicin-SWNT complexes without fluorescein-BSA, and 
doxorubiein alone. Figure 4-10a shows a low level of fluorescence, indicating that 
fluorescein-BSA conjugates are only able to enter cells to a small extent, which 
demonstrates that SWNTs play an important role as a delivery system. However, when 
comparing Figures 4-10b and 4-10c it is noted that this is not the case for doxorubicin: 
due to its molecular structure, the drug is able to cross cell membranes without the help 
of a carrier system and accumulates in the cell nuclei, as shown before. Nevertheless, 
the nanotubes still play an important role, as they enable molecular targeting via the 
attachment of monoclonal antibodies and are crucial for the delivery of drugs that are 
not taken up by cells under normal conditions.
4.4 Evaluation of the therapeutic efficacy via cell viability
assays
Once it was proven by confocal microscopy that the drug-loaded nanotubes were able to 
deliver their therapeutie payload to WiDr cells, the next step was to examine their 
therapeutic efficacy by means of cell viability assays and compare it to that of free 
doxorubicin. The result is shown in Figure 4-11: the nanotube-drug conjugates became 
less efficacious, the more complex they became.
While simple doxorubiein-loaded CNTs were only slightly less efficacious than free 
doxorubicin, covalent conjugation of BSA to the drug conjugates reduced cytotoxicity 
by 50%. The attachment of another entity, CEA antibodies, even resulted in a 7-fold 
reduction in cytotoxicity compared to the free drug.
A possible explanation might lie in the fact that the complexes precipitated during the 
various conjugation steps; in fact, the extent of preeipitation inereased with each 
additional layer of molecules attaehed. Although the synthesis technique was designed 
to minimize preeipitation, it had not been possible to avoid it completely. At this stage 
of the study, the reasons underlying the effects seen with the conjugate preparation were 
unclear. Follow-up studies dedicated to solve this problem will be presented in the next 
chapter.
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Figure 4-11 D ose-response curves fo r  WiDr cells after 96  h o f  incubation with the different nanotube- 
drug complexes, fitted  using the 4-param eter model. The more complex the conjugates, the less active
they appear to become.
4.5 Conclusions
This chapter presents a novel funetionalization approach to equip oxSWNTs with three 
different agents for multimodal drug delivery. It is demonstrated that SWNTs can 
successfully transport a potent anti-eaneer drug to human eaneer cells with subsequent 
transloeation of the drug to the nucleus, while the SWNTs remain in the cytoplasm. 
This finding suggests that SWNTs may be used to enhance cellular pharmacokinetics 
and have considerable implications for improving anti-cancer drug delivery. However, 
the complexes showed a rather poor therapeutie efficacy in cell viability assays 
compared to free doxorubiein, likely due to precipitation of the complexes during the 
synthesis steps and during the incubation period in cellular growth medium during the 
cell viability assay. Thus, next steps will aim to improve the dispersion stability of the 
developed drug delivery system in chemical, as well as in biological environments.
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5 Stability study of functionalized CNTs 
towards higher dispersion efficacy in 
chemical and biological environments
Aqueous dispersions of functionalized CNTs are now widely used for biomedical 
applications in a number of areas, for example for gene and drug delivery. Their 
stability in the various chemical and biological environments they encounter during 
functionalization and in vitro/in vivo experiments is a definite factor influencing cell 
uptake and biodistribution. It depends on a wide range of parameters, such as pH and 
salt concentration of the surrounding medium, as well as length, aspect ratio, surfaee 
charge, and functionalization scheme of the applied nanotubes. Although many of these 
aspects have been investigated separately, no study is available in the literature to date 
whieh examines these parameters simultaneously. Therefore, we have chosen five types 
of CNTs, varying in their dimensions and surface properties, for a multi-dimensional 
analysis of dispersion stability. To examine the influence of oxidation debris, the 
samples were analyzed before and after removal of the debris. The first study examined 
the dispersion behaviour of oxidized CNTs in salt solutions of differing pH and 
concentrations, whereas the seeond study investigated their stability in cellular growth 
media of varying serum concentrations and human plasma. To enhance the 
dispersability of CNTs in these environments, the influence of different 
functionalization methods (RNA-wrapping or covalent PEGylation) was studied. 
Finally, a potential toxic effect of all CNTs samples on WiDr colon cancer cells was 
investigated by means of cell viability assays and RNA-wrapping and covalent 
PEGylation were tested as options to improve their biocompatibility.
The results of these studies indicate that both CNT dimensions and surfaee 
functionalization have a significant influence on their dispersion and in vitro behavior. 
In particular, factors such as a short aspect ratio, presence of oxidation debris and serum 
proteins, low salt concentration, and an appropriate pH are shown to improve the
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dispersion stability. Furthermore, covalent surfaee funetionalization with amine- 
terminated PEG is demonstrated to stabilize CNT dispersions in various media and to 
reduce deleterious effects on cultured cells. These findings provide crucial data for the 
development of biofunctionalization protocols, e.g. for potential cancer theranostics, 
and optimizing the stability of functionalized CNTs in various biological environments.
5.1 Functionalization of CNTs and sample characterization
Acid oxidation is commonly used to render pristine CNTs soluble in water and 
introduce functionalities to the tube surface. In this study, the same acid oxidation 
protocol was applied to all samples. Because different types of CNTs exhibit different 
susceptibilities towards acid oxidation, varying extents of CNT shortening were 
observed, as demonstrated by AFM analysis (Figure 5-1). Nanolab SWNTs and long & 
thin MWNTs remained most intact, followed by DWNTs, and finally CoMoCAT® 
SWNTs and short & thick MWNTs. In the case of CoMoCAT® SWNTs, this is likely 
due to their smaller diameter (~ 0.8 nm) in comparison to Nanolab SWNTs (~ 1.5 nm), 
which makes them more prone to breakage by acids and sonication.^^ In the case of 
short & thick MWNTs, however, it seems likely that the reduction in average particle 
size is due to size fraetioning of the CNTs during ultra-eentrifugation. The pristine tubes 
exhibit diameters from 110 to 170 nm and hence, oxidation of the outer layer appears to 
be insufficient to solubilize such heavy tubes. Only the shortest and thinnest CNT 
species in the sample appear to have been rendered soluble by oxidation, so that they 
remain in the supernatant during high-speed ultra-centrifugation. Indeed, AFM height 
analysis showed that most tubes in the sample after acid oxidation had diameters 
between 15 and 40 nm and few up to 80 nm (data not shown). Furthermore, the yield 
was only 1%, compared to 5 and 15 % for the other samples.
Phase analysis light scattering (PALS) measurements of 20 pg/mL oxCNT dispersions 
in water were carried out to obtain the size distributions of the various samples. The 
mean values of the obtained size distributions were subject to a mathematical 
transformation to account for the anisotropic shape of CNTs as described in the 
methodology and are displayed in each panel of Figure 5-1.
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Chapter 5 Stability study of functionalized CNTs towards higher dispersion efficacy
The results are in good agreement with the AFM results, except probably in the ease of 
the Nanolab oxSWNTs, of whieh the majority seems to be longer than the / yalue 
suggests. Howeyer, this sample also contains yery small CNT fragments barely yisible 
in the AFM images, thus lowering the mean length obtained. The PALS data further 
indicates that remoyal of oxidation debris by NaOH washing changes the mean yalues 
of the size distributions. In the case of CoMoCAT® SWNTs and short & thick 
MWNTs, the mean particle size beeomes slightly larger, whereas in the ease of the other 
CNT samples it decreases to some extent. A possible explanation might lie in the effect 
of oxidation debris on the bundling states of the nanotubes. In the ease of longer 
nanotubes, such as Nanolab SWNTs, DWNTs, and long & thin MWNTs, oxidation 
debris might promote bundling by gluing nanotubes to each other, as illustrated in 
Figure 5-2. Remoyal of the debris would lead to debundling of the tubes and thus to a 
decrease of the mean particle size. Short nanotubes, howeyer, are more likely to form 
well-dispersed, micelle-like structures: In this ease, remoyal of oxidation debris might 
result in the formation of agglomerates, as obseryed for CoMoCAT® oxSWNTs and 
short & thick MWNTs in the AFM images (Figures 5-lg/ and 5-lj), and hence result in 
an increase of mean particle size.
Long CNTs covered with oxidation debris:
formation of bundles glued together by debris
Short CNTs covered with oxidation debris:
formation of micelle-like structures
Figure 5-2 Possible effect o f  oxidation debris on the bundling behavior o f  a) long CNTs, suggesting the 
form ation o f  bundles, and b) short CNTs, suggesting the form ation o f  m icelle-like structures.
Another obseryation was that the full width at half maximum (FWHM) decreased after 
NaOH washing, indicating a narrower size distribution. This might again be a reflection
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of the de-bundling behavior, as described above. Debundling of long CNTs by NaOH 
washing removed the largest structures, whereas agglomeration of short CNTs after 
removal of oxidation debris removed the smallest structures; both resulting in a 
narrower size distribution.
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Figure 5-3 Characterization o f  Nanolab oxSWNT sam ples before and after N aOH  wash, as w ell as o f  the 
oxidation debris in th efd tra te  o f  the NaOH wash. First row (a-c): HR-TEM analysis, demonstrating the 
rem oval o f  oxidation debris by NaOH washing and the non-tiibular composition o f  the debris. Second  
row (d-f): Raman analysis o f  the same sample.
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To further investigate the effect of NaOH washing on the morphology of oxCNTs, 
Nanolab oxSWNTs were examined by Raman spectroscopy (excitation at 633 nm) and 
HR-TEM before and after NaOH washing (Figure 5-3). In addition, the oxidation debris 
in the filtrate of the NaOH wash was analyzed by the same methods to obtain an idea of 
its composition.
Figure 5-3a demonstrates that the surface of the unwashed oxSWNTs is covered with a 
uniform layer of oxidation debris, whereas the tubes in the washed samples (Figure 5- 
3b) feature a cleaner surface (also visible in the AFM images in Figure 5-1). HR-TEM 
analysis of the debris fraction reveals non-tubular, globular shaped structures (Figure 5- 
3c). Raman analysis of the CNTs showed a significant decrease of the Id/Ig ratio from 
6.8 to 6.0 ±0.1%  after NaOH washing, indicating the possible removal of defective 
material from the sample. Similar to this, Worsely et al. observed a decrease of the of 
the Id/Iq ratio from 14% to 10% (after first NaOH wash) and 7% (after third NaOH 
wash) for their sample of oxidised SWNTs.^^^^  ^This rather dramatic decrease once more 
indicates that the quality of their starting material is worse than that of the nanotubes 
used in this chapter. Indeed, the quality of the nanotubes used by Worsley et al. is stated 
by the manufacturer to range between 40-60%, whereas the quality of pristine Nanolab 
SWNTs is supposedly higher than 95%.
The Raman spectrum of the oxidation debris in the filtrate (Figure 5-3f) shows a close 
resemblance to the spectrum of common graphite with an Id/ Iq ratio of about 67.1 ±
0.1% and indicates that the debris consists of highly disordered graphitic carbon. The 
lack of radial breathing modes (RBM) confirms the absence of smaller more ordered 
tubular structures in the form of SWNTs. Furthermore, a change in the RBMs can be 
observed (Figure 5-4). The spectrum of the unwashed sample features two main peaks 
at 188 cm"^  and 295 cm"\ relating to accumulated diameters at 1.27 and 0.79 ± 0.01 nm. 
In the spectrum of the NaOH-washed sample, however, the first peak is split up into 
four intense peaks ranging from 181 cm'^ to 213 cm'^ with much lower intensities. This 
is indicative of a narrower diameter distribution, i. e. due to removal of a defective outer 
layer of the present double-walled tubes or dissolution of slightly larger diameter tubes. 
The second peak at 295 cm"\ relating to CNTs with a diameter of about 0.79 nm, 
remains unchanged.
84
Chapter 5 Stability study of functionalized CNTs towards higher dispersion efficacy
NaOH-washed
unwashed400
300
200
10000
150 200 250 300 350
Raman shift (1/cm)
Figure 5-4 M agnified cutout o f  the Raman spectra in Figure 5-3e and f  to compare the RBMs o f  oxidized  
Nanolab SWNTs before and after N aOH  washing.
Besides the samples’ morphologies, their Zeta potentials were measured as a function of 
pH. The Zeta potential is a measure of electrostatic interactions between colloidal 
particles and has been used in the literature to investigate the density of acidic sites on 
the surface of MWNTs and the stability of the colloidal MWNT d i s p e r s i o n s . A n  
increase in absolute Zeta potential leads to enhanced electrostatic repulsion and is 
therefore associated with improvement of the stability of particle dispersions. Herein, 
short & thick oxMWNTs were chosen for Zeta potential measurements, as they contain 
the largest tubes with the lowest aspect ratio and hence afforded the best and most 
accurate results with the phase analysis light scattering (PALS) technique, which is 
normally used for spherical colloids. Both unwashed and NaOH-washed oxMWNTs 
were investigated to account for the effect of oxidation debris.
Figure 5-5 shows that in both cases the Zeta potential is least negative at pH 2. It then 
becomes more negative with increasing pH, as more carboxylic groups become 
deprotonated, and finally stabilizes around pH 8. When comparing the two different 
samples, it becomes apparent that the Zeta potential of the unwashed sample is more 
negative than that of the NaOH-washed samples over the whole pH-range. This is likely 
due to the presence of oxidation debris in the unwashed sample, which contains a major 
part of the samples’ functionalities^^^^’^^^^^ and hence contributes to the total Zeta 
potential, as long as it is attached to the CNT surface. At a basic pH, however, the 
debris detaches from the tubes and since the size of the particles in the debris is no
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longer large enough to give rise to light scattering, it ceases to contribute to the Zeta 
potential, which also explains the slight increase at a pH above 10.
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Figure 5-5 Zeta poten tia l o f  short & thick MWNTs (unwashed and NaOH -washed) as a function o f  pH. 
The Zeta potential decreased with increasing pH, as more and more carboxylic groups becom e 
deprotonated. The Zeta potential o f  the unwashed sam ple was higher because the oxidation debris  
contains a m ajor part o f  the sam ples’ functionalities.
5.2 Stability studies of oxCNT dispersions in buffers of 
varying pH and salt concentrations
The pH and salt concentration of an aqueous medium highly influences charged 
molecules and objects within their boundaries. Thus, the stability of CNT dispersions is 
also influenced by pH and salt concentration of the environment and if they are to be 
used for theranostic purposes, these aspects must be studied in detail. Hence, a multi­
parameter study of CNT dispersion stability was conducted by subjecting dispersions of 
five different types of oxidized SWNTs, DWNTs, and MWNTs (with and without 
oxidation debris) to buffers of varying concentrations and pH (2 to 12). As discussed 
previously, oxidation debris tends to stabilize CNT dispersions by acting as a surfactant 
or charge buffer.
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Table 5-1 M ethodology fo r  scoring the dispersion stability o f  oxCNT dispersions in buffers
0 Total Clear 0 - 5
1 Heavy Light grey 5 - 1 0
2 Medium, clearly visible Mid grey 1 0 - 2 5
3 Little, barely visible Dark grey 2 5 - 5 0
4 No visible agglomerates Dark grey 5 0 -  100
The stability of each dispersion was assessed and scored after 4 days according to a 
scale from 0 to 4 as indicated in Table 5-1 and Figure 5-6, using the depicted 
dispersions as references.
0 1 2
Figure 5-6 Scoring the dispersion stability o f  oxCNTs in buffer solutions o f  varying p H  and concentration
(supplementary to Table 5-1).
This semi-quantitative analysis technique was chosen due to the high number of 
samples to analyze in the course of these experiments (55 measurements for each 
sample, 10 samples in total, all measurements carried out in duplicate or triplicate), 
although this means of analysis can only convey a trend rather than provide statistically 
sound data. In order to validate this methodology, one of the samples (oxMWNTs long 
& thin, NaOH-washed) was selected and analyzed in a quantitative manner by spinning 
down precipitated tubes after the 4-day incubation period and measuring the absorbance 
of the supernatants by UV/vis absorption spectroscopy. Expressed as a ratio to the 
initial absorbance (before centrifugation), one obtains a percentage of how many tubes 
remained dispersed after centrifugation, which is referred to as “stability of dispersion
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(%)” in Figure 5-7. The obtained quantitative results were then converted using the 
logarithmic precipitation suggested in Figure 5-7 (i.e. all values between 0 and 5% were 
scored “0”, all values between 5 and 10% scored “1” and so on). A comparison of these 
transformed quantitative results with the semi-quantitative results obtained through 
rating by eye indicated agreement in 89% of all data points.
1. Quantitative UV/vis results 2. Transformation scheme
0 -5% 0
5%-10% 1
10% -  25% 2
25% -  50% 3
50%-100% 4
3. Transformed UV/vis results 4. Semi-quantitative results
(rating by eye)
50 12
Agreement 
in 89 % of all 
data points!
< >■
20^
30
40
50
I
I
IS
Figure 5 -7  Validation o f  semi-quantitative analysis technique: Fully quantitative results obtained by 
UV/vis analysis are transformed using the logarithmic scale in Table 5-1, resulting in 89%  conformity
with the sem i-quantitative results.
The results of the multi-parameter study presented in the following will be discussed in 
the framework of the Derjaguin, Landau, Verwey and Overbeek (DLVO) theory, 
which describes the stability of colloidal solutions as a function of attractive forces,
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such as van-der Waals and n-n interactions, and repulsive forces caused by the 
electrostatic double layer surrounding each particle. Both the Zeta potential and width 
of the electric double layer contribute to the total repulsive force. A higher absolute Zeta 
potential leads to enhanced electrostatic repulsion and hence is a major factor 
influencing dispersion stability.
Another aspect affecting oxCNT dispersion stability is the type of counter-ions present, 
giving rise to a so-called “lyotropic effect”. Although counter ions of the same valence 
have similar critical agglomeration concentrations (CACs), small differences can exist 
due to the different ion sizes. The order of the CAC for monovalent cations is > Cs^ 
> Rb^ > N H / > Na"^  > Li^, indicating that Na"^  ions have a greater capability to induce 
agglomeration in dispersions than ions. The lyotropic effect is of considerable 
importance in this experiment due to the manner in which the buffers were prepared 
(citrate buffers for pH 2 to 6 and phosphate buffers from pH 7 to 12), leading to the 
lowest Na"^  concentrations at pH 2 and 7 and highest Na"^  concentrations at pH 6 and 12.
Taken together, the stability of the CNT dispersions is influenced by three main 
parameters: the Zeta potential, the Na"^  concentration of the buffers, and the presence of 
oxidation debris in unwashed oxCNT samples. This is illustrated in Figure 5-8, in which 
both Zeta potential (A) and Na"^  concentration (B) were plotted as a function of pH and 
normalized, with the highest absolute Zeta potential and the lowest Na"^  concentration 
corresponding to a value of 1 (optimal dispersion stability); and the highest Na"^  
concentration and lowest absolute Zeta potential corresponding to a value of 0 (minimal 
dispersion stability). In the case of the unwashed sample, a third curve (C) was 
generated to account for the surfactant properties of oxidation debris in the unwashed 
sample, which was normalized in the same fashion. The resulting curves (Ri) and (R2) 
are linear combinations of the three effects; generated in a way to optimally mimick the 
experimental data. Note that this was mainly done in order to explain and understand 
the experimental data rather than to set up a theoretical model for the effect of pH on 
dispersion stability. In the case of the NaOH-washed samples, both effects (A) and (B) 
were weighed equally {R2 = V2 A2 + V2 B). In the case of the unwashed samples, 
however, the experimental data (Figure 5-9) suggested that the effect of the oxidation 
debris (C) is dominating, which was implicated by giving it a higher weight (75%) than 
the effects (A) and (B), which were each weighted with 12.5% (Ri = Vs Ai + Vs B +
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Nanolab SWNTs (unwashed)
oxidation debris present
1
Ri = % Ai + Vs B + 3/4 C
0
412 10 8 6 2
pH
Nanolab SWNTs (NaOH-washed)
oxidation debris washed off
0)
Q.W■D
0
1
1
0
412 10 8 6 2
R 2 = V2 A2 + 1/2 B
pH
Figure 5-8 Illustration o f  the various factors affecting CNT dispersion stabilities with (A) being the effect o f  
the Zeta potential, (B) the effect o f  the Na'  ^concentration and (C) the effect o f  the oxidation d eb ris’ 
surfactant properties as functions o f  pH. The resulting green curves (R) are combinations o f  effects (A-C).
Effect of buffer concentration:
Figure 5-9 shows the results of the multi-parameter stability study, looking at the effects 
of pH and salt concentration on various types of oxCNT dispersions. With regard to the 
salt (buffer) concentration, the plots show that all oxCNT dispersions agglomerate more 
readily as it increases, regardless of the pH. This effect originates from the compression 
of the electrical double layer surrounding the oxCNTs by high salt concentrations, 
which destabilizes dispersions, as also described by Peng et al.^ ^^ "^ ^
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Effect of CNT type and shape:
The experiment further shows that the dimensions of the CNTs after oxidation clearly 
influence the stability of the resulting CNT dispersions. Sorting the different CNT 
samples by length according to the AFM and PALS data leads to the following order: 
oxSWNTs Nanolab »  oxDWNTs »  oxMWNTs (long & thin) »  oxMWNTs (short & 
thick) »  oxSWNTs CoMoCAT®. A comparison with the solubility profiles in Figure 
5-9 indicates that the order is the same for dispersion stability: oxSWNTs Nanolab 
being most sensitiye to changes in buffer pH and concentration and CoMoCAT® 
oxSWNTs and short & thick MWNTs being somewhat insensitiye to these parameters. 
This behayior can be attributed to the fact that long CNTs are prone to increased inter­
tube attraction due to y an der Waals forces and K-n interactions (assuming a similar 
extent of surface oxidation) and are thereby being more likely to form agglomerates and 
bundles in comparison to short CNTs.
Effect of pH:
The effect of pH is in fact a superposition of three separate factors -  Zeta potential, Na"^  
ion concentration, and presence of oxidation debris. To simplify discussion of the 
experimental findings, these three effects were combined in a resulting curye, as 
illustrated in Figure 5-8. Curye (A) depicts the effect of the Zeta potential on dispersion 
stability: In the case of CNTs, the absolute Zeta potential is lowest at low pH, where 
most carboxylic groups are protonated (and hence uncharged), resulting in poor aqueous 
solubility. Theoretically, the lowest solubility would appear around the isoelectric point 
of CNTs or “point of zero charge”, which lies at a pH of about The further the pH 
deyiates from the isoelectric point, the more carboxylic groups become deprotonated, 
leading to a higher absolute Zeta potential and enhanced dispersion s t a b i l i t y . C u r y e  
(B) describes the lyotropic effect caused by changes in the Na"^  concentration, due to the 
way the buffers are composed (the curye was generated by inyerting and normalizing 
the Na"^  concentration in the buffers). It features two minima at pH 6 and 12, where the 
Na"^  concentration is highest and thus exerts the strongest destabilizing effect. Curye (C) 
was generated to account for the effect of oxidation debris in the unwashed sample. Its 
interaction with the CNT surface is strongest at low pHs and becomes weaker with 
increasing pH, until it completely detaches at a pH > 11 due to increased hydrophilicity 
of both the debris and the CNTs, which weakens the n-K interactions. In fact. Figure 5-9
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shows that unwashed CNTs were much less susceptible to agglomeration at lower 
buffer concentrations than their NaOH-washed counterparts. Only at pH > 11, where 
total detachment of the debris occurs, the solubility of unwashed oxCNTs dropped 
almost instantly. Because the experimental results indicate that the shape of the stability 
profiles is dominated by this effect, it was giyen a higher weighting in the semi- 
empirical model than the effect of Zeta potential and Na"^  concentration, as explained 
aboye.
In summary, CNT dispersions containing short and unwashed tubes exhibited the best 
stability. Howeyer, the presence of oxidation debris is not always desirable, especially if 
molecules are to be attached to the CNT surface in a coyalent manner. In these cases, 
agglomeration can be ayoided by using buffers of low concentrations and low Na"^  
content.
5.3 Stability study of oxSWNTs in cellular growth media of 
varying serum concentrations
For biomedical use, the requirements of CNTs to be stable in both buffer solutions and 
the yarious physiological enyironments they encounter in the body are critical pre­
requisites. The stability of oxidized Nanolab SWNTs with different surface 
functionalizations was therefore inyestigated in cellular growth media of yarying serum 
concentrations, as well as in human plasma (Figure 5-10). The two selected 
functionalization schemes, PEGylation and RNA-wrapping, are of particular clinical 
importance. The PEGylation of drugs and nanoparticulate-drug formulations is a widely 
used approach to reduce immunogenicity and non-specific interactions with proteins, as 
well as to enhance blood circulation times. RN A-wrapping, on the other hand, is highly 
releyant with regard to the deliyery of therapeutic RNA, such as siRNA and mRNA, 
which are nucleic acids directly functional in cells. Furthermore, RNA is less mutagenic 
than DNA, as it cannot integrate into the host chromosome and can also be used for the 
purification of CNTs, if the RNA is subsequently remoyed by the enzyme RNAse, as 
demonstrated in preyious work of our group.
We tested the dispersion stability of yarious oxSWNT samples in cell medium by 
incubation in the medium for 24 h, followed by a centrifugation step to remoye 
agglomerates that might haye formed. The amount of remaining nanotubes in the
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supernatant was determined by UV/yisible absorption spectroscopy with a SWNT in 
water dispersion serying as the 100% yalue. To examine the influence of the serum 
concentration, fiye different serum concentrations were tested, ranging from 0 to 10%. 
Furthermore, unwashed and NaOH-washed SWNTs were compared and it was 
inyestigated, whether RNA-wrapping and PEGylation could improye dispersion 
stability. Figure 5-10a shows that all inyestigated CNT formulations were poorly stable 
in serum-free cellular growth medium. This is not surprising, since serum-free medium 
is nothing more than a solution of yarious salts and other compounds at a concentration 
of 154 mM -  a concentration, at which all oxCNT formulations inyestigated in this 
study immediately precipitated. Howeyer, the presence of only 2.5% fetal calf serum 
(FCS) increased the dispersion stability by more than 50%, presumably due to serum 
proteins attaching to the CNT surface. A further increase in FCS concentration resulted 
in 80-90% stability and thus became comparable to that of CNTs in water. The highest 
stability was obtained for unwashed, PEGylated oxSWNTs with a stability of 100% in 
both water and FCS-supplemented cell medium, whereas RNA-wrapped, non-oxidized 
CNTs were the least stable with only 49% in water and 38% in FCS-supplemented cell 
medium. The other oxidized CNTs gaye similar high ley els of stability with PEGylated, 
NaOH-washed oxSWNTs being the least stable. In this particular case, the nanotubes 
precipitated during the PEGylation reaction and although they could be redispersed after 
completion of the coupling reaction, the sample neyertheless seemed to haye forfeited 
stability.
In a separate study it was tested whether the PEG density affects the dispersion stability 
of PEGylated oxSWNTs in cell medium. Instead of Nanolab oxSWNTs, CoMoCAT® 
oxSWNTs for this experiment, as they are more stable and thus also allowed for 
studying the dispersion stability in serum-free cell medium, which -  in comparison -  
caused almost complete precipitation of PEGylated Nanolab oxSWNTs. The oxSWNTs 
nanotubes were conjugated to amine-terminated PEG molecules at initial weight ratios 
ranging from 50:1 to 1:1 (50:1 was the ratio used in the experiment presented in Figure 
5-lOa). Unreacted PEG was remoyed after the reaction. Figure 5-10b shows that higher 
PEG densities indeed improye the dispersion stability in serum-free cell medium to a 
significant extent. An initial PEG/SWNT ratio of 50:1 is able to keep about 60% of the 
nanotubes in dispersion, likely due to electrostatic repulsion of the positiyely charged 
PEG chains. At lower PEG/SWNT ratios, this effect decreases until it is no longer 
sufficient to maintain the systems’ dispersion stability. A similar trend is obseryed in
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cell medium containing 10% FCS, again with the highest initial PEG/SWNT ratio 
affording the highest dispersion stability. It is, however, much less substantial, which is 
in accordance with the fact that PEG prevents non-specific interactions with serum 
proteins (seen also in Figure 5-10c). The observed stabilizing effect caused by serum 
proteins is likely due to electrostatic interactions of the proteins with the terminal amine 
group of the PEG chains, resulting in steric stabilization, rather than to proteins 
adsorbing onto the nanotube surface.
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Figure 5-10 a) Stability o f  oxidized SWNTs (unwashed & NaOH -washed) with different surface coatings 
in cellular growth medium o f  varying serum concen trations (0% - 10%). Note that the error bars are  
included, but very sm all and thus hardly visible, b) Influence o f  the PEG  density on the stability o f  
oxidized SWNTs in cellular growth medium, c) Stability o f  oxidized SWNTs with different surface
coatings in human plasma.
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We have also tested the dispersion stability of the oxSWNT samples in human plasma 
in order to simulate the therapeutic application of CNTs. In this case UV/yis absorption 
spectroscopy cannot be used, as plasma absorbs at wayelengths around 600 -  1000 nm. 
Instead, the increase in particle size due to agglomeration effects by PALS 
measurements was measured after a 96 h incubation period in plasma. The particle size 
of the same sample in water served as a control. Figure 5-10c shows that after the 
incubation period, the mean particle size increased from 455 nm (oxSWNTs in water) to 
642 nm, which is likely due to attachment of plasma proteins, such as fibrinogen, 
albumin and apolipoproteins, to the nanotube s u r f a c e . N o t e  that fibrinogen is only 
present in plasma, but not in serum. These non-specific interactions between plasma 
proteins and SWNTs can be prevented by an appropriate surface functionalization 
scheme. In this study, RNA-wrapping and covalent PEGylation were tested as two 
possibilities. As Figure 5-10b shows, RNA-wrapping resulted only in a slight decrease 
of mean particle size (about 30 nm), which is likely due to degradation of RNA in 
biological environments by RNAses after a certain period. Covalent PEGylation, 
however, decreased the mean particle size by 140 nm (from 642 nm to 502 nm), which 
is only 46 nm more than the mean particle size of the oxSWNT sample in water. This 
shows that covalent PEGylation can effectively prevent non-specific adsorption of 
plasma proteins to the nanotube surface.
These experiments demonstrate that the dispersion properties of oxCNTs are 
significantly changed when passing from a chemical environment to a biological 
environment due to high salt concentrations and the attachment of plasma/serum 
proteins to the CNT surface. Although the latter can help to stabilize oxCNT 
dispersions, especially at high salt concentrations as found in the body, it might be 
disadvantageous when replacing functional surface coatings. Thus, it is usually the best 
option to design CNTs with intended biomedical use in such a way, that non-specific 
interactions with proteins are prevented, for example by PEGylation.
5.4 Evaluating the effect of the various nanotube 
preparations on cell viability
A study by Becker et demonstrated that adherent human lung fibroblasts
preferentially take up nanotubes shorter than 200 nm, indicating that the dispersion state 
of CNTs is likely to influence cellular exposure, cytotoxicity and response of cells to
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CNTs. They observed acute cytotoxicity only for very high CNT concentrations (197 
jig/mL and 360 |ig/mL), which is about 10-times higher than concentrations typically 
used in in vitro and in vivo experiments. However, their study examined only one CNT 
sample (CoMoCAT® SWNTs wrapped with DNA), which was separated into different 
length fractions. In the experiments presented in this chapter, WiDr colon cancer cells 
were incubated with 5 different oxCNT samples (all NaOH-washed) at various 
concentrations for 96 h to investigate the effect of CNT size and dispersion properties 
on cell viability.
The applied MTT viability assay is a standard colorimetric assay, which measures the 
activity of mitochondrial enzymes reducing the MTT reagent (thiazolyl blue tétrazolium 
bromide) to yield a purple formazan product.^^^^  ^Because it has been reported that some 
viability assays, ineluding MTT, can lead to false positive results when used with CNTs 
due to assay reagent adsorbing to the CNT surfaee,^^^^  ^ the cell medium containing the 
CNT was exchanged with fresh medium just before adding the MTT dye. The main goal 
was to examine the effect of CNT dimensions and different surface funtionalizations on 
cell viability at concentrations commonly used for in vitro and in vivo experiments.
Figure 5-1 la  shows the viability curves of WiDr colon cancer cells as measured by an 
adapted MTT assay, which have been incubated with the 5 different oxCNT samples for 
96 h. The viability curves do not show a dose-dependent toxicity, which might be 
attributed to the fact that cellular uptake of CNTs is incomplete and thus, the effective 
CNT concentrations acting upon the cells are lower than the inoeulation concentrations. 
All CNT samples, however, induced about 5-15% cell death after the incubation period, 
independent of the inoculation concentration. This might be due to inhibition of cell 
proliferation^^®^  ^ or decreased adhesion, whieh are both effects that would be 
predominantly observed for long incubation times, as seen in this study. A length- 
dependent effect on cell viability was not observed for the tested coneentration range, 
but might become apparent at higher CNT concentrations.
In the second part of this study, the effect of two different types of surface 
functionalizations on cell viability was examined (Figure 5-lib). RNA-wrapping did 
not significantly reduce the cytotoxic effect of the CNT samples, but PEGylation 
resulted in a statistically significant decrease in cytotoxicity. This might be due to better 
dispersion stability or could be a consequenee of the ability of PEGylation to reduce
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non-specific uptake by c e l l s -  an ability, which is often utilized in the framework of 
targeted drug delivery studies.
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Figure 5-11 Results o f  adapted MTT cytotoxicity assay on WiDr human colon cancer cells after an 
incubation period  o f  96 h with various sam ples o f  oxCNTs (NaOH -washed) at concentrations ranging 
from  0.5 to 20 pg/mL. a) D ose-response curves fo r  the 5 different types o f  CNTs, showing a loss o f  cell 
viability o f  about 15-25%, but no dose-dependency a t this concentration range, b) average cell viability  
fo r  Nanolab oxSWNTs with different surface functionalizations, indicating that PEG ylation results in a 
statistically significant decrease in cytotoxicity. The “cells o n ly” control correlates with 100%  cell
viability.
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5.5 Conclusions
This study is the first of its kind to present a multi-parameter stability analysis of 
various types of functionalized CNTs in environments relevant for biomedical studies. 
Its findings are of considerable value for selecting the most appropriate material and 
functionalization protocol for in vitro or in vivo applications. It is demonstrated that the 
same acid oxidation protocol leaves some CNT samples nearly unaltered, whereas 
others are significantly broken up, leading to altered CNT dimensions and surface 
properties, which in turn influence their dispersion in salt solutions, cellular growth 
media and human plasma. A similar diversity was found for the effeet of the removal of 
oxidation debris, which leaves the tubes with a clean surfaee, but also impairs 
dispersion stability. However, functionalization of CNTs with appropriate biomolecules 
allows for tailoring of their surface properties and is shown to improve dispersion 
stability, as well as to reduce cytotoxicity. Overall, this study demonstrates that an 
extended knowledge of CNT dispersion is of paramount importance, if they are to fulfill 
their promise for applications in the biomedical field. It thereby provides a valuable 
platform for the development of CNT formulations for current and future biomedical 
applications. In particular, its findings will be used in the following chapter to optimize 
the CNT-based drug delivery system developed in Chapter 4, which suffered from 
impaired therapeutic efficacy due to preeipitation problems.
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6 Targeted delivery of anti-cancer drugs 
to cells by carbon nanotubes
In Chapter 4, a CNT-based drug delivery system was developed, which was able to 
successfully deliver the anti-cancer drug doxorubicin to WiDr colon cancer cells. 
However, the nanotube-drug complexes exhibited poor stability in biological 
environments, which compromised their cytotoxic effects as shown by the MTT 
viability assays. Chapter 5 was thus aimed at optimising the dispersion stability of 
CNTs in chemical and biological environments. Based on the findings of these 
experiments, this chapter focuses on the optimization of the previously developed drug 
delivery system. In summary, this includes the following amendments: First, BSA, 
which was previously used as a linker, was replaced with branched, amine-terminated 
PEG, which not only stabilizes the system against agglomeration in chemical and 
biological environments, but also increases biocompatibility and prevents unspecific 
protein adsorption onto the n a no v ec to r . B es id es ,  a flexible polymeric spacer 
between a nanocarrier and the targeting agent provides the latter with free greater 
volume und thus a greater likelihood to interaet with cellular target structures. 
Second, the type of CNTs used was changed: instead of Nanolab oxSWNTs with an 
average length of about 450 nm, CoMoCAT® oxSWNTs with an average length of 100 
nm were used as a delivery platform. Shorter CNTs not only have a greater potential to 
be taken up by mammalian cells as demonstrated by Becker et al.,^ °^^  ^but also allow for 
elimination through the kidney and bile duets in an in vivo setting.^^ ^^  ^ Third, an 
additional anti-caneer drug -  mitoxantrone -  was tested as a therapeutic payload. It 
belongs to the group of anthracenedions, is also fluorescent, and features a mechanism 
of action similar to that of doxorubicin, but is more stable towards degradation. Finally, 
folate targeting was tested as an alternative targeting option to the previously applied 
monoclonal antibodies.
In the first part of this chapter, the applied oxSWNT sample was characterized and the 
binding of the two anti-cancer drugs doxorubicin and mitoxantrone to the oxSWNTs 
optimized by varying the reaetion parameters and functionalization scheme. The aim
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was to optimize drug loading whilst maintaining the dispersion stability of the system 
and the activity of the drugs. Next, drug release was examined in buffers of 
physiological pH (7.4) or slightly acidic pH (5.5), as well as in cellular growth medium. 
Subsequently, the fate of the complexes upon internalization was visualized by means 
of confocal microscopy and lastly, their therapeutic efficacy was tested in in vitro 
studies with a particular focus on targeting.
6.1 Preparation and characterization of the applied carbon 
nanotubes:
In the previous chapter, five different types of oxCNTs were compared with regard to 
their dispersion stability. The findings suggested that oxSWNTs produced by the 
CoMoCAT® method exhibited the highest dispersion stability, likely due to their short 
aspect ratio after acid oxidation. Thus, this sample was selected as the most promising 
candidate for the development of a CNT-based drug delivery system.
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Figure 6-1 Characterisation o f  the used oxSWNTs by a) atom ic force  microscopy, b) UV/vis absorption
spectroscopy, and c) Raman spectroscopy.
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Figure 6-1 shows the characterization results after analysis by atomic force microscopy 
(AFM), Raman spectroscopy, and UV/vis absorption spectroscopy. The mean particle 
size of the oxSWNTs was about 126 ± 8 nm, as determined by phase analysis light 
scattering (PALS) in Chapter 5. Considering that pristine SWNTs are usually several 
micrometers long, this demonstrates that the acid treatment has shortened the nanotubes 
by more than 90%, which is also evident in the AFM image (Figure 6-la). Their Raman 
spectrum (Figure 6-lb) featured three prominent peaks: the radial breathing mode 
(RBM) at 263 cm"\ which is inversely proportional to the tube diameter, the disorder- 
related D-band at 1315 cm '\ and the graphitic G-band at 1584 cm"\ The intensity ratio 
of the D- to the G-band is an indicator of the structural disorder originating from the 
formation of in the graphitic structure. In the case of the oxSWNTs examined in this 
study, the 1d /1g  ratio was 69.0 ± 0.1%, which indicated a high density of 
defects/functional groups, especially in comparison with the initially used SWNTs in 
Chapter 4, which featured an 1d /1g  ratio of about 7.2%. This also explains why the 
typical UV/vis features of non-oxidised SWNTs were absent after acid oxidation 
(Figure 6-lc). It should furthermore be noted that the sample had been washed with 
NaOH and HCl after acid oxidation and was thus free of oxidation debris.
6.2 Optimization of drug binding to oxSWNTs
The next experiments will focus on optimising the binding of the two anti-cancer drugs 
doxorubicin and mitoxantrone to oxSWNTs by varying the reaction parameters and 
functionalization scheme. The aim was to find the conditions, which yield maximal 
drug loading, while maintaining the dispersion stability of the system and the activity of 
the drugs.
6.2.1 Degradation of doxorubicin and mitoxantrone as a function of 
pH, light, and temperature
The first experiment was designed to determine the optimal pH and temperature 
conditions for the two drugs. It is well-known that both doxorubicin and mitoxantrone 
are not ideal drugs from an analytical point of view. Doxorubicin is known to self­
associate in concentrated solutions, is liable to photolytic decomposition and degrades 
at unfavourable pH c o n d i t i o n s . I t  is most stable at pH 4, converts into the 7-
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hydroxyaglykone in more acidic conditions and destabilizes at basic pH due to 
enolization of the C9 side chain. Similarly, mitoxantrone is also most stable at pH 4 and 
shows accelerated degradation at higher pH, under UV irradiation, and at higher 
t e m p e r a t u r e s . I t  furthermore forms precipitates upon refrigeration, which redissolve 
after warming to room temperature without a loss of efficacy.^^^^^
Drug delivery experiments are usually performed with a pH range of 5.5-7.5 to maintain 
cell viability, yet we and o t h e r s f o u n d  that the binding of doxorubicin and 
mitoxantrone to CNTs works best at high pH, at which the drugs are deprotonated. This 
indicates that very likely a compromise has to be found between achieving optimal drug 
loading while maintaining the activity of the drugs. We therefore incubated both drug 
molecules at a range of pH (5-9) and temperatures (4 °C vs. 25 °C) for 3 days and then 
re-evaluated their cytotoxicity by means of MTT cell viability assays. A dose-response 
curve was generated for every data point (drug/pH/temperature) order to calculate the 
corresponding IC50 values (i. e. the concentration, which kills half of the cell 
population), which were then were plotted against the pH.
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Figure 6-2 Therapeutic ejficacy o f  doxorubicin and mitoxantrone after a 3-day incubation period  a t pH  
5-9 a t 4 °C in the dark (solid lines) o r at 25 °C in daylight (dashed lines). IC50 values w ere obtained by  
fitting the dose-response curve o f  each data poin t using the four-param eter model. The corresponding  
photographs show the respective drug solutions after incubation in daylight to dem onstrate the visible
aggregation effects.
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Figure 6-2 shows how the cytotoxicity of the drugs, indicated by IC50 values, was 
affected by pH. Doxorubicin incubated at 25 °C in daylight was unstable above pH 6 
and rendered entirely inactive at pH 9. When the same solutions were incubated at 4 °C 
in the dark, however, doxorubicin did not lose its activity up to pH 8 but lost some 
activity at pH 9. This is in accordance with the literature^^^^  ^and shows that degradation 
of doxorubicin was considerably accelerated by light and high pH, possibly due to the 
promotion of oxidation reactions or the formation of drug polymers, which are 
incapable of penetrating the cellular membrane, as suggested by Williams and 
Tritton.^^^^  ^ The self-aggregation of neutral antracycline molecules via 7C-stacking is 
consistent with our studies, which indicated that doxorubicin forms visible agglomerates 
above pH 7, with the extent of agglomeration correlating with a loss of activity 
(photograph beneath the diagram in Figure 6-2).
In contrast, mitoxantrone was stable over the 3-day incubation period for all pH values 
(Figure 2b), although some loss of activity was observed at pH 7 when incubated in 
daylight at 25 °C in light, but not at 4 °C in darkness. Interestingly, the drug also tended 
to precipitate at pH 7 (and, to a lesser extent, at pH 6 or 8), which correlated with the 
loss of activity at this pH. However, compared to doxorubicin this effect was much less 
marked, which is consistent with the fact that mitoxantrone solutions form precipitates 
when kept at low temperatures, whilst maintaining their cytotoxic effect.^^ ^^ ^
The conclusion of these experiments was that, in order to maintain drug activity, 
binding experiments should be performed at low temperatures and under protection 
from light and, for doxorubicin, at pH 8 or lower.
6.2.2 Effect of pH on drug binding
Next, the influence of the pH on drug binding was investigated. Both doxorubicin and 
mitoxantrone are able to attach to the surface of CNTs by n-n interactions due to their 
inherent aromatic structure. In addition, both drug molecules contain pH-sensitive 
amine groups, which makes their binding to CNTs pH-dependent (enhanced at high pH 
and reduced at low pH).^ ^^  ^This potentially allows for drug release in acidic endosomes 
and the microenvironment of tumors. To evaluate the pH-dependence of drug binding, 
oxSWNTs were incubated with the two drugs at pH 5 to 9 for 24 h, after which the 
samples were filtered and the quantity of unbound drug in the filtrate measured by
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UV/vis absorption spectroscopy. Samples without CNTs (also from pH 5-9) served as 
controls.
Figure 6-3 shows that, as expected, both doxorubicin and mitoxantrone bound to CNTs 
to a greater extent with increasing pH, with maximal binding at pH 8-9. This is due to 
the majority of amino groups being protonated at these pH (having pKa values between 
8.3 and 8.6), which makes them more hydrophobic and capable of binding to the CNT 
surface via n-n interactions. In combination with the results of the previous experiment, 
it can be concluded that a pH of 8 is optimal for the binding of doxorubicin to 
oxSWNTs and a pH of 9 optimal for mitoxantrone, provided that the binding reaction is 
carried out at 4 °C in the dark.
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Figure 6-3 a) Binding o f  doxorubicin and mitoxantrone to oxSWNTs a t p H  ranging from  5 to 9: The 
higher the pH, the higher the drug binding, b) Chemical structures o f  doxorubicin and mitoxantrone.
However, it was noticed that the nanotubes precipitated out of solution during the drug- 
binding incubation. This was not surprising, as it is well-known that oxCNTs give rise 
to electrostatic interactions with salts, such as the two anticancer drugs investigated 
here, which can impair the dispersion stability due to charge neutralization. 
Precipitation did not influence the efficacy of drug binding; however, it is of course 
essential that any clinical formulation remains stable in the circulation, which is why 
dispersion stability is a critical factor. In Chapter 5 it was shown that the dispersion 
stability of oxCNTs and also their biocompatibility toward cancer cells can be improved 
by covalent conjugation to polyethylene glycol (PEG).^ '^^  ^ “PEGylation” is also a
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widely-used pharmaceutical formulation strategy in clinical settings, as it reduces 
immunogenicity and non-specific interactions with plasma proteins, while 
concomitantly prolonging blood circulation times. It was therefore attempted to 
optimize the dispersion stability of PEGylated oxSWNTs in the presence of the drugs 
while monitoring the degree of drug loading and maintaining the activity of the drugs.
6.2.3 Effect of the PEG type on drug loading and dispersion 
stability
Five different types of PEG molecules were tested with regard to their effect on drug 
binding and dispersion stability. This included a homobifunctional, amine-terminated 
PEG (PEG 2 OOO-NH2), two heterobifunctional PEGs of different chain lengths (PEG 
440-CGGH and PEG 3000-CGGH), and a branched PEG with four amine-terminated 
arms (branched PEG 2 5 OO-NH2), all of which were covalently linked to oxSWNTs via 
one of their amine groups.
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Figure 6-4 Effect o f  the PEG  type on drug binding and dispersion stability: Only one PEG  candidate -  
branched PEG 2 5 OO-NH2 -  was able to prom ote a stable dispersion after addition o f  the drugs, whereas 
in all other cases, the nanotubes precip ita ted  out o f  solution.
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As a fifth candidate, an amine-terminated phospholipid-PEG (PL-PEG2 OOO-NH2) was 
investigated, which is widely used as a dispersion agent for CNTs/^ '^^^^  ^In this case, the 
functionalization was based on non-covalent interactions promoted by the binding of the 
phospholipid-moiety to the CNT surface. The ideal PEG candidate should optimally 
stabilize CNT dispersions without impairing drug binding through steric hindrance or 
repulsive electrostatic interactions, as described in the next paragraph.
Figure 6-4 shows the effect of the different PEG types on drug binding and dispersion 
stability. PEGylation reduced the binding of doxorubicin by approximately 10%, 
whereas the binding of mitoxantrone was only slightly reduced. Drug binding for each 
of the PEG molecules was very similar; however, only the oxSWNT sample 
functionalized with branched PEG 2 5 OO-NH2 remained stable, whereas in all other cases 
the nanotubes had precipitated out of solution. Based on these results, it was therefore 
decided to use branched PEG 2 5 OO-NH2 for all further experiments.
6.2.4 Effect of the PEG density on drug loading and dispersion 
stability
The optimal PEG molecule (branched PEG 2 5 OO-NH2) was conjugated to oxSWNTs in 
various concentrations to investigate the effect of PEG density on drug loading and 
dispersion stability. In this experiment, the oxSWNT concentration was kept constant, 
while branched PEG was added at concentrations ranging from 5 mM to 0.1 mM. After 
the conjugation reaction, unreacted PEG molecules were removed by filtration through 
0.2 pm polycarbonate filters. Note that the PEG concentrations refer to the initially 
added concentrations and not to the final concentrations after filtration. As illustrated in 
Figure 6-5a, drug binding was inversely proportional to PEG density, presumably due to 
sterical hindrance: the more PEG chains are attached to the nanotube surface, the less 
accessible the surface becomes for drug molecules due to the long, flexible PEG chains 
sticking out into the solvent. Furthermore, both the PEG chains and the drugs feature 
amine functionalities, which are partly positive charged at pH 8, resulting in 
electrostatic repulsion.
The dispersion stability, on the contrary, was directly proportional to PEG density 
(Figure 6-5b). The number of PEG chains per nanotube length is not known in this case; 
however, in a study by Liu et al., in which phospholipid-PEG conjugates were attached 
non-covalently to oxSWNTs, the number of PEG molecules per 10 nm of SWNT length
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was estimated to be about 3. This indicates that the surface of the nanotubes is not fully 
covered with PEG molecules, especially because PEG itself does not adhere to the 
nanotube surface due its hydrophilicity. However, PEG chains are quite flexible 
molecules and in this case also branched, which gives rise to interactions of PEG chains 
attached to the same nanotube, as well as of PEG chains attached to different nanotubes. 
Although there is a possibility of hydrogen bond formation between PEG chains, 
electrostatic repulsion is more probable to occur as the PEG chains are amine- 
terminated and therefore partly positive charged, as indicated above.
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Figure 6-5 Impact o f  the PEG density on drug binding and dispersion stability, a) The low er the PEG  
density, the higher the drug binding b) The higher the PEG density, the higher the dispersion stability.
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When comparing the two drugs, mitoxantrone-loaded oxSW N T speg (mito- 
oxSW N T speg) were less stable than doxorubicin-loaded oxSW N T speg (dox- 
oxSW N Tspeg); presumably because mitoxantrone is a bivalent salt, whereas 
doxorubicin is monovalent. In balancing the contrary effects of PEG density on drug 
binding and dispersion stability, the latter effect appeared to be stronger; thereby 
subsequent experiments were performed at the highest PEG density to maximise 
dispersion stability, whilst recognizing an inevitable loss of drug binding capacity.
The chosen oxSW N T peg sample was mixed with the two drugs at drug/oxSWNTpEo 
weight ratios optimised to bind all the drug and thus eliminating the need for a filtration 
step to remove unbound drug. It was found that a ratio of approximately 1:2 was ideal 
(data not shown), corresponding to a final drug concentration of 25 pM (or 14.5 pg/mL 
doxorubicin and 12.9 pg/mL mitoxantrone, respectively) and a final oxSW N T peg  
concentration of 25 pg/mL. The absence of free drug (at zero time) is demonstrated in 
the next section.
6.3 Drug release at varying conditions
The release of both doxorubicin and mitoxantrone should be promoted at low pH due to 
their amine functionalities, which render them hydrophilic at low pH and hydrophobic 
at high pH. At a physiological pH, however, the drug should remain firmly attached to 
its nanocarrier. To study drug release at both conditions, dox-oxSWNTspEG or mito- 
oxSWNTspEG were incubated in buffers at pH 7.4 or 5.5 for 3 days. After every 24 h, 
the samples were filtered and the released drugs in the filtrates measured by UV/vis 
absorption spectroscopy. Addiotionally, drug release was also assayed in cellular 
growth medium (buffered at pH 7.4), mimicking the conditions of a typical cell viability 
assay, to investigate whether serum proteins might cause extracellular drug release by 
replacing the drug coating.
As observed in Figure 6-6, the drugs were gradually released from their nanotube carrier 
at pH 5.5 with 44.1 ± 4.8% of doxorubicin and 55.0 ± 6.2% of mitoxantrone released 
after 72 h. In contrast, only 7.2 ± 4.8% of doxorubicin and 7.6 ± 1.9% of mitoxantrone 
was released at pH 7.4 after the same time. Incubation of the drug-oxSW NTpEo  
conjugates in cell growth medium did however release significant quantities of drug: 
22.5 ± 3.6% of doxorubicin and 20.9 ± 2.0% of mitoxantrone by 72 h. This suggests 
that shows that bound drugs were gradually being displaced on the C N T  surface by
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components of the cell culture medium during the incubation, most probably by serum 
proteins from the fetal calf serum component. This potentially allows for extracellular 
release of the drug from the CNT carrier and its subsequent diffusion through the cell 
membrane without its nanocarrier, although only in the case of long blood circulation 
times (1-3 days).
100-
80-
60-O)2*D
■§ 40-
C —■—pH 5.5 
- — pH 7.4 
—A—cell medium
CO
0 24 48 72
time (h)
100-
80-
60D)2T3
■§ 40 
c
'■—pH 5.5 
• —pH 7.4 
cell medium
I 20 -
0 24 48 72
time (h)
Figure 6 -6  Release o f  the drugs doxorubicin (a) and mitoxantrone (b )from  their oxS W N T peg carrier a t 
pH  5.5 and pH  7.4 and in cell culture medium.
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6.4 Intracellular distribution of oxSWNTpEc-doxorubicin 
conjugates
HeLa cells were incubated with dox-oxSWNTspEo for 4 h (Figure 6-7) and drug uptake 
monitored by confocal microscopy, taking advantage of the inherent drug fluoresence. 
The confocal images show that doxorubicin (red. Figure 6-7b) was entirely located in 
the cell nucleus (counterstained with ToPro 3, in blue, Figure 6-7c), proving its 
successful release from the nanotubes (labeled with fluorescein, in green), which were 
distributed as discrete spots in the cytoplasm (Figure 6-7a), indicating localisation 
within endosomes. Additional studies in our laboratory are further investigating the 
uptake mechanism and will be published separately/^^^^
Figure 6-7  Confocal m icroscopy image ofHeLxi cells after 4 h incubation with doxorubicin-loaded, 
fluorescein-labeled o xSW N T speg- Distribution o f  the green fluorescent o xS W N T speg Is shown in (a), red  
fluorescent drug in (b) and blue nuclear counterstain in (c).The cell boundaries are visible in the 
transmitted light image (d). Panels (e) and (f) are overlaps o f  (a-d) and (a-c), respectively.
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Effect of dispersion stability on cellular uptake and 
therapeutic activity of the drug-CNT complexes
We first aimed to investigate whether the dispersion stability of drug-loaded nanotubes 
affected the drugs’ therapeutic activity on cultured cells. Therefore, two types of 
oxSWNTspEG were used with different PEG densities (5 mM and 0.25 mM), associated 
with dispersion stabilities of 90-100% and 0%, respectively.
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Figures 6-8a and b display the dose-response curves obtained as a result of the 
performed M T T  viability assays. o xS W N T speg alone (both well-dispersed and 
precipitated) are non-toxic at low doses, but lead to about 20% cytotoxicity at the
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highest dose. It remains to be investigated whether this is due to the nanotubes 
themselves or the rather toxic catalyst used for their synthesis (Cobalt and 
Molybdenum). The latter is, however, rather unlikely because exposed metallic catalyst 
particles are usually dissolved during acid oxidation and only those encapsulated in 
graphite sheets r e m a i n , w h i c h  pose no danger to biological systems. At medium 
doses, the well-dispersed o x S W N T speg appeared slightly more cytotoxic than 
precipitated o xS W N T speg, which might be due to enhanced cellular uptake. When 
comparing the drug-loaded samples, it appears that the stable, well-dispersed samples 
are slightly more potent than the precipitated ones, although the effect is not significant, 
indicating that cells are able to take up precipitates of nanotubes, as reported by Mu et 
al.”®'
Figure 6-8a and b show that the IC50 values of the drugs alone and after attachment to 
CNTs are similar, indicating that the CNT-bound drug has a similar cytotoxic activity as 
the free drug. However, the shape of the dose-response curves was flatter for the 
nanotube-bound drugs and lacked a sharp threshold, so that at lower drug concentrations 
the nanotube-bound drug was more cytotoxic than free drug, whereas the reverse was 
true for higher drug concentrations. The reasons for the altered dose-response curves are 
unclear, but are likely due to incomplete uptake of the nanotubes and/or incomplete 
drug release.
6.6 Active targeting as an option to improvement the 
systems selectivity and effectivity
The targeting aspect is a crucial part of a drug delivery system, as it introduces 
selectivity. In Chapter 4, monoclonal CEA-antibodies were attached to oxSWNTs to 
achieve this goal -  however, the resulting targeted compounds were less potent than the 
untargeted ones. This could be due to the antibodies’ binding sites having been blocked 
as a result of the random conjugation chemistry, or to extensive crosslinking, which 
might result in complexes too large to be internalized by cells. Another fact to consider 
is that CEA-expressing cancer cell lines can have different binding and internalization 
characteristics. Ford et al., for example, compared two colorectal carcinoma cell lines 
(SKCOl and LS174T), both strongly CEA-expressing, and found that SKCOl showed 
the highest antibody binding but variable anti-CEA internalization, whereas LS174T
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cells were the most avid intemalizers/^^^^ However, in both cases internalization was 
observed within the first 30 minutes.
In order to find out what exactly went wrong with the chosen targeting method, it was 
first investigated whether the antibodies themselves are internalized by CEA-expressing 
WiDr cells at all by incubating WiDr cells with 500 ng CEA antibodies alone for 
varying time periods (30 min, 1 h, 2 h, and 4 h).
30 min
CD
<D
X
Figure 6-9 Confocal images o f  WiDr and HeLa cells incubated with a monoclonal, FITC-labeled  
antiCEA-antibody (green) fo r  30  min, 1 h, 2 h, or 4  h. Cell nuclei are stained in blue. The antibody binds 
WiDr cells, but is mainly localized on the membrane and does not seem to be internalized within the 
examined period  o f  time. No antibody binding w as observed fo r  HeLa cells, which do not express CEA.
Figure 6-9 shows that the antibody bound only to CEA-expressing WiDr cells, but not 
to HeLa cells, which proved its specificity. However, the antibody was not internalized 
within 4 h, but remained attached to the cellular membrance. Furthermore, not all cells 
seemed to express CEA antigen: as a rough estimation, approximately 10% of all cells 
had been stained. This indicates that the targeting problem using CEA antibodies might 
be due to the incapability of the antibody to be internalized by WiDr eells after binding 
to the target protein CEA on the cellular membrane.
It was therefore decided to test a different active targeting scheme by substituting the 
antibodies with folic acid. The folate-receptor is significantly upregulated by a broad 
spectrum of human cancers, in some cases by two orders of magnitude, facilitating 
cellular internalization of folate-conjugated nanocarriers by receptor-mediated
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endocytosis/^^ '^^^^  ^ To investigate whether folate-targeting would enhance drug- 
delivery, folate was covalently attached to the amine termini of the PEG chains, as 
described in the methodology. HeLa cells were maintained in folate-depleted growth 
medium for several passages to induee overexpression of the folate-receptor. Cells were 
incubated with folate-targeted dox-oxSWNTSpEc for 72 h.
700
Ü
Figure 6-10 Comparison oflC so values o f  fo la te-targeted  dox-oxSWNTspEc and controls. Red: 
untargeted, drug-loaded oxSW N T speg, blue: folate-targeted, dox-oxSWNTs peg after saturation o f  the
fo la te  receptors with free  folate.
Figure 6-10 displays the resulting IC50 values: Non-targeted, dox-oxSWNTS p E o  were as 
efficacious as the drug alone in killing 50% of the eell population with IC50 values 
around 550 nM. The system’s therapeutic efficacy was significantly enhanced (IC50 = 
432 ± 52 nM, ?<0.05) when folate was conjugated to the PEG chains as a targeting 
agent. However, when the folate-receptors were saturated with free folic acid, the 
efficacy was again comparable to that of the untargeted system, confirming the 
selectivity of the targeting approach.
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6.7 Conclusions
In this chapter, a CNT-mediated drug delivery system was developed for two different 
anti-cancer drugs, affording high biological and chemical stability, high drug loading 
and selective cancer treatment in an in vitro scenario via an active targeting scheme. 
After optimizing the synthesis parameters to obtain maximal drug loading while 
maintaining the dispersion stability of the system, pH-dependent drug release in buffer 
solutions was demonstrated and cellular uptake of the nanovectors, as well as 
intracellular drug release, confirmed by means of confocal microscopy. Finally, the 
therapeutic efficacy of the system in cell viability assays was evaluated and it was found 
that an insufficient dispersion stability has a slightly deleterious effect. Furthermore, it 
was shown that by attaching folic acid to the system, a widely-used active targeting 
approach, the efficacy was significantly enhanced and exceeded that of the free drugs. 
Keeping in mind that free doxorubicin and mitoxantrone are both highly effective in in 
vitro experiments due to their aqueous solubility and membrane permeability, this is an 
eneouraging result. The targeted, drug loaded CNTs are selective in contrast to the free 
drugs and additionally allow for sustained release, which is likely to reduce drug-related 
side effects in animal models and clinical studies. Overall, this study demonstrates the 
potential of CNTs as a multimodal drug delivery system and presents a 
functionalization scheme able to overcome many of the problems encountered in this 
area of application.
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7 Conclusions & Future Work
In recent years, CNTs have emerged as a new tool for transporting therapeutic 
molecules into cells. CNTs may hold several advantages over other nano vectors, such 
an exceptionally high drug loading capacity due to their high surface area, and the 
option of endocytosis-independent cell uptake, enabling direct, cytoplasmic delivery of 
drugs. This thesis was aimed at the development of a multi-modal targeted drug 
delivery system based on CNTs.
This chapter will summarize the major findings of the thesis and draw a comparison 
between this study and the literature. Subsequently, future work will be proposed and 
discussed and a critical assessment of the suitability of CNTs as drug delivery vectors 
provided.
The first results chapter (Chapter 4) of this thesis presented a CNT-based drug delivery 
system, which was designed to deliver the anti-cancer drug doxorubicin to WiDr colon 
cancer cells and involved the attachment of monoclonal CEA antibodies as an active 
targeting agent. The antibody was attached to the CNTs using fluorescently-labeled 
BSA as a linker. Due to its numerous functionalities, one BSA molecule can bind 
multiple antibody molecules and thus increase the degree of coupling manifold. The 
delivery of doxorubicin could be demonstrated successfully by confocal microscopy -  
however, the system exhibited a poor performance in quantitative in vitro cell viability 
assays, likely due to insufficient dispersion stability of the CNT-drug complexes at 
physiological salt concentrations. Chapter 5 was therefore aimed at optimizing the 
stability of oxidized CNT dispersions at these conditions. Five different types of CNTs 
were investigated, including SWNTs, DWNTs, and MWNTs; all featuring different 
diameters and length distributions. Furthermore, RNA-wrapping and PEGylation were 
tested as functionalization schemes to further improve the dispersion stability. Amongst 
other things, it was found that short CNTs, such as oxidized CoMoCAT® SWNTs, 
covered with oxidation debris exhibited the best dispersion stability. Additionally, 
covalent PEGylation was found to further improve the dispersion stability of all 
examined CNT samples.
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Based on these findings, the drug delivery system developed in Chapter 4 was 
optimized in Chapter 6 in order to improve its performance in in vitro studies. Instead of 
oxidized Nanolab SWNTs, oxidized CoMoCAT® SWNTs were used, which are 
considerably shorter and thus emerged to be the only sample that did not precipitate 
during the drug loading step. Furthermore, the previously used linker molecule BSA 
was replaced with branched, amine-terminated PEG in order to stabilize the system 
against agglomeration in chemical and biological environments. Lastly, folic acid was 
tested as an active targeting agent instead of anti-CEA antibodies after it became clear 
that the antibodies were not internalized after binding to WiDr cells. It was 
demonstrated that the system showed a much better performance than the original one 
developed in Chapter 4, likely due to enhanced stability of the CNT-drug complexes 
and a more efficacious targeting scheme.
Overall, the performance of the drug delivery system developed in this thesis compares 
favorably with the literature. The loading efficacy of doxorubicin to carbon nanotubes, 
commonly expressed as the weight ratio of drugiCNTs, was 2:1 for the complexes 
developed in Chapter 6. This is similar to the work of Liu et al.,^ ^^ ^^  who achieved a 
loading ratio of 2.5:1 by the same functionlization scheme, and superior to the work of 
Chaudhuri et al.,^ ^^  ^ who obtained a ratio of 0.28:1 by covalent conjugation of 
doxorubixin to CNTs. Regarding drug release at slightly acidic conditions, our results 
are also comparable to published studies featuring similar systems,^^^’^ ^^  ^ with 44% 
release of doxorubiein at pH 5.5 after 72 h, compared to about 50% release reported in 
the studies mentioned. One of the most important parameters when comparing drug 
delivery systems, however, is in vitro therapeutic efficacy. Our system exhibited similar 
efficacy than free doxorubicin after a 72 h incubation period and a statistically 
significant enhancement of 22% when folate was attached as a targeting agent. In 
comparison, Liu et al. also obtained similar cytotoxicity for their untargeted system to 
free doxorubicin, but observed an enhancement of 62.5% (an IC50 of 3 pM compared to 
8 pM) after attaching an RGD peptide as a targeting agent. In another study by Sun et 
al. doxorubicin was loaded onto nano-graphene oxide as a carrier, which was covalently 
functionalized with branched PEG molecules similar to the system in this thesis. The 
attachment of Rituxan, a monoclonal antibody serving as a targeting agent, led to a two­
fold inerease in cytotoxicity at an administered dose of 2 pM and a four-fold increase in 
cytotoxicity at a dose of 10 pM. Although both examples achieved a higher increase in 
cytotoxicity after the attachment of a targeting agent than observed for our system, it
118
Chapter 7___________________________________________ Conclusion & Future Work
has to be noted that the IC50 value of our system was about 0.5 pM, whereas the two 
studies mentioned reported IC50 values between 2-10 pM. This indicates that our system 
is overall more potent than the discussed literature examples, possibly because special 
care was taken to avoid degradation of the drug under the conditions in the 
functionalization procedure.
Future work may involve an investigation of the uptake pathway of the developed drug- 
CNT-complexes and their subsequent fate inside the cell. The next big step would then 
take the experiments into an in vivo setup, which would include dose-finding studies 
and investigations of the pharmacodynamics, biodistribution, and elimination of the 
CNT-drug complexes. Furthermore, a higher therapeutic efficacy could possibly be 
might be achieved by combining different therapeutic approaches, such as the 
simultaneous delivery of a cytotoxic drug and therapeutic nucleic acids or CNT- 
mediated drug delivery followed by a hyperthermic treatment. Especially in the last 
three years, promising in vivo studies using CNTs as drug delivery systems have been 
published, of which some already applied combinational therapeutic approaches. 
However, since CNTs are still a rather novel material, no clinical studies have been 
undertaken to date.
This leads over to the last part of this conclusion, which will attempt to provide a 
critical assessment of the overall suitability of CNTs for drug delivery purposes. 
Starting with the synthesis of CNTs, much progess has been made in recent years 
towards samples of higher quality with narrower distributions of CNT type, dimensions 
and electronic structure. Nevertheless, there are still huge differences between 
commercially available CNT samples, even if they are of the same type and prepared by 
the same synthesis method. Additionally, most samples do not contain one specific type 
of CNTs, but a collection of tubes with different chiralities, lengths, electronic structure, 
and number of walls. For this reason, various separation methods are currently under 
development in order to obtain more homogeneous samples, such as DNA-assisted 
s e p a r a t i o n , u l t r acen t r i fu g a t io n ,sugar gradients,^ ^^ "^  ^ and gel electrophoresis. 
These may lead to a great improvement of CNT sample quality and monodispersity, as 
the next years will likely show.
More relevant to biological applications, CNTs are prone to agglomeration in 
physiological environments, even when functionalized. Especially in the case of non- 
covalent functionalization, the sorption of surfactant molecules onto the CNT surface is
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strongly dependent on the properties of the dispersion medium and thus susceptible to 
changes in pH and salt concentration. Additionally, no general functionalization method 
or surfactant exists to date which can successfully disperse all kinds of CNT samples. 
On the contrary, an appropriate functionalization scheme generally has to be found and 
optimized for every new CNT sample. For this reason, acid oxidation is often used as a 
general functionalization approach. This method, however, also does not hold the holy 
grail, since it creates defects and oxidation debris. Thus, researchers often apply a 
combination of these methods -  acid oxidation and non-covalent functionalization or 
acid oxidation plus covalent attachment of stabilizing molecules, such as PEG or 
proteins, to achieve satisfactory results.
Once an appropriate functionalization scheme has been found, subsequent experiments 
in the biomedical area often investigate cellular uptake of CNTs. It is often stated in the 
literature that CNTs are easily taken up by cells -  however, as so often, reality is 
slightly more complicated. First of all, experiments in this thesis showed that only well- 
dispersed CNTs and maybe small bundles are taken up by cells, whereas precipitation 
of a CNT sample can compromise its cell entry abilities. Secondly, the interaction with 
serum proteins present in cellular growth media has to be well understood and 
controlled, as various serum proteins have been found to attach readily to the surface of 
CNTs and to replace functional surface coatings. Following successful cellular uptake, 
the next issue concerns their intracellular distribution. For a couple of years, there has 
been a controversy about the uptake mechanism of CNTs with clathrin-mediated 
endocytosis and energy-independent, mechanical “piercing” as the two major 
possibilities. Newest findings have shown that both options are possible, but that in 
most cases the CNTs still end up in endosomes. This is unfavorable for the delivery of 
genetic material and certain drugs, which are rendered inactive in the degradative 
environment of the endolysosomal pathway. Again, several approaches have been 
developed to ensure release of the payload, either by integrating cleavable bonds or pH- 
dependent binding, as applied in this thesis, or by inducing the rupture of endosomes.
This leads to the last potential problem of CNTs used for biomedical appliations: the 
issue of in vitro and in vivo toxieity. Many studies have shown that pristine and 
functionalized CNTs have hazardous effects on cells and living organisms, which often 
do not manifest in acute toxicity, but in subtle changes potentially leading to medium 
and long-term toxic effects. This is particularly important when considering that CNTs 
in their entity are not biodegradable and have been observed to accumulate in cells and
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organisms for weeks or even months. Much work is currently done to improve the 
biocompatibility of CNT formulations, for example by functionalization or the use of 
short CNTs. Nevertheless, it will very likely take much more time until results of long­
term toxicity studies will be available and the question of toxicity can be answered once 
and for all.
This discussion demonstrates that although CNTs may offer several advantages over 
other nanoparticulate drug delivery vectors, they also possess various drawbacks. 
Nevertheless, this thesis has successfully demonstrated the development of a targeted, 
CNT-based drug delivery system for the anti-cancer drugs doxorubicin and 
mitoxantrone with promising in vitro results. Overall, it seems likely that advances in 
CNT synthesis and a better understanding of CNT toxicity will be the determining 
faetors for the future success of CNTs for biomedical applications.
121
Bibliography
Bibliography
[1] Radushkevich, L. V., Lukyanovich, V. M. "O strukture ugleroda,
obrazujucegosja pri termiceskom razlozenii okisi ugleroda na zeleznom 
kontakte" Zurn Fis. Chim. 1952,26, 88-95.
[2] Dresselhaus, M. S. "Carbon nanotubes - Introduction" Journal o f Materials 
Research 1998,13, 2355-2356.
[3] Monthioux, M., Kuznetsov, V. L. "Who should be given the credit for the 
discovery of carbon nanotubes?" Carbon 2006, 44, 1621-1623.
[4] lijima, S. "Helical microtubules of graphitic carbon" Nature 1991, 354, 56-58.
[5] Odom, T. W., Huang, J. L., Kim, P., et al. "Structure and electronic properties of 
carbon nanotubes" Journal o f Physical Chemistry B 2000,104, 2794-2809.
[6] Louie, S. G., in Carbon Nanotubes: Synthesis, Structure, Properties and
Applications, (Eds: Dresselhaus, M. S., Dresselhaus, G., Avouris, P.), Springer, 
Berlin/Heidelberg 2001, 113-145.
[7] lijima. S., Ichihashi, T. "Single-shell carbon nanotubes of 1-nm diameter" 
Nature 1993, 363, 603-605.
[8] Dresselhaus, M. S., Dresselhaus, G., Avouris, P., Carbon nanotubes: synthesis, 
structure, properties and applications. Springer, Berlin/Heidelberg 2001.
[9] O'Connell, M. J., Carbon nanotubes: properties and applications, CRC press, 
Taylor & Franeis group, Boca Raton 2006.
[10] Yakobson, B. 1., Avouris, P., in Carbon Nanotubes: Synthesis, Structure,
Properties and Applications, (Eds: Dresselhaus, M. S., Dresselhaus, G.,
Avouris, P.), Springer, Berlin/Heidelberg 2001, 287-327.
[11] Lee, N. S., Chung, D. S., Han, 1. T., et al. "Application of carbon nanotubes to 
field emission displays" Diamond and Related Materials 2001,10, 265-270.
[12] Carey, J. D., Silva, S. R. P., in Nanomaterials handbook, (Ed: Gogotsi, Y.), 
CRC Press, Boca Raton 2006, 665-684.
122
Bibliography
[13] Feldman, A. K., Steigerwald, M. L., Guo, X., et al. "Molecular electronic 
devices based on single-walled carbon nanotube electrodes" Accounts o f 
Chemical Research 2008, 41, 1731-1741.
[14] Lyshevski, S. E., Nano and molecular electronics handbook, CRC Press, Boca 
Raton 2007.
[15] Li, C., Chen, Y. H., Wang, Y. B., et al. "A fullerene-single wall carbon nanotube 
complex for polymer bulk heterojunetion photovoltaic cells" Journal o f 
Materials Chemistry 2007,17, 2406-2411.
[16] Pushparaj, V. L., Shaijumon, M. M., Kumar, A., et al. "Flexible energy storage 
devices based on nanocomposite paper" Proceedings o f the National Academy o f 
Sciences o f the United States o f America 2007,104, 13574-13577.
[17] Dai, H. J., Hafner, J. H., Rinzler, A. G., et al. "Nanotubes as nanoprobes in 
scanning probe microscopy" Nature 1996, 384, 147-150.
[18] Schlaf, R., Emirov, Y., Bieber, J. A., et al. "Using carbon nanotube cantilevers in 
scanning probe metrology" Metrology, Inspection, and Process Control for  
MicrolithographyXvi, Pts 1 &2 2002,4689, 53-57.
[19] Roy, S., Vedala, H., Choi, W. "Vertically aligned carbon nanotube probes for 
monitoring blood cholesterol" Nanotechnology 2006,17, S14-S18.
[20] Star, A., Joshi, V., Skarupo, S., et al. "Gas sensor array based on metal- 
decorated carbon nanotubes" Journal o f Physical Chemistry B 2006,110, 21014- 
21020.
[21] Sethuraman, A., Stroscio, M., Dutta, M., in Biological nanostructures and 
applications o f nanostructures in biology, (Eds; Stroscio, M., Dutta, M.), 
Kluwer Academic Publishers, New York 2004, 51-68.
[22] Bianco, A., Kostarelos, K., Partidos, C. D., et al. "Biomedieal applications of 
functionalised carbon nanotubes" Chemical Communications 2005, 571-577.
[23] Yang, W. R., Thordarson, P., Gooding, J. J., et al. "Carbon nanotubes for 
biological and biomedical applications" Nanotechnology 2007,18, 412001.
[24] Harrison, B. S., Atala, A. "Carbon nanotube applications for tissue engineering" 
Biomaterials 2007,28, 344-353.
[25] Ebbesen, T. W., Ajayan, P. M. "Large-scale synthesis of carbon nanotubes" 
Nature 1992, 358, 220-222.
[26] Mann, D., in Carbon nanotubes: Properties and applications, (Ed: O'Connell, 
M. J.), CRC Press, Boca Raton 2006, 20-49.
123
Bibliography
[27] Shanov, V., Yun, Y. H. "Synthesis and characterization of carbon nanotube 
materials" Journal o f the University o f Chemical Technology and Metallurgy 
2006,41, 377-390.
[28] Sato, Y., Yanagi, K., Miyata, Y., et al. "Chiral-angle distribution for separated 
single-walled carbon nanotubes" Nano Letters 2008, 8, 3151-3154.
[29] Itkis, M. E., Perea, D. E., Jung, R., et al. "Comparison of analytical techniques 
for purity evaluation of single-walled carbon nanotubes" Journal o f the 
American Chemical Society 2005,127, 3439-3448.
[30] Chiang, I. W., Brinson, B. E., Smalley, R. E., et al. "Purification and 
characterization of single-wall carbon nanotubes" Journal o f Physical Chemistry 
B 2001,105, 1157-1161.
[31] Kataura, H., Kumazawa, Y., Maniwa, Y., et al. "Optical properties of single-wall 
carbon nanotubes" Synthetic Metals 1999,103, 2555-2558.
[32] Itkis, M. E., Perea, D. E., Niyogi, S., et al. "Purity evaluation of as-prepared 
single-walled carbon nanotube soot by use of solution-phase near-IR 
spectroscopy" Nano Letters 2003, 3, 309-314.
[33] Monthioux, M., Smith, B. W., Burteaux, B., et al. "Sensitivity of single-wall 
carbon nanotubes to chemical processing: an electron microscopy investigation" 
Carbon 2001, 39, 1251-1272.
[34] Jorio, A., Pimenta, M. A., Souza, A. G., et al. "Characterizing carbon nanotube 
samples with resonance Raman scattering" New Journal o f Physics 2003, 5, 1- 
17.
[35] Eklund, P. C., Holden, J. M., Jishi, R. A. "Vibrational-modes of carbon 
nanotubes - spectroscopy and theory" Carbon 1995, 33, 959-972.
[36] Dillon, A. C., Yudasaka, M., Dresselhaus, M. S. "Employing Raman 
spectroscopy to qualitatively evaluate the purity of carbon single-wall nanotube 
materials" J  Nanosci Nanotechnol 2004, 4, 691-703.
[37] Pang, L. S. K., Saxby, J. D., Chatfield, S. P. "Thermogravimetric analysis of 
carbon nanotubes and nanoparticles" Journal o f Physical Chemistry 1993, 97, 
6941-6942.
[38] Hou, P. X., Liu, C., Cheng, H. M. "Purification of carbon nanotubes" Carbon 
2008, 46, 2003-2025.
[39] Ebbesen, T. W., Ajayan, P. M., Hiura, H., et al. "Purification of nanotubes" 
Nature 1994, 367, 519-519.
124
Bibliography
[40] Rinzler, A. G., Liu, J., Dai, H., et al. "Large-scale purification of single-wall 
carbon nanotubes; process, product, and characterization" Applied Physics a- 
Materials Science & Processing 1998, 67, 29-37.
[41] Tobias, G., Shao, L. D., Salzmann, C. G., et al. "Purification and opening of 
carbon nanotubes using steam" Journal o f Physical Chemistry B 2006, 110, 
22318-22322.
[42] Shelimov, K. B., Esenaliev, R. O., Rinzler, A. G., et al. "Purification of single­
wall carbon nanotubes by ultrasonically assisted filtration" Chemical Physics 
Letters 1998, 282, 429-434.
[43] Harutyunyan, A. R., Pradhan, B. K., Chang, J. P., et al. "Purification of single­
wall carbon nanotubes by selective microwave heating of catalyst particles" 
Journal o f Physical Chemistry B 2002,106, 8671-8675.
[44] Zhang, J., Zou, H. L., Qing, Q., et al. "Effect of chemical oxidation on the 
structure of single-walled carbon nanotubes" Journal o f Physical Chemistry B 
2003, 707,3712-3718.
[45] Hu, H., Zhao, B., Itkis, M. E., et al. "Nitrie acid purification of single-walled 
carbon nanotubes" Journal o f Physical Chemistry B 2003,107, 13838-13842.
[46] Shao, L., Tobias, G., Salzmann, C. G., et al. "Removal of amorphous carbon for 
the efficient sidewall functionalisation of single-walled carbon nanotubes" 
Chemical Communications 2007, 5090-5092.
[47] Nagasawa, S., Yudasaka, M., Hirahara, K., et al. "Effect of oxidation on single­
wall carbon nanotubes" Chemical Physics Letters 2000, 328, 374-380.
[48] Rosea, I. D., Watari, P., Uo, M., et al. "Oxidation of multiwalled carbon 
nanotubes by nitric acid" Carbon 2005, 43, 3124-3131.
[49] Vivekchand, S. R. C., Jayakanth, R., Govindaraj, A., et al. "The problem of 
purifying single-walled carbon nanotubes" Small 2005, 7, 920-923.
[50] Geng, H. Z., Zhang, X. B., Mao, S. H., et al. "Opening and closing of single-wall 
carbon nanotubes" Chemical Physics Letters 2004, 399, 109-113.
[51] Jeynes, J. C. G., Mendoza, E., Chow, D. C. S., et al. "Generation of chemically 
unmodified pure single-walled carbon nanotubes by solubilizing with RNA and 
treatment with libonuclease A" Advanced Materials 2006,18, 1598-1602.
[52] Liu, Z., Davis, C., Cai, W. B., et al. "Circulation and long-term fate of 
functionalized, biocompatible single-walled carbon nanotubes in mice probed by 
Raman spectroscopy" Proceedings o f the National Academy o f Sciences o f the 
United States o f America 2008,105, 1410-1415.
125
Bibliography
[53] Islam, M. P., Rojas, E., Bergey, D. M., et al. "High weight fraction surfactant 
solubilization of single-wall carbon nanotubes in water" Nano Letters 2003, 3, 
269-273.
[54] Simmons, T. J., Bult, J., Hashim, D. P., et al. "Noncovalent functionalization as 
an alternative to oxidative acid treatment of single wall carbon nanotubes with 
applications for polymer composites" Acs Nano 2009, 3, 865-870.
[55] Zorbas, V., Ortiz-Acevedo, A., Dalton, A. B., et al. "Preparation and 
characterization of individual peptide-wrapped single-walled carbon nanotubes" 
Journal o f the American Chemical Society 2004,126, 7222-7227.
[56] Lin, Y., Allard, L. P., Sun, Y. P. "Protein-affinity of single-walled carbon 
nanotubes in water" Journal o f Physical Chemistry B 2004,108, 3760-3764.
[57] Wenseleers, W., Vlasov, I. L, Goovaerts, E., et al. "Efficient isolation and 
solubilization of pristine single-walled nanotubes in bile salt micelles" Advanced 
Functional Materials 2004,14, 1105-1112.
[58] O'Connell, M. J., Boul, P., Ericson, L. M., et al. "Reversible water-solubilization 
of single-walled carbon nanotubes by polymer wrapping" Chemical Physics 
Letters 2001, 342, 265-271.
[59] Prencipe, G., Tabakman, S. M., Welsher, K., et al. "PEG-branched polymer for 
functionalization of nanomaterials with ultralong blood circulation" Journal o f 
the American Chemical Society 2009,131, 4783-4787.
[60] Zheng, M., Jagota, A., Semke, E. D., et al. "DNA-assisted dispersion and 
separation of carbon nanotubes" Nature Materials 2003,2, 338-342.
[61] Nakashima, N., Okuzono, S., Murakami, H., et al. "DNA dissolves single-walled 
carbon nanotubes in water" Chemistry Letters 2003, 32, 456-457.
[62] Bahr, J. L., Tour, J. M. "Covalent chemistry of single-wall carbon nanotubes" 
Journal o f Materials Chemistry 2002,12, 1952-1958.
[63] Hirsch, A. "Punctionalization of single-walled carbon nanotubes" Angewandte 
Chemie-International Edition 2002,41, 1853-1859.
[64] Liu, J., Rinzler, A. G., Dai, H. J., et al. "Pullerene pipes" Science 1998, 280, 
1253-1256.
[65] Mickelson, E. T., Huffman, C. B., Rinzler, A. G., et al. "Pluorination of single­
wall carbon nanotubes" Chemical Physics Letters 1998, 296, 188-194.
126
Bibliography
[66] Georgakilas, V., Tagmatarchis, N., Pantarotto, D., et al. "Amino acid 
functionalisation of water soluble carbon nanotubes" Chemical Communications 
2002, 3050-3051.
[67] Zhang, Y., Shi, Z., Gu, Z., et al. "Structure modification of single-wall carbon 
nanotubes" Carbon 2000, 38, 2055-2059.
[68] Li, Y., Zhang, X. B., Luo, J. H., et al. "Purification of CVD synthesized single­
wall carbon nanotubes by different acid oxidation treatments" Nanotechnology 
2004,15, 1645-1649.
[69] Staros, J. V., Wright, R. W., Swingle, D. M. "Enhancement by N- 
hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling 
reactions" Analytical Biochemistry 1986,156, 220-222.
[70] Huang, W. J., Taylor, S., Fu, K. P., et al. "Attaching proteins to carbon 
nanotubes via diimide-activated amidation" Nano Letters 2002, 2, 311-314.
[71] Gromov, A., Dittmer, S., Svensson, J., et al. "Covalent amino-functionalisation 
of single-wall carbon nanotubes" Journal o f Materials Chemistry 2005, 15, 
3334-3339.
[72] D'Este, M., De Nardi, M., Menna, E. "A co-functionalization approach to 
soluble and funetional single-walled carbon nanotubes" European Journal o f 
Organic Chemistry 2006, 2517-2522.
[73] Tasis, D., Tagmatarchis, N., Bianco, A., et al. "Chemistry of carbon nanotubes" 
Chemical Reviews 2006,106, 1105-1136.
[74] Georgakilas, V., Kordatos, K., Prato, M., et al. "Organic functionalization of 
carbon nanotubes" Journal o f the American Chemical Society 2002, 124, 760- 
761.
[75] Prato, M., Kostarelos, K., Bianco, A. "Functionalized carbon nanotubes in drug 
design and discovery" Accounts o f Chemical Research 2008, 41, 60-68.
[76] Pastorin, G., Wu, W., Wieckowski, S., et al. "Double functionalisation of carbon 
nanotubes for multimodal drug delivery" Chemical Communications 2006, 
1182-1184.
[77] Kam, N. W. S., Liu, Z., Dai, H. J. "Punctionalization of carbon nanotubes via 
cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent 
gene silencing" Journal o f the American Chemical Society 2005, 127, 12492- 
12493.
[78] Chaudhuri, P., Soni, S., Sengupta, S. "Single-walled carbon nanotube- 
conjugated chemotherapy exhibits increased therapeutic index in melanoma" 
Nanotechnology 2010,21, 025102.
127
Bibliography
[79] Samori, C., Ali-Boucetta, H., Sainz, R., et al. "Enhanced anticancer activity of 
multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers" 
Chemical Communications 2010,46, 1494-1496.
[80] Gotovac, S., Yang, C. M., Hattori, Y., et al. "Adsorption of polyaromatic 
hydrocarbons on single wall carbon nanotubes of different functionalities and 
diameters" Journal o f Colloid and Interface Science 2007, 314, 18-24.
[81] Sheng, G. D., Shao, D. D., Ren, X. M., et al. "Kinetics and thermodynamics of 
adsorption of ionizable aromatic compounds from aqueous solutions by as- 
prepared and oxidized multi walled carbon nanotubes" Journal o f Hazardous 
Materials 2010,178,505-516.
[82] Yang, X. Y., Zhang, X. Y., Liu, Z. P., et al. "High-efficiency loading and 
controlled release of doxorubicin hydrochloride on graphene oxide" Journal o f 
Physical Chemistry C 2008,112, 17554-17558.
[83] Liu, Z., Sun, X. M., Nakayama-Ratchford, N., et al. "Supramolecular chemistry 
on water-soluble carbon nanotubes for drug loading and delivery" Acs Nano
2007,1, 50-56.
[84] Yudasaka, M., Ajima, K., Suenaga, K., et al. "Nano-extraction and nano­
condensation for C-60 incorporation into single-wall carbon nanotubes in liquid 
phases" Chemical Physics Letters 2003, 380,42-46.
[85] Leonhardt, A., Hampel, S., Muller, C., et al. "Synthesis, properties, and 
applications of ferromagnetic-filled carbon nanotubes" Chemical Vapor 
Deposition 2006,12, 380-387.
[86] Gao, H. J., Kong, Y., Cui, D. X., et al. "Spontaneous insertion of DNA 
oligonucleotides into carbon nanotubes" Nano Letters 2003, 3, 471-473.
[87] Kim, B. M., Qian, S., Ban, H. H. "Pilling carbon nanotubes with particles" Nano 
Letters 2005, 5, 873-878.
[88] Hilder, T. A., Hill, J. M. "Carbon nanotubes as drug delivery nanocapsules" 
Current Applied Physics 2008, 8, 258-261.
[89] Hilder, T. A., Hill, J. M. "Probability of encapsulation of paclitaxel and 
doxorubicin into carbon nanotubes" Micro & Nano Letters 2008, 3, 41-49.
[90] Hampel, S., Kunze, D., Haase, D., et al. "Carbon nanotubes filled with a 
chemotherapeutic agent; a nanoearrier mediates inhibition of tumor cell growth" 
Nanomed 2008, 3, 175-182.
[91] Tripisciano, C., Costa, S., Kalenczuk, R. J., et al. "Cisplatin filled multiwalled 
carbon nanotubes - a novel molecular hybrid of anticancer drug container" 
European Physical Journal B 2010, 75, 141-146.
128
Bibliography
[92] Pantarotto, D., Briand, J. P., Prato, M., et al. "Translocation of bioactive peptides 
across cell membranes by carbon nanotubes" Chemical Communications 2004, 
16-17.
[93] Kam, N. W. S., Dai, H. J. "Carbon nanotubes as intracellular protein 
transporters: Generality and biological functionality" Journal o f the American 
Chemical Society 2005,127, 6021-6026.
[94] Gao, L. Z., Nie, L., Wang, T. H., et al. "Carbon nanotube delivery of the GFP 
gene into mammalian cells" ChemBioChem 2006, 7, 239-242.
[95] Panhuis, M. I. H. "Vaccine delivery by carbon nanotubes" Chemistry & Biology 
2003,10, 897-898.
[96] Liu, Z., Chen, K., Davis, C., et al. "Drug delivery with carbon nanotubes for in 
vivo cancer treatment" Cancer Research 2008, 68, 6652-6660.
[97] Kam, N. W. S., Jessop, T. C., Wender, P. A., et al. "Nanotube molecular 
transporters: Internalization of carbon nanotube-protein conjugates into 
mammalian cells" Journal o f the American Chemical Society 2004, 126, 6850- 
6851.
[98] Nakayama-Ratchford, N., Bangsaruntip, S., Sun, X. M., et al. "Noncovalent 
functionalization of carbon nanotubes by fluorescein-polyethylene glycol: 
Supramolecular conjugates with pH-dependent absorbance and fluorescence" 
Journal o f the American Chemical Society 2007,129, 2448-4-.
[99] Kam, N. W. S., O'Connell, M., Wisdom, J. A., et al. "Carbon nanotubes as 
multifunctional biological transporters and near-infrared agents for selective 
cancer cell destruction" Proceedings o f the National Academy o f Sciences o f the 
United States o f America 2005,102, 11600-11605.
[100] Lacerda, L., Pastorin, G., Gathercole, D., et al. "Intracellular trafficking of 
carbon nanotubes by confocal laser scanning microscopy" Advanced Materials 
2007,19, 1480-1484.
[101] Welsher, K., Liu, Z., Daranciang, D., et al. "Selective probing and imaging of 
cells with single walled carbon nanotubes as near-infrared fluorescent 
molecules" Nano Letters 2008, 8, 586-590.
[102] Heller, D. A., Balk, S., Eurell, T. E., et al. "Single-walled carbon nanotube 
spectroscopy in live cells: Towards long-term labels and optical sensors" 
Advanced Materials 2005,17, 2793-2399.
[103] Mu, Q. X., Broughton, D. L., Yan, B. "Endosomal leakage and nuclear 
translocation of multiwalled carbon nanotubes: developing a model for cell 
uptake" Nano Letters 2009, 9,4370-4375.
129
Bibliography
[104] Poland, C. A., Duffin, R., Kinloch, I., et al. "Carbon nanotubes introduced into 
the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study" 
Nature Nanotechnology 2008, 3, 423-428.
[105] Kostarelos, K. "The long and short of carbon nanotube toxicity" Nature 
Biotechnology 2008, 26, 774-776.
[106] Donaldson, K., Tran, C. L. "An introduction to the short-term toxicology of 
respirable industrial fibres" Mutation Research-Fundamental and Molecular 
Mechanisms o f Mutagenesis 2004, 553, 5-9.
[107] Shvedova, A. A., Kisin, E., Murray, A. R., et al. "Inhalation vs. aspiration of 
single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, 
oxidative stress, and mutagenesis" American Journal o f Physiology-Lung 
Cellular and Molecular Physiology 2008, 295, L552-L565.
[108] Mutlu, G. M., Budinger, G. R. S., Green, A. A., et al. "Biocompatible nanoscale 
dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary 
toxicity" Nano Letters 2010,10, 1664-1670.
[109] Kagan, V. E., Bayir, H., Shvedova, A. A. "Nanomedicine and nanotoxicology: 
two sides of the same coin" Nanomedicine 2005,1, 313-316.
[110] Foldvari, M., Bagonluri, M. "Carbon nanotubes as functional excipients for 
nanomedicines: II. Drug delivery and biocompatibility issues" Nanomedicine 
2008, 4, 183-200.
[111] Flahaut, E., Durrieu, M. C., Remy-Zolghadri, M., et al. "Investigation of the 
cytotoxieity of CCVD carbon nanotubes towards human umbilical vein 
endothelial cells" Carbon 2006,44, 1093-1099.
[112] Isobe, H., Tanaka, T., Maeda, R., et al. "Preparation, purification, 
characterization, and cytotoxicity assessment of water-soluble, transition-metal- 
free carbon nanotube aggregates" Angewandte Chemie-lnternational Edition 
2006,45, 6676-6680.
[113] Manna, S. K., Sarkar, S., Barr, J., et al. "Single-walled carbon nanotube induces 
oxidative stress and activates nuclear transcription factor-kappa B in human 
kératinocytes" Nano Letters 2005, 5, 1676-1684.
[114] De Nicola, M., Gattia, D. M., Bellucci, S., et al. "Effeet of different carbon 
nanotubes on cell viability and proliferation" Journal o f Physics-Condensed 
Matter 2001,19, 1-7.
[115] Brown, D. M., Kinloch, I. A., Bangert, U., et al. "An in vitro study of the 
potential of carbon nanotubes and nanofibres to induce inflammatory mediators 
and frustrated phagocytosis" Carbon 2007, 45, 1743-1756.
130
Bibliography
[116] Tian, F. R., Cui, D. X., Schwarz, H., et al. "Cytotoxicity of single-wall carbon 
nanotubes on human fibroblasts" Toxicology In Vitro 2006, 20, 1202-1212.
[117] Yang, Z., Zhang, Y. G., Yang, Y. L. A., et al. "Pharmacological and 
toxicological target organelles and safe use of single-walled carbon nanotubes as 
drug carriers in treating Alzheimer disease" Nanomedicine-Nanotechnology 
Biology and Medicine 2010, 6, 427-441.
[118] Wick, P., Manser, P., Limbach, L. K., et al. "The degree and kind of 
agglomeration affect carbon nanotube cytotoxicity" Toxicology Letters 2007, 
168, 121-131.
[119] Sayes, C. M., Liang, F., Hudson, J. L., et al. "Functionalization density 
dependence of single-walled carbon nanotubes cytotoxicity in vitro" Toxicology 
Letters 2006,161, 135-142.
[120] Dumortier, H., Lacotte, S., Pastorin, G., et al. "Functionalized carbon nanotubes 
are non-cytotoxic and preserve the functionality of primary immune cells" Nano 
Letters 2006, 6, 1522-1528.
[121] Kagan, V. E., Konduru, N. V., Feng, W. H., et al. "Carbon nanotubes degraded 
by neutrophil myeloperoxidase induce less pulmonary inflammation" Nature 
Nanotechnology 2010, 5, 354-359.
[122] Liu, X., Hurt, R. H., Kane, A. B. "Biodurability of single-walled carbon 
nanotubes depends on surface functionalization" Carbon N  Y, 48, 1961-1969.
[123] Meng, J., Song, L., Xu, H., et al. "Effects of single-walled carbon nanotubes on 
the functions of plasma proteins and potentials in vascular prostheses" 
Nanomedicine: Nanotechnology, Biology and Medicine 2005,1, 136-142.
[124] Salvador-Morales, C., Flahaut, E., Sim, E., et al. "Complement aetivation and 
protein adsorption by carbon nanotubes" Molecular Immunology 2006, 43, 193- 
201.
[125] Schipper, M. L., Nakayama-Ratchford, N., Davis, C. R., et al. "A pilot 
toxicology study of single-walled carbon nanotubes in a small sample of mice" 
Nature Nanotechnology 2008, 3, 216-221.
[126] Yang, S. T., Wang, X., Jia, G., et al. "Long-term accumulation and low toxicity 
of single-walled carbon nanotubes in intravenously exposed mice" Toxicology 
Letters 2008,181, 182-189.
[127] Leeuw, T. K., Reith, R. M., Simonette, R. A., et al. "Single-walled carbon 
nanotubes in the intact organism: near IR-imaging and biocompatibility studies 
in drosophila" Nano Letters 2007, 7, 2650-2654.
131
Bibliography
[128] Mouchet, F., Landois, P., Sarremejean, E., et al. "Characterisation and in vivo 
ecotoxicity evaluation of double-wall carbon nanotubes in larvae of the 
amphibian Xenopus laevis" Aquatic Toxicology 2008, 87, 127-137.
[129] Smith, C. J., Shaw, B. J., Handy, R. D. "Toxicity of single walled carbon 
nanotubes to rainbow trout (oncorhynchus mykiss): Respiratory toxicity, organ 
pathologies, and other physiological effects" Aquatic Toxicology 2007, 82, 94- 
109.
[130] Cheng, J. P., Rahaut, E., Cheng, S. H. "Effect of carbon nanotubes on 
developing zebrafish (Danio rerio) embryos" Environmental Toxicology and 
Chemistry 2007, 26, 708-716.
[131] Worle-Knirsch, J. M., Pulskamp, K., Krug, H. F. "Oops they did it again! 
Carbon nanotubes hoax scientists in viability assays" Nano Letters 2006, 6, 
1261-1268.
[132] Jemal, A., Siegel, R., Ward, E., et al. "Cancer statistics 2009" CA: A Cancer 
Journal for Clinicians 2009, 59, 225-249.
[133] http://www.cancereouncil.com.au/editorial.asp?pageid=2169
[134] Kuper, H., Adami, H. O., Boffetta, P. "Tobacco use, cancer causation and public 
health impact" Journal o f Internal Medicine 2002, 251,455-466.
[135] Bourdes, V., Boffetta, P., Pisani, P. "Environmental exposure to asbestos and 
risk of pleural mesothelioma: review and meta-analysis - Environmental 
exposure to asbestos and mesothelioma" European Journal o f Epidemiology 
2000, 76,411-417.
[136] Rigel, D. S. "Cutaneous ultraviolet exposure and its relationship to the 
development of skin cancer" Journal o f the American Academy o f Dermatology 
2008,58, S129-132.
[137] zur Hausen, H. "Viruses in human cancers" Science 1991, 254, 1167-1173.
[138] Frank, T. S. "Hereditary cancer syndromes" Archives o f Pathology and 
Laboratory Medicine 2001, 725, 85-90.
[139] Coley, H., MRC Clinical Oncology and Radiotherapeutics Unit, University of 
Cambridge, 1989.
[140] "Targeted cancer therapies" National Cancer Institute Fact Sheet 7.49 2009.
[141] Hait, W. N. "Targeted cancer therapeutics" Cancer Research 2009, 69, 1263- 
1267.
132
Bibliography
[142] McCarron, P. A., Olwill, S. A., Marouf, W. M. Y., et al. "Antibody conjugates 
and therapeutic strategies" Molecular Interventions 2005, 5, 368-380.
[143] Gold, P., Goldenberg, N. A. "The carcinoembryonic antigen (CEA): past, 
present, and future" McGill Journal o f Medicine 1997, 3, 46-66.
[144] Goldenberg, D. M., Neville, A. M., Carter, A. C., et al. "CEA 
(Carcinoembryonic-Antigen) - Its role as a marker in the management of cancer" 
Journal o f Cancer Research and Clinical Oncology 1981,101, 239-242.
[145] Byrne, J. D., Betancourt, T., Brannon-Peppas, L. "Active targeting schemes for 
nanoparticle systems in cancer therapeutics" Advanced Drug Delivery Reviews 
2008, 60, 1615-1626.
[146] Kirpotin, D. B., Drummond, D. C., Shao, Y., et al. "Antibody targeting of long- 
circulating lipidic nanoparticles does not increase tumor localization but does 
increase internalization in animal models" Cancer Research 2006, 66, 6732- 
6740.
[147] Lee, L. S., Conover, C., Shi, C., et al. "Prolonged circulating lives of single­
chain Fv proteins conjugated with polyethylene glycol: A comparison of 
conjugation chemistries and compounds" Bioconjugate Chemistry 1999, 10, 
973-981.
[148] Farokhzad, O. C., Cheng, J. J., Teply, B. A., et al. "Targeted nanoparticle- 
aptamer bioconjugates for cancer chemotherapy in vivo" Proceedings o f the 
National Academy o f Sciences o f the United States o f America 2006, 103, 6315- 
6320.
[149] Proske, D., Blank, M., Buhmann, R., et al. "Aptamers - basic research, drug 
development, and clinical applications" Applied Microbiology and 
Biotechnology 2005, 69, 367-374.
[150] Rusconi, C. P., Roberts, J. D., Pitoc, G. A., et al. "Antidote-mediated control of 
an anticoagulant aptamer in vivo" Nature Biotechnology 2004, 22, 1423-1428.
[151] Burmeister, P. E., Lewis, S. D., Silva, R. F., et al. "Direct in vitro selection of a 2 
'-O-methyl aptamer to VEGF" Chemistry & Biology 2005,12, 25-33.
[152] Ruoslahti, E. "Specialization of tumour vasculature" Nature Reviews Cancer
2002,2, 83-90.
[153] Sudimack, J., Lee, R. J. "Targeted drug delivery via the folate receptor" 
Advanced Drug Delivery Reviews 2000, 41, 147-162.
[154] Zhao, X., Li, H., Lee, R. J. "Targeted drug delivery via folate receptors" Expert 
Opin Drug Deliv 2008, 5, 309-319.
133
Bibliography
[155] Lu, Y., Sega, E., Leamon, C. P., et al. "Folate receptor-targeted immunotherapy 
of cancer: mechanism and therapeutic potential" Adv Drug Deliv Rev 2004, 56, 
1161-1176.
[156] Russell-Jones, G., McTavish, K., McEwan, J., et al. "Vitamin-mediated targeting 
as a potential mechanism to increase drug uptake by tumours" Journal o f 
Inorganic Biochemistry 2^^^, 98, 1625-1633.
[157] Shmeeda, H., Mak, L., Tzemach, D., et al. "Intracellular uptake and intracavitary 
targeting of folate-conjugated liposomes in a mouse lymphoma model with up- 
regulated folate receptors" Molecular Cancer Therapeutics 2006, 5, 818-824.
[158] Wu, J., Liu, Q., Lee, R. J. "A folate receptor-targeted liposomal formulation for 
paclitaxel" International Journal o f Pharmaceutics 2006, 316, 148-153.
[159] Wu, A. M., Senter, P. D. "Arming antibodies: prospects and challenges for 
immunoconjugates" Nature Biotechnology 2005, 23, 1137-1146.
[160] Niculescu-Duvaz, L, Springer, C. J. "Antibody-directed enzyme prodrug therapy 
(ADEPT): A review" Advanced Drug Delivery Reviews 1997, 26, 151-172.
[161] Ferrari, M. "Cancer nanotechnology: Opportunities and challenges" Nature 
Reviews Cancer 2005, 5, 161-171.
[162] Iyer, A. K., Khaled, G., Fang, J., et al. "Exploiting the enhanced permeability 
and retention effect for tumor targeting" Drug Discovery Today 2006, I I ,  812- 
818.
[163] Gottlieb, J. J., Washenik, K., Chachoua, A., et al. "Treatment of classic Kaposi's 
sarcoma with liposomal encapsulated doxorubicin" Lancet 1997, 350, 1363- 
1364.
[164] Tannock, I. F., Rotin, D. "Acid pH in tumors and its potential for therapeutic 
exploitation" Cancer Research 1989, 49, 4373-4384.
[165] Wu, W., Wieckowski, S., Pastorin, G., et al. "Targeted delivery of amphotericin 
B to cells by using functionalized carbon nanotubes" Angewandte Chemie- 
International Edition 2005, 44, 6358-6362.
[166] Ali-Boucetta, H., Al-Jamal, K. T., McCarthy, D., et al. "Multiwalled carbon 
nanotube-doxorubicin supramolecular complexes for cancer therapeutics" 
Chemical Communications 2008, 459-461.
[167] Feazell, R. P., Nakayama-Ratchford, N., Dai, H., et al. "Soluble single-walled 
carbon nanotubes as longboat delivery systems for Platinum(IV) anticancer drug 
design" Journal o f the American Chemical Society 2007,129, 8438-8439.
134
Bibliography
[168] Chen, J., Chen, S., Zhao, X., et al. "Functionalized single-walled carbon 
nanotubes as rationally designed vehicles for tumor-targeted drug delivery" 
Journal o f the American Chemical Society 2008,130, 16778-16785.
[169] Dhar, S., Liu, Z., Thomale, J., et al. "Targeted single-wall carbon nanotube- 
mediated Pt(IV) prodrug delivery using folate as a homing device" Journal o f 
the American Chemical Society 2008,130, 11467-11476.
[170] Heister, E., Neves, V., Tîlmaciu, C., et al. "Triple functionalisation of single­
walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a 
fluorescent marker for targeted cancer therapy" Carbon 2009, 47, 2152-2160.
[171] Ou, Z. M., Wu, B. Y., Xing, D., et al. "Functional single-walled carbon 
nanotubes based on an integrin alpha(v)beta(3) monoclonal antibody for highly 
efficient cancer cell targeting" Nanotechnology 2009, 20, 105102.
[172] Zhang, X. K., Meng, L. J., Lu, Q. G., et al. "Targeted delivery and controlled 
release of doxorubicin to cancer cells using modified single wall carbon 
nanotubes" Biomaterials 2009, 30, 6041-6047.
[173] Lay, C. L., Liu, H. Q., Tan, H. R., et al. "Delivery of paclitaxel by physically 
loading onto poly(ethyleneglycol) (PEG)-graft carbon nanotubes for potent 
cancer therapeutics" Nanotechnology 2010, 21, 065101.
[174] Li, R. B., Wu, R., Zhao, L., et al. "P-glycoprotein antibody functionalized 
carbon nanotube overcomes the multidrug resistance of human leukemia cells" 
Acs Nano 2010, 4, 1399-1408.
[175] McDevitt, M. R., Chattopadhyay, D., Kappel, B. J., et al. "Tumor targeting with 
antibody-functionalized, radiolabeled carbon nanotubes" Journal o f Nuclear 
Medicine 2007, 48, 1180-1189.
[176] Bhirde, A. A., Patel, V., Gavard, J., et al. "Targeted killing of cancer cells in 
vivo and in vitro with EGF-directed carbon nanotube-based drug delivery" Acs 
VOMO 2009, j , 307-316.
[177] Wu, W., Li, R. T., Bian, X. C., et al. "Covalently combining carbon nanotubes 
with anticancer agent: preparation and antitumor activity" Acs Nano 2009, 3, 
2740-2750.
[178] Liu, Z., Fan, A. C., Rakhra, K., et al. "Supramolecular stacking of doxorubicin 
on carbon nanotubes for in vivo cancer therapy" Angewandte Chemie. 
International Ed. In English 2009, 48, 7668-7672.
[179] Chaudhuri, P., Harfouche, R., Soni, S., et al. "Shape effect of carbon 
nanovectors on angiogenesis" Acs Nano 2010, 4, 574-582.
135
Bibliography
[180] Chaudhuri, P., Paraskar, A., Soni, S., et al. "Fullerenol-cytotoxic conjugates for 
cancer chemotherapy" Acs Nano 2009, 3, 2505-2514.
[181] Lacerda, L., Soundararajan, A., Singh, R., et al. "Dynamic imaging of 
functionalized multi-walled carbon nanotube systemic circulation and urinary 
excretion" Advanced Materials 2008,20, 225-230.
[182] Ruggiero, A., Villa, C. H., Bander, E., et al. "Paradoxical glomerular filtration of 
carbon nanotubes" Proceedings o f the National Academy o f Sciences o f the 
United States o f America, 107, 12369-12374.
[183] Dresselhaus, M. S., Dresselhaus, G., Saito, R., et al. "Raman spectroscopy of 
carbon nanotubes" Physics Reports-Review Section o f Physics Letters 2005, 409, 
47-99.
[184] Dillon, A. C., Gennett, T., Jones, K. M., et al. "A simple and complete 
purification of single-walled carbon nanotube materials" Advanced Materials 
1999,1 1 ,1354-1358.
[185] Costa, S., Borowiak-Palen, E., Kruszynska, M., et al. "Characterization of 
carbon nanotubes by Raman spectroscopy" Materials Science-Poland 2008, 26, 
433-441.
[186] Dresselhaus, M. S., Dresselhaus, G., Hofmann, M. "The big picture of Raman 
scattering in carbon nanotubes" Vibrational Spectroscopy 2007,45, 71-81.
[187] Derjaguin, B. V., Landau, L. D. "Theory of the stability of strongly charged 
lyophobic sols and of the adhesion of strongly charged particles in solutions of 
electrolytes" Acta Physicochim URSS 1941,14, 733-762.
[188] Verwey, E. J. W. "Theory of the stability of lyophobic colloids" Journal o f 
Physical Chemistry 1948, 51, 631-636.
[189] Cherkasova, A. S., Shan, J. W. "Impact of altering aspect ratio of the loading 
particles on a suspension's thermal conductivity" Proceedings o f IMECE 2008: 
Heat Transfer, Fluid Flows, and Thermal Systems 2009,10, 1979-1989.
[190] Grabarek, Z., Gergely, J. "Zero-Length Crosslinking Procedure with the Use of 
Active Esters" Analytical Biochemistry 1990,185, 131-135.
[191] Mosmann, T. "Rapid colorimetric assay for cellular growth and survival - 
Application to proliferation and cytotoxicity assays" Journal o f Immunological 
Methods 1983, 65, 55-63.
[192] Ford, C. H. J., Tsaltas, G. C., Osborne, P. A., et al. "Novel flow cytometric 
analysis of the progress and route of internalization of a monoclonal anti- 
carcinoembryonic antigen (CEA) antibody" Cytometry 1996, 23, 228-240.
136
Bibliography
[193] Saito, R., Kataura, H. "Optical properties and Raman spectroscopy of carbon 
nanotubes" Carbon Nanotubes 2001, 80, 213-246.
[194] Bachilo, S. M., Strano, M. S., Kittrell, C., et al. "Structure-assigned optical 
spectra of single-walled carbon nanotubes" Science 2002, 298, 2361-2366.
[195] Worsley, K. A., Kalinina, I., Bekyarova, E., et al. "Functionalization and 
dissolution of nitric acid treated single-walled carbon nanotubes" Journal o f the 
American Chemical Society 2009,131, 18153-18158.
[196] Fumera, M. "Carbon nanotubes contain residual metal catalyst nanoparticles 
even after washing with nitric acid at elevated temperature because these metal 
nanoparticles are sheathed by several graphene sheets" Langmuir 2007, 23, 
6453-6458.
[197] Cech, J., Curran, S. A., Zhang, D., et al. "Functionalization of multi-walled 
carbon nanotubes: Direct proof of sidewall thiolation" Physica Status Solidi B 
2006,243, 3221-3225.
[198] Azamian, B. R., Coleman, K. S., Davis, J. J., et al. "Directly observed covalent 
coupling of quantum dots to single-wall carbon nanotubes" Chem Commun 
(Camb) 2002, 366-367.
[199] Wright, A. K., Thompson, M. R. "Hydrodynamic structure of bovine serum 
albumin determined by transient electric birefringence" Biophysical Journal 
1975,15, 137-141.
[200] Janssen, M. J. H., Crommelin, D. J. A., Storm, G., et al. "Doxorubicin 
Decomposition on Storage - Effect of Ph, Type of Buffer and Liposome 
Encapsulation" International Journal o f Pharmaceutics 1985, 23, 1-11.
[201] Beijnen, J. H., Vanderhouwen, O. A. G. J., Underberg, W. J. M. "Aspects of the 
degradation kinetics of doxorubicin in aqueous solution" International Journal 
o f Pharmaceutics 1986, 32, 123-131.
[202] Hu, H., Yu, A. P., Kim, E., et al. "Influence of the zeta potential on the 
dispersability and purification of single-walled carbon nanotubes" Journal o f 
Physical Chemistry B 109, 11520-11524.
[203] Wang, Z. W., Shirley, M. D., Meikle, S. T., et al. "The surface acidity of acid 
oxidised multi-walled carbon nanotubes and the influence of in-situ generated 
fulvic acids on their stability in aqueous dispersions" Carbon 2009, 47, 73-79.
[204] Peng, X. J., Jia, J. J., Gong, X. M., et al. "Aqueous stability of oxidized carbon 
nanotubes and the precipitation by salts" Journal o f Hazardous Materials 2009, 
165, 1239-1242.
137
Bibliography
[205] McPhail, M. R., Sells, J. A., He, Z., et al. "Charging nano walls: Adjusting the 
carbon nanotube isoelectric point via surface functionalization" Journal o f 
Physical Chemistry C 2009,113, 14102-14109.
[206] Jiang, J. K., Oberdorster, G., Biswas, P. "Characterization of size, surface 
charge, and agglomeration state of nanoparticle dispersions for toxicological 
studies" Journal o f Nanoparticle Research 2009,11, 77-89.
[207] Becker, M. L., Fagan, J. A., Gallant, N. D., et al. "Length-dependent uptake of 
DNA-wrapped single-walled carbon nanotubes" Advanced Materials 2007, 19, 
939-945.
[208] Cui, D. X., Tian, F. R., Ozkan, C. S., et al. "Effect of single wall carbon 
nanotubes on human HEK293 cells" Toxicology Letters 2005,155, 73-85.
[209] Kaiser, J. P., Wick, P., Manser, P., et al. "Single walled carbon nanotubes 
(SWCNT) affect cell physiology and cell architecture" Journal o f Materials 
Science-Materials in Medicine 2008,19, 1523-1527.
[210] Zeineldin, R., Al-Haik, M., Hudson, L. G. "Role of polyethylene glycol integrity 
in specific receptor targeting of carbon nanotubes to cancer cells" Nano Letters
2009, 9,751-757.
[211] He, Q. J., Zhang, J. M., Shi, J. L., et al. "The effect of PEGylation of 
mesoporous silica nanoparticles on nonspecific binding of serum proteins and 
cellular responses" Biomaterials 2010, 31, 1085-1092.
[212] Wong, J. Y., Kuhl, T. L., Israelachvili, J. N., et al. "Direct measurement of a 
tethered ligand-receptor interaction potential" Science 1997, 275, 820-822.
[213] Kolosnjaj-Tabi, J., Hartman, K. B., Boudjemaa, S., et al. "In vivo behavior of 
large doses of ultrashort and full-length single-walled carbon nanotubes after 
oral and intraperitoneal administration to swiss mice" Acs Nano.
[214] Verdejo, R., Lamoriniere, S., Cottam, B., et al. "Removal of oxidation debris 
from multi-walled carbon nanotubes" Chemical Communications 2007, 513-515.
[215] Wang, D. P., Liang, G. Z., Tu, Y. H. "Stability of mitoxantrone hydrochloride in 
solution" Drug Development and Industrial Pharmacy 1994, 20, 1895-1903.
[216] Cancer Care Nova Scotia, in Systemic Therapy Manual for Cancer Treatment,
2010, 208-210.
[217] Bouma, J., Beijnen, J. H., Bult, A., et al. "Anthracycline antitumor agents - a 
review of physicochemical, analytical and stability properties" Pharmaceutisch 
Weekblad-Scientific Edition 1986, 8, 109-133.
138
Bibliography
[218] Williams, B. A., Tritton, T. R. "Photoinactivation of anthracyclines" 
Photochemistry and Photobiology 1981, 34, 131-134.
[219] Heister, E., Lamprecht, C., Neves, V., et al. "Higher dispersion efficacy of 
functionalized carbon nanotubes in chemical and biological environments" Acs 
Nano 2010, 4, 2615-2626.
[220] Lamprecht, C., Danzberger, J., Lukanov, P., et al. "AFM imaging of 
functionalized double-walled carbon nanotubes" Ultramicroscopy 2009, 109, 
899-906.
[221] Neves, V., Heister, E., Costa, S., et al. "Uptake and release of double-walled 
carbon nanotubes by mammalian cells" Advanced Functional Materials 2010, 
20, 3272-3279.
[222] Sun, X. M., Liu, Z., Welsher, K., et al. "Nano-graphene oxide for cellular 
imaging and drug delivery" Nano Research 2008,1, 203-212.
[223] Green, A. A., Hersam, M. C. "Ultracentrifugation of single-walled nanotubes" 
Materials Today 2007,10, 59-60.
[224] Yanagi, K., litsuka. T., Fujii, S., et al. "Separations of metallic and 
semiconducting carbon nanotubes by using sucrose as a gradient medium" 
Journal o f Physical Chemistry C 2008,112, 18889-18894.
[225] Heller, D. A., Mayrhofer, R. M., Baik, S., et al. "Concomitant length and 
diameter separation of single-walled carbon nanotubes" Journal o f the American 
Chemical Society 2004,126, 14567-14573.
139
Reproduced with permission of copyright owner. Further reproduction prohibited without permission.
